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Abstract
The aim of this study was to gain important insights into the effects of peroxidized 
docosahexaenoic acid (pDHA) on the retinal pigment epithelium (RPE), and whether 
its effects can cause RPE cell dysfunction in a way similar to that observed in retinal 
ageing and the pathogenesis of age-related macular degeneration (AMD).
Initially, the time-course of in vitro peroxidation of DHA was monitored, culminating 
in formation of products able to absorb light above 400 nm. Cultured RPE cells were 
then exposed to this pDHA, which was shown to be toxic, both in dark and light- 
exposed conditions. Various cell viability assays were carried out indicating RPE cell 
death after exposure to pDHA is likely to occur by apoptosis. The effects of pDHA 
were reduced in the presence of various agents -  a-tocopherol, glutathione, N- 
acetylcysteine, and phosphatidylethanolamine (PE).
Measurements of singlet oxygen, transient and superoxide production were carried 
out to determine the photosensitizing properties of pDHA. The ability of PE to reduce 
the production of these species was investigated but it was shown to have no effect on 
their yield, although singlet oxygen lifetime was reduced.
Finally, lysosomal enzyme activity, lysosomal integrity and accumulation of 
fluorescent and undegraded material were monitored after exposure to pDHA, 
demonstrating that pDHA was able to disrupt the ability of the RPE to fully degrade 
phagocytosed material.
In summary, pDHA is able to affect RPE cell viability directly when exposed 
extracellularly, and can also affect essential normal functions of the RPE 
intracellularly. In conjunction with published findings that pDHA is present in the 
retina -  both within and around the RPE -  the data presented here support the theory 
that pDHA can play an important role in causing RPE dysfunction, resulting in a loss 
of the protective role these cells play for photoreceptors, as occurs in retinal ageing 
and AMD.
v
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Chapter 1:
Introduction
1. Introduction
1.1 General introduction
Cells of the neural retina and the retinal pigment epithelium (RPE) interact closely. 
Photoreceptor cells depend on RPE cells for provision of nutrients, synthesis of 
interphotoreceptor matrix, recycling o f retinoids and for certain aspects of 
photoreceptor renewal. Healthy function of the RPE is therefore vital, and dysfunction 
could lead to a downstream alteration of normal photoreceptor cell function, leading 
to visual impairment. One disease state in which this occurs is age-related macular 
degeneration (AMD). This naturally occurring age-dependent condition is thought to 
involve accumulation of intracellular lipofuscin granules in the RPE, which may 
induce (photo-)oxidative damage, which can in turn cause RPE dysfunction. The 
exact mechanism of formation of lipofuscin is not yet fully understood but appears to 
involve a loss of the ability of the RPE cells to properly degrade phagocytosed outer 
segment discs, possibly due to alterations in lysosome physiology, lysosomal 
enzymes, or other physiological properties of RPE cells. Membranes of 
photoreceptors are enriched with docosahexaenoic acid (DHA), a long-chain 
polyunsaturated fatty acid (LC-PUFA). It is thought that DHA may be easily 
peroxidized in the retina due to a variety of factors. This thesis aims to investigate the 
role that this process may play in age-related changes in the RPE, and in the onset of 
RPE dysfunction and AMD.
This introduction will provide a background to the normal structure and function of 
the RPE, with particular focus on its support role for photoreceptor cells, and discuss 
age-related changes that commonly occur. Additionally, the importance of DHA to 
the retina will be discussed, including an introduction to the consequences of 
peroxidation of this LC-PUFA.
1.2 Structure and function of the RPE
The RPE is a monolayer which separates the neural retina from the underlying 
choroidal circulation (see Figure 1.1). RPE cells have two distinct membrane regions, 
separated by tight junctions -  the apical surface, with its distinctive microvilli which 
are in intimate contact with photoreceptor outer segments, and the basal region which 
lies adjacent to Bruch’s membrane. Bruch’s membrane is an acellular layer consisting
2
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of five distinct connective tissue layers. It lies between the RPE and the fenestrated 
choriocapillaris and functions as a highly porous and permeable membrane which 
allows free diffusion of nutrients, water and waste material (Marshall et a l , 1998).
RPE cells are columnar in the foveal region where photoreceptor cells are more dense, 
with a diameter of approximately 12 pm, but more flattened in the periphery of the 
retina, with a 60 pm diameter, where photoreceptor cells are less dense, resulting in 
an estimated ratio of ~25-45 photoreceptors per RPE cell (Marmor, 1998; Lamb and 
Simon, 2004).
Vitreous
Inner limiting membrane 
Nerve fibre layer 
Ganglion cell layer
Inner piexiform layer 
Inner nuclear layer 
Outer piexiform layer
Outer nuclear layer ) 
Outer limiting membrane > 
Outer segment f
Retinal pigment epithelium J 
Bruch’s membrane -S 
Choriocapillaris <
Choroid
Figure 1.1 The layers o f the retina and choroid (from Pulido, 2002)
The RPE plays an important role in protecting the retina and provides a multi-faceted 
support role for photoreceptor cells. This support role starts early in the development 
of the retina, with the RPE actively involved in promoting correct orientation and 
differentiation of photoreceptors (German et al., 2008). The interaction and support 
continue in the fully developed retina and are essential for proper functioning of the 
retina. The main functions of the RPE are summarized in Figure 1.2, and discussed in 
greater detail below.
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Figure 1.2 Summary o f RPE functions; MV = microvilli; OS = outer segments; epithel = epithelium; PEDF = 
pigment epithelium-derived growth factor; VEGF = vascular epithelium growth factor (modified from Strauss, 2005).
1. Introduction
1.2.1 Photoreceptor outer segment renewal and phagocytosis by RPE
The renewal of photoreceptor outer segments (POS) is a multi-step process in which 
the RPE plays a vital role. Photoreceptor discs are synthesized at the inner segment, 
while at the distal end of the outer segment discs are shed and phagocytosed by RPE 
cells. After internalization, these discs are degraded, with certain components returned 
to photoreceptors for re-incorporation into new discs, and waste products removed to 
the choroidal blood supply. Although the exact reasons for this process are not fully 
understood, it has been postulated to function effectively as a surrogate antioxidant -  
oxidized lipids etc. are physically removed from the POS, then (except in cases of 
RPE dysfunction or excessive formation of oxidized products) they become degraded 
and removed from the retina (Winkler, 2008).
1.2.1.1 Outer segment disc renewal
Photoreceptor cells, like other neuronal cells, do not generally undergo further 
division after differentiation and maturation, thus, damaged or dead cells can not be 
replaced by new cells. They have, therefore, developed a mechanism by which certain 
cellular components can be renewed in order to maintain healthy and fully functional 
cells (Young and Droz, 1968). Specifically, the discs which form the rod and cone 
POS and contain the visual pigment molecules undergo constant renewal and 
replacement. This was described by Young (1967) who demonstrated that proteins 
synthesized in rod photoreceptor inner segments are incorporated into the base of the 
POS, forming a discrete band which is then seen to move along the length of the POS. 
This well defined band suggests that the proteins form part of the disc structure seen 
in the POS. Movement of the band implies that the POS discs are constantly renewed, 
with formation of new discs at the base of the POS, followed by displacement of these 
older discs along the length of the POS as further discs are formed. The rate of 
formation of new discs appears to be temperature dependent in some species (Young, 
1967), and also possibly light-dependent (Besharse et al., 1977). In cone 
photoreceptors, the situation is rather more complex as the disc membranes in the 
POS are continuous with one another, in contrast with the discrete discs present in rod 
POS. Yet, it has been shown that cones do in fact shed their tips (Hogan et al., 1974).
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During development of the photoreceptor cells, disc synthesis results in lengthening 
of the POS. In mature photoreceptors, however, the formation of new discs is 
normally balanced with removal of discs at the distal tip of the POS in order to 
maintain a constant length.
1.2.1.2 Phagocytosis of POS discs
The process of distal tip disc removal has been shown to involve the RPE, by 
demonstrating the presence of phagosomes in the RPE containing segments of POS 
discs (Young and Bok, 1969). In contrast to the gradual and continuous process of 
insertion of new discs at the base of POS, removal of discs seems to occur 
intermittently, with larger groups of multiple discs detached simultaneously. POS 
removal and phagocytosis appear to be light sensitive, with the peak rate of 
phagocytosis of rods occurring at the onset of light after periods of dark, and/or 
dependent on a circadian clock mechanism (Hollyfleld et al., 1976; Besharse et al., 
1977; Besharse and Defoe, 1998). The shedding pattern for cones also occurs in a 
cyclical pattern, but it seems somewhat more complex, with variation in timing 
between species (summarized in Bok, 1985).
Using electron microscopy it has been demonstrated that the RPE may actually play 
an active role in the detachment process, rather than a purely passive action of 
“mopping up” detached discs. As shown in Figure 1.3, RPE cells form actin- 
containing pseudopodia -  processes which are broader and more closely in contact 
with the POS than the apical microvilli that are also present. These processes have 
been shown to ensheath and intrude into the rod POS and are thought to aid in the 
detachment process, then continue to phagocytose the discs (Matsumoto et al., 1987). 
It has been shown that RPE membrane molecules are also vital for this process. For 
example, avp5 integrin appears essential for recognition and initial binding of POS 
(Finnemann et al., 1997). Additionally, the scavenger receptor CD36 appears to play a 
role in enhancing rates of phagocytosis by interacting with oxidized lipids, thus 
enhancing phagocytosis in pro-oxidant conditions -  possibly also explaining the 
upregulation of phagocytosis upon light exposure (Finnemann and Silverstein, 2001; 
Sun et al., 2006).
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Phagosomes containing the detached discs, which rapidly start to undergo chemical 
and physical changes, appear to become localized to the basal region of the RPE cells, 
closer to the underlying blood supply into which waste products can be delivered after 
complete degradation of the discs (Young and Bok, 1969).
Figure 1.3 Phagocytosis o f POS discs by RPE cells showing (A) RPE cell with 
microvilli (MV) in close contact with adjacent rod POS; (B) formation o f pseudopodia 
(PsP) and initiation o f  disc detachment; (C) intrusion o f  pseudopodia into POS; (D) 
complete detachment o f  disc segment while surrounded by pseudopodia; (E) 
internalization o f discs forming phagosome (Ph), and withdrawal o f pseudopodia 
(adaptedfrom Matsumoto et al, 1987).
1.2.1.3 Lysosomal degradation of phagocytosed tips
RPE lysosomes contain many enzymes: cathepsins, a-mannosidase, N-acetyl-p-D- 
glucosaminidase, acid lipase, acid phosphatase, a-fucosidase, a-galactosidase, a- 
glucosidase, p-galactosidase, P-glucosidase, p-glucuronidase, and phospholipases Aj 
and A2 (summarised in Kennedy et al., 1995). These enzymes appear to be specialized 
for POS membrane degradation, and are, in fact, more potent than liver lysosomal 
enzymes at degrading these targets. Normal activity of many these enzymes requires a 
low lysosomal pH of approximately 4.5, which is maintained by a lysosome ATP- 
driven proton pump (Schutt and Holz, 2001; Bergmann et al., 2004). Distribution of 
these enzymes varies in different regions of the retina, implying that the functions of 
the lysosomal system differ throughout the retina, perhaps due to variation in 
photoreceptor density, or rates of shedding of discs (Cabral et a l, 1990). Following 
degradation of POS by these enzymes, certain products such as DHA (discussed in
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Section 1.4.2.2) may be recycled to the photoreceptors, while waste products are 
released into the choriocapillaris (Schutt and Holz, 2001).
1.2.2 Barrier and protective roles o f the RPE
The retina has two distinct blood supplies -  the central retinal arteries which enter the 
eye at the optic nerve head, and the choriocapillaris which lies beneath Bruch’s 
membrane. Despite the fact that the central retinal arteries form the blood supply for 
most of the neural retina, this circulation only accounts for approximately 5% of total 
blood-flow to the retina, with the majority being supplied by the choriocapillaris. This 
is a net-like bed of fenestrated arteries, which supplies the outer part of the retina, 
including the RPE and photoreceptors. This part of the retina is, therefore, very well 
oxygenated, which has important consequences in relation to photo-oxidative damage.
The presence of tight junctions between RPE cells results in formation of a physical 
barrier severely restricting diffusion of molecules directly between blood and the 
retina via an extracellular route. This, along with the endothelial cell layer of the inner 
retinal blood circulation, forms the blood-retina barrier (Cunha-Vaz, 2004). Selective 
localization of specific receptors and channels to the apical or basal surfaces of RPE 
cells does, however, allow transport across the barrier via an intracellular route 
(Forrester et al., 2002). This allows a flow of nutrients into the retina to supply 
adjacent photoreceptors, and removal of waste products and water from the retina 
back into the blood supply. Removal of fluids from the interphotoreceptor region, 
along with the presence of the interphotoreceptor matrix, which is produced by the 
RPE, helps to maintain adhesion of the neural retina to the RPE layer. Ion channels in 
the RPE also allow retention of essential ion concentrations to maintain electro­
excitability of photoreceptor cells (Wimmers et al., 2007).
In addition to controlling the flow of material between the choroid and the retina, the 
RPE can itself release growth factors, in particular vascular endothelial growth factor 
(VEGF) and pigment epithelium derived growth factor (PEDF). These are both 
important in controlling angiogenesis, and it appears there is a fine balance between 
these two factors to counteract pro-angiogenic VEGF with anti-angiogenic PEDF 
(Bhutto et al., 2006). Indeed, in retinas with neovascular AMD, PEDF levels are
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shown to decrease, and VEGF is upregulated compared with non-AMD retinas 
(Lopez et al., 1996; Bhutto et al., 2006).
1.2.3 Melanosomes and melanin
RPE cells contain melanosomes -  pigment granules containing melanin. Their 
putative protective role has been studied, but has revealed conflicting results. They are 
thought to have several beneficial functions. Firstly, they absorb light, which reduces 
scatter within the eye, improving vision and reducing light damage. Secondly, they 
may also act in an antioxidant and free radical scavenging capacity, although the 
presence of high levels of other antioxidants in the RPE suggests that this function of 
melanin may not be significant (Boulton, 1998). Although supplementation of 
cultured cells with melanin appears to protect cells from light damage (Seagle et al., 
2006), other studies have shown no protective effect in cultured cells fed with 
melanosomes (Zareba et al., 2006), and that in vitro light-activation of melanosomes 
may cause lipid peroxidation and production of reactive oxygen species, with 
increased photoreactivity with age (Dontsov et al., 1999; Rozanowska et al., 2002a).
1.2.4 Renewal o f the visual pigment chromophore, 11-cis-retinal
The RPE plays a vital role in the renewal of the photoreceptor visual pigment 
chromophore 11-c/s-retinal (summarized in Figure 1.4). Upon excitation of 
photoreceptors by light, 11 -cis-retinal, which forms part of the rhodopsin molecule, is 
converted to all-rra«s-retinal, then enzymatically reduced to all-/ra«s-retinol, which is 
released from the photoreceptor cell. This is then taken up into RPE cells and 
converted to 11 -cis-retinol, then 11 -c/s-retinal by a number of enzymes. 11 -czs-retinal 
is then transported back to the photoreceptors where it is reinserted into existing discs 
throughout the POS to regenerate visual pigments and inserted into newly formed 
discs in the inner segment (Chader et al., 1998). The exact mechanism of transport of 
the compounds between the photoreceptors and RPE, via the extracellular space, is 
not yet fully understood but appears to involve an interphotoreceptor retinoid binding 
protein (Liou et al., 1982). High DHA concentrations can directly induce the release 
of retinoids from this protein, thus providing a mechanism for targeting recycled 
retinoids to photoreceptors, where DHA concentrations are very high (Chen et al.,
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1993; Chen et al., 1996). Movement within the RPE may be regulated by a specific 
cellular retinol binding protein and other retinoid binding proteins. These binding 
proteins may be important not only for “carrying” the retinoids along the correct 
pathways, but also for protecting them from oxidative or enzyme attack (Besharse and 
Defoe, 1998).
Photoreceptor
cell rhodopsin 
(opsin + 11-c/s-retinal)
11 -c/s-retinal
f l ig h t
all-frans-retinal
i\ 4
all-frans-retinolV
Extracellular space
f
11-c/s-retinal
11-c/s-retinol <4-
all-frans-retinol
RPE cell
all-frans-retinyl
esters
Figure 1.4 Schematic diagram o f  retinoid isomerization in photoreceptors and RPE 
cells (adaptedfrom Chader et al., 1998)
1.2.5 Antioxidants
The RPE contains several common antioxidant enzymes -  superoxide dismutase 
(SOD), catalase, glutathione peroxidase - and other antioxidants and free radical 
scavengers - vitamins A and E, and ascorbate (Forrester et al., 2002). In fact, RPE 
cells appear to show an adaptive response to oxidative stress, resulting in upregulation 
of antioxidants and increased nuclear DNA protection (Jarrett and Boulton, 2005). 
Other “detoxification” enzymes, which act through mechanisms other than free 
radical scavenging, may also be important, such as glutathione-S-transferase, aldose 
reductase and aldehyde dehydrogenase (Esterbauer et al., 1991; Choudhary et al.,
2003). These enzymes have been shown to be active in detoxification of lipid-derived 
aldehydes in cultured RPE cells (Choudhary et al., 2005).
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Another group of molecules which are particularly important in the retina are 
carotenoids. These are a large family of plant pigments, two of which -  lutein and 
zeaxanthin -  are found in the macular region of the retina and give the macula its 
yellow colour (Whitehead et al., 2006). Levels of these pigments have been shown to 
increase in the majority of subjects whose diets are supplemented (Curran-Celentano 
et al., 2001; Trieschmann et al., 2007). Carotenoids are hydrophobic molecules and 
thus restricted to cell membranes. They display two potential modes of protection in 
the retina: firstly, they are able to absorb light and thus improve visual acuity and 
protect other cellular components from photo-damage, and secondly, they act in an 
antioxidant capacity and are able to quench singlet oxygen and scavenge free radicals 
(Britton, 1995; Liebler and McClure, 1996; Edge et al., 1997; El-Agamey et al., 
2004).
1.3 Age-related macular degeneration
As described above, the RPE has several distinct roles which are vital for supporting 
photoreceptor cells. It follows that maintenance of RPE cellular homeostasis is 
essential for the proper functioning of photoreceptor cells and, therefore, of the visual 
sensory system as a whole. It has been shown, however, that with age, RPE cells 
undergo changes which may result in RPE dysfunction, possibly leading to 
development of AMD. These changes are discussed in greater detail below.
It is estimated that approximately 50% of blindness in developed countries is 
attributable to AMD in the aged population (Owen et al., 2003; Resnikoff et al., 
2004), and that it affects approximately 200,000 people over the age of 75 in the UK, 
with prevalence increasing with age (Owen et al., 2003; Evans et al., 2004).
1.3.1 Age-related changes in the RPE and Bruch’s membrane
The retina undergoes many age-related changes, some of which are in part due to the 
unique environment o f the retina, with high blood flow and therefore also high O2 
levels and extensive light exposure in many parts of the retina, in addition to high 
levels of polyunsaturated fatty acids. Important changes in the RPE involve alterations 
in pigmentation, with decreased melanosome levels and increased lipofuscin due to
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incomplete degradation of phagocytosed POS discs and also changes in optical 
characteristics of these granules (Feeney-Bums et a l , 1984; Boulton et a l , 1990; 
Docchio et a l , 1991; Schutt and Holz, 2001; Boulton et a l , 2004). With age there is 
also an increase in formation of pigment complexes such as melanolipofuscin 
(Feeney-Bums et a l, 1984).
The structure of Bruch’s membrane, which is normally a highly permeable membrane, 
also changes and becomes denser and thicker, with some calcification and 
degeneration of collagen and elastin, potentially resulting in splitting of the membrane 
(Schutt and Holz, 2001). Accumulation of metabolic products also occurs, resulting in 
impaired fluid flow through the membrane. These products are likely to be of 
RPE/POS origin and notably, include lipids which show increased levels of 
peroxidation with age, and may result in reduction of flow o f water and water-soluble 
molecules through the now lipophilic Bruch’s membrane (Spaide et a l,  1999). This 
accumulation may also lead to an immune response. Furthermore, capillaries of the 
choriocapillaris become smaller and further apart and they are reduced in number 
(Abdelsalam et a l,  1999; Spaide et a l,  1999; Schutt and Holz, 2001).
The formation of the main types of AMD-related deposits -  lipofuscin (in the RPE) 
and drusen (on Bruch’s membrane) -  is discussed in greater detail below.
1.3.2 Lipofuscin
1.3.2.1 Lipofuscin composition and distribution
Retinal lipofuscin forms in the RPE as membrane-bound granules, derived 
predominantly from lysosomes that are unable to completely degrade phagocytosed 
POS tips. They have traditionally been thought to consist of a mixture of lipids and 
proteins (Kennedy et a l ,  1995; Roth et a l,  2004), however, recent studies show 
minimal levels of proteins but confirm the presence of oxidized lipid-protein adducts 
(Gu et a l,  2003a; Ng et a l ,  2008).
Lipofuscin granules tend to be localized in the basal half of RPE cells and are more 
commonly found in macular cells than non-macular cells (Kennedy et a l,  1995).
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Their topographical distribution also matches that of drusen deposits in Bruch’s 
membrane, suggesting that there may be a link between their formation (Roth et a l , 
2004). Several distinct fluorophores have been identified in retinal lipofuscin, with the 
majority of work focused on A2E (2-[2,6-dimethyl-8-(2,6,6-trimethyl-1-cyclohexen- 
l-yl)-l£,3£,5£,7£-octotetraenyl]-l-(2-hydroxylethyl)-4-[4-methyl-6-(2,6,6-trimethyl- 
1 -cyclohexen- l-yl)-l£,3£,5£-hexatrienyl]-pyridinium), which is derived from the 
interaction of alWraws-retinal with phosphatidylethanolamine (Lamb and Simon, 
2004). This molecule and its isomers are at least partially responsible for the 
yellow/gold fluorescence of lipofuscin (Sparrow et al., 1999; Ben-Shabat et al., 2002; 
Fishkin et al., 2005).
1.3.2.2 Lipofuscin formation
Formation of lipofuscin is predominantly attributed to lysosomal dysfunction. 
Possible causes include oxidative damage to POS components, particularly lipids, 
which would be enhanced by the pro-oxidant conditions including high O2 levels and 
high fluxes of light, and by the decreased function of antioxidants and free radical 
scavengers. Decrease in melanin content may also contribute because of the resultant 
increase in light scatter and decrease in free radical scavenging. Direct decrease of 
lysosomal enzyme activity may also be induced by other mechanisms -  for example, 
genetic aberrations, or direct effects of peroxidized molecules (Kennedy et al., 1995; 
Roth et al., 2004). Other findings show that oxidized lipid-protein complexes may 
affect enzyme activation and lysosomal maturity indirectly through inhibition of 
different signalling molecules, or they may form products which are resistant to 
lysosomal digestion (Hoppe et al., 2004a,b). Lipofuscin itself is also able to interfere 
with lysosomal activity by causing loss of lysosomal integrity and inhibition of 
lysosomal enzyme activity, thus perpetuating its own formation (Wihlmark et al., 
1997; Wassell et al., 1999; Davies et al., 2001; Shamsi and Boulton, 2001).
A2E, which is acquired through POS phagocytosis, has also been shown to reduce 
lysosomal function. It has been shown, however, that this is not due to direct 
inhibition of enzymes, but rather due to inhibition of the proton pumps which 
normally maintain the low pH required by most lysosomal enzymes to function 
properly (Bermann et al., 2001; Finnemann et al., 2002; Bergmann et al., 2004). This
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appears to happen in a concentration-dependent manner, indicative of its detergent­
like mechanism of action (Sparrow et a l , 1999)
1.3.2.3 Lipofuscin toxicity
Lipofuscin has several detrimental effects on RPE cells -  it can inhibit the phagocytic 
process by causing lysosomal dysfunction, as described above, and it can cause 
changes in cellular architecture, but importantly, it can act as a photosensitizer -  
excitation by light can cause lipofuscin, or a component thereof, to produce damaging 
reactive oxygen species (Ambati et al., 2003a). This has been shown in vitro to cause 
RPE cell death, with particular sensitivity to blue light (Wihlmark et al., 1997; Davies 
et al., 2001). Light exposure of lipofuscin granules results in O2 uptake, in an age- and 
wavelength- dependent manner -  increasing with age and at shorter wavelengths, with 
blue light being the most efficient within the range of light likely to reach the adult 
retina (Rozanowska et al., 1995; Pawlak et a l , 2002; Rozanowska et a l , 2002a). In 
conjunction with O2 uptake, lipofuscin granules are able to produce several reactive 
oxygen species: highly reactive singlet oxygen, superoxide, hydrogen peroxide, and 
lipid peroxides (Boulton et a l , 1993; Rozanowska et a l , 1995; Rozanowska et a l , 
1998). Lipofuscin granules can also induce peroxidation of PUFA in dark conditions 
(Dontsov et a l , 1999)
The lipofuscin component, A2E, has been shown to induce photo-damage in RPE 
cells after artificially loading cells with this molecule (Schutt et a l , 2000; Sparrow et 
a l,  2000; Sparrow and Cai, 2001). However, other studies investigating lipofuscin 
phototoxicity have demonstrated that in lipofuscin-fed cells where photo-damage was 
observed, A2E concentrations were too low to account for the observed toxicity 
(Davies et a l ,  2001). Furthermore, the action spectrum for A2E induced O2 uptake is 
different to lipofuscin (Pawlak et a l,  2002), and although irradiation of A2E causes 
formation of singlet oxygen and superoxide, levels are not as high as would be 
required if A2E were the main cause of lipofuscin-induced oxygen species production 
(Pawlak et a l,  2003). Thus, based on A2E content in lipofuscin and comparison of 
their photochemical properties, it is clear that the contribution of A2E to lipofuscin 
photoreactivity is minor (Rozanowska and Sama, 2005). Therefore, the exact
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component(s) of lipofuscin that gives it its photosensitizing properties remains 
unidentified.
1.3.3 Drusen and other Bruch’s membrane deposits
Drusen are lipid-rich deposits which occur between the RPE basement membrane and 
the collagenous layer of Bruch’s membrane. Two main types are identified clinically 
-  hard and soft. Hard drusen are generally small, occur from an early age in a large 
proportion of the general population, and are not usually regarded as clinically 
important (Klein et a l , 2002a). However, their presence in large numbers may 
precede formation of soft drusen and their disappearance may precede atrophy of 
overlying RPE and neural retina (Abdelsalam et al., 1999; Hageman et a l , 2001; 
Klein et a l , 2002a). Soft drusen have less well defined margins and are usually larger 
and, when large and confluent, tend to be considered as precursors to choroidal 
neovascularization (Abdelsalam et a l,  1999; Hageman et a l,  2001).
Drusen are composed of a variety of proteins, which differ between drusen from 
“healthy” and AMD-affected eyes. Lipids are also found, including adducts between 
proteins and peroxidation products of DHA, such as carboxyethylpyrroles (CEP). 
These adducts are more abundant in AMD samples compared with normal samples 
(Crabb et a l , 2002).
Other deposits include basal laminar and basal linear deposits. Basal laminar deposits 
form between the RPE and Bruch’s membrane. There are several types including 
amorphous, and fibrillar deposits which contain high levels of collagen (Hageman et 
a l,  2001; Sarks et a l,  2007). It has been shown that these deposits may increase 
during oxidant stress (Marin-Castano et a l,  2006). Basement linear deposits form 
externally to the RPE basement membrane, within Bruch’s membrane. They consist 
of membranous debris and may fuse to form soft drusen (Sarks et a l, 2007). The 
presence of continuous basal linear and basal laminar deposits in combination is a 
marker of early AMD, although neither of these deposits, at early stages, are clinically 
observable (Sarks et a l , 2007).
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RPE material trapped within Bruch’s membrane is also able to initiate an immune 
response. This may result in removal of the waste products, but these deposits also act 
as seeding sites for drusen growth, with the final drusen deposits shown to contain 
various proteins related to inflammation, and complement products (Roth et al.,
2004).
Other lipids are also found within Bruch’s membrane. These appear to be lipids of 
cellular origin and include LC-PUFA such as DHA. Levels of peroxidized lipids 
increase with age and lipids show broad fluorescence emission spectra, indicative of 
cross-linking with proteins, which would help retain these lipids in the membrane 
(Spaide et al., 1999)
1.3.4 The role o f the immune response in AMD
As described above, in addition to the presence of proteins and lipids derived from 
POS, drusen deposits may contain inflammatory markers such as components of the 
complement cascade. It seems that components of RPE lipofuscin, including certain 
oxidation products of A2E, are able to elicit an immune response (Zhou et a l , 2006). 
It has also been shown that antibodies against CEP are higher in AMD, suggesting the 
occurrence of an autoimmune mechanism (Gu et al., 2003a). Additionally, several 
gene knockout experiments have been carried out to investigate the functions of 
certain genes related to the immune system and identify its role in AMD onset.
In a complement factor H (CFH) knockout, mice developed severe alterations in 
retinal structure and function (Coffey et al., 2007). CFH is normally expressed and 
released by RPE cells, and functions as a suppressant of the alternative complement 
pathway (Hageman et al., 2005). In the knockout mouse, severe disorganization of the 
retina was observed, and complement component 3 was found in the retina, indicating 
an immune response (Coffey et al., 2007). Strikingly, although there was an increase 
in fluorescent material, as observed in AMD, there was a decrease in electron dense 
material below the RPE layer, and also thinning of Bruch’s membrane. These two 
changes are the opposite of those expected in AMD, and imply that lack of CFH may 
result in either increased removal of accumulated material (and thus thinning of
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Bruch’s membrane) due to the increased immune response, or that CFH is required 
for the initial accumulation of the material (Coffey et al., 2007).
Knockout experiments have also been carried out in mice to induce deficiencies in 
monocyte chemoattractant protein-1 (Ccl-2) and its receptor, C-C chemokine 
receptor-2 (Ccr-2) (Ambati et al., 2003b). In wildtype mice, Ccl-2 synthesis by RPE 
and choroid epithelial cells is induced by the presence of C5a and IgG, and results in 
attraction of macrophages and infiltration into the choroid, leading to removal of 
C5a/IgG. In the knockouts, young mice showed normal retinal function. However, 
older mice displayed AMD-like characteristics -  Bruch’s membrane thickening, 
formation of drusen and lipofuscin, neovascularization and general retinal dysfunction 
and degeneration. It is suggested that this is caused by a deficiency of the 
chemoattractant system, thus resulting in accumulation of C5a/IgG, and subsequent 
development of the phenotype observed (Ambati et a l , 2003b).
Studies of genetic variations which lead to increased susceptibility to AMD have 
highlighted other components of the immune system which potentially play a role in 
the onset of AMD. These are discussed in greater detail in Section 1.3.6.2 below.
1.3.5 Causes o f visual impairment in AMD
AMD is generally subdivided into two types -  “wet” neovascular AMD, which affects 
approximately 10% of AMD sufferers but causes 75% of AMD-related serious vision 
loss, and “dry” AMD, characterized by atrophy of the RPE and outer neural retina and 
which affects 90% of AMD sufferers but only causes approximately 25% of cases of 
AMD-related serious vision loss (Abdelsalam et al., 1999).
1.3.5.1 Neovascularization and wet AMD
Choroidal neovascularization is the growth of new blood vessels from the choroid, 
through Bruch’s membrane and into the retina.
Angiogenesis at the level of Bruch’s membrane and the RPE is normally prevented by 
a precise balance of different pro- and anti-angiogenic growth factors, such as PEDF 
and VEGF. When diffusion of water and molecules through Bruch’s membrane is
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reduced due to, for example, presence of hydrophobic, lipid-rich drusen or other 
matter, this balance of factors may be affected and angiogenesis may begin (Schutt 
and Holz, 2001; Roth et al., 2004).
The lipid-rich composition of drusen and other Bruch’s membrane deposits may also 
contribute to neovascularization. CEP adducts, which increase in Bruch’s membrane 
with age, have been shown to stimulate angiogenesis (Ebrahem et al., 2006), while in 
vivo studies in rabbits have shown that linoleic acid hydroperoxides (introduced by 
subretinal injection) are able to stimulate choroidal neovascularization, possibly by 
inducing angiogenic cytokine expression in RPE cells (Tamai et al., 2002). 
Additionally, exposure of RPE cells to reactive oxygen species, as would occur on 
photo-activation of lipofuscin and lipids, leads to an increase in VEGF expression, 
thus promoting angiogenic pathways (Kuroki et a l , 1996).
It may also be necessary for Bruch’s membrane to be partially damaged to allow 
angiogenesis to occur, but as described above, this commonly occurs with age. New 
blood vessels pass through Bruch’s membrane then pass horizontally, either between 
Bruch’s membrane and the RPE, or further into the neural retina. Loss of vision may 
then occur as a result of haemorrhage, scarring, exudation and/or retinal detachment 
(Schutt and Holz, 2001; Roth et al., 2004; Ebrahem et al., 2006).
1.3.5.2 Geographic atrophy and dry AMD
Geographic atrophy is often preceded by accumulation of lipofuscin in the RPE, a 
process which is described in greater detail in Section 1.3.2, along with its deleterious 
effects. Accumulation of lipofuscin, which can be observed clinically by fundus 
autofluorescence imaging, may lead to RPE dysfunction due to its phototoxic 
properties, described above. This occurs predominantly in the perifoveal area, 
correlating with regions of highest rod density. Due to the important support role of 
the RPE, dysfunction in this cell layer results in loss of photoreceptor cells which 
directly affects the ability of the retina to process light signals. Cell death also occurs 
in the choriocapillaris (Schutt and Holz, 2001; Roth et al., 2004).
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1,3.6 Risk factors for AMD
The aetiology of AMD is not yet fully understood, but is likely to occur as a result of 
interplay between a variety of risk factors.
Age is considered to be the most important risk factor for AMD, with prevalence of 
AMD increasing significantly with age (Klein, 1999; McCarty et al., 2001; AREDS 
Research Group, 2005). Additionally, several genetic and modifiable environmental 
risk factors have been studied.
1.3.6.1 Environmental risk factors
Cigarette-smoking is known to be an important modifiable risk factor for AMD. Four 
major studies -  the Beaver Dam Eye Study, the Age-Related Eye Disease Study 
(AREDS), the US Twin Study of AMD and the Blue Mountains study -  have all 
shown increased risk of AMD amongst smokers (Klein et al., 2002b; AREDS 
Research Group, 2005; Seddon et al., 2006; Tan et al., 2007). Dietary factors such as 
raised high density lipoprotein levels also increased the risk of AMD -  in some cases 
on its own, but also by further increasing the risk caused by smoking (Klein et a l , 
2002a; AREDS Research Group, 2005; Seddon et a l , 2006). Intake of omega-3 fatty 
acids or fish reduced the risk of AMD; however this did also depend on omega-6 fatty 
acid intake, with a lower ratio of omega-6 to omega-3 shown to provide the greatest 
benefit (Chua et a l,  2006; Seddon et a l,  2006).
Several studies have suggested that an important risk factor for AMD, which links 
with evidence of photosensitized damage occurring in the retina, is sunlight. The 
Beaver Dam Eye Study in particular has focussed on the effects of light, and has 
demonstrated in medium and long-term studies that prolonged exposure to high levels 
of sunlight increases the risk of AMD and that the use of sunglasses in certain groups 
can confer protection (Cruickshanks et a l,  1993; Tomany et a l,  2004). In particular, 
protection from blue light warrants further investigation (Hawse, 2006). It is 
important to note, however, that other studies have shown no significant effect of light 
exposure (The Eye Disease Case-Control Study Group, 1992; McCarty et a l,  2001). 
Several studies have indicated there may also be a link between cataract surgery and
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increased incidence of AMD, or further progression of early AMD, but results 
between these studies also seem inconsistent (reviewed in Bockelbrink et al., 2008).
1.3.6.2 Genetic risk factors
As with the environmental risk factors, genetic risk factors do not directly cause 
AMD, but are regarded as susceptibility factors, where certain genetic variations 
increase the risk of developing AMD.
At chromosome 10q26 there is a region o f high numbers of single nucleotide 
polymorphisms. One in particular, rs 10490824, which is located within the 
LOC387715 gene, has a strong association with AMD susceptibility. This gene 
encodes a protein which is localized in the outer mitochondrial membrane, and is 
expressed at moderate levels in the retina (Kanda et al., 2007). Although the function 
of this protein is not fully understood, it has been suggested that the observed A69S 
substitution may alter sensitivity to oxidative damage due to altered mitochondrial 
function, and that this may explain the statistical interaction between this gene 
variation and history of smoking in the risk of developing AMD (Haines et al., 2007; 
Schaumberg et al., 2007).
Another gene which has been linked with AMD is that of CFH, on chromosome lq32, 
which shows several variants in humans. As described above, CFH normally 
suppresses the alternative complement pathway (Hageman et al., 2005), and 
deficiencies in mice can cause severe retinal abnormalities (Coffey et al., 2007). In 
humans, one particular variant allele, Y402H, is expressed in nearly 60% of the white 
population in the USA. Risk of AMD with this variant increases 2-fold for 
heterozygotes, and 5-fold for homozygotes (Schaumberg et al., 2007).
The combination of these two AMD-related genetic factors increases susceptibility to 
AMD 50-fold in those homozygous for both changes. In total, -65%  of AMD cases 
appear to be attributable to variations in these genes (Schaumberg et al., 2007). 
Additionally, the risks induced by both of the AMD susceptibility factors above are 
further increased by environmental factors, with smoking and obesity shown to cause 
significant further increases (Schaumberg et al., 2007).
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In addition to CFH being a susceptibility factor for AMD, variations in other 
complement components appear to show protective properties: in complement 
component 2/complement factor B (C2/CFB) on chromosome 6, and complement 
component 3 (C3) on chromosome 19 (Haines et al., 2007). Additionally, associations 
have been shown between ABCR mutations and AMD. ABCR, a member or the ATP 
binding cassette transporter family of proteins, is a photoreceptor-specific protein 
which has known mutations which cause Stargardt disease, an early onset form of 
macular degeneration with similar characteristics to AMD (Allikmets et al., 1997).
1.3.7 Current therapeutic strategies
The main focus of treatment to date has been to prevent and reduce the choroidal 
neovascularization observed in “wet” AMD. This has taken two main pathways -  
ablation of formed vessels by photocoagulation or photodynamic therapy, and 
prevention of formation through blocking the actions of VEGF.
Photocoagulation for treating neovascularization involves the use of a high power 
laser to effectively bum the neovascular complexes (Berger and Fine, 1999). This has 
been shown in a major trial to reduce further severe vision loss compared with 
untreated patients (Macular Photocoagulation Study Group, 1982). However, due to 
the high laser power required, damage to retinal cells may occur leading to loss of 
central vision after treatment of subfoveal lesions, particularly after treatment of 
larger lesions. Therefore, other treatments have been sought (Macular 
Photocoagulation Study Group, 1994; Berger and Fine, 1999).
Photodynamic therapy (PDT) involves the use of Verteporfin, a photosensitizer which 
is given intravenously and is then activated when the retina is exposed to a 689 nm 
laser source. Long-term studies have shown reduced vision loss in patients who have 
undergone PDT versus controls (TAP Study Group, 1999; Bresler and TAP Study 
Group, 2001).
Alternatively, the VEGF-mediated pro-angiogenic signalling cascade is targeted 
(Lopez et al., 1996; Ng and Adamis, 2005). Several drugs have been found to be 
beneficial via this route in AMD after intravitreal injection. Macugen (or pegaptanib)
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is an aptamer -  a modified RNA oligonucleotide -  which has the ability to bind 
specifically to VEGF165 -  the isoform of VEGF found in the retina, thus allowing it 
to act specifically on AMD-related neovascularization (Ruckman et al., 1998; Ng and 
Adamis, 2005).
Alternative therapies involve the use of antibodies or antibody fragments, which bind 
to VEGF, thus disabling it. Examples include Avastin (or Bevacizumab) which has 
been shown to have a positive effect in AMD, although it is licensed for treatment of 
colorectal cancer (Bashshur et al., 2006). A related antibody, Lucentis (or 
Ranibizumab), is a chemically modified version of Avastin with a higher affinity for 
VEGF and is specifically licensed for treatment of AMD. It has been shown to reduce 
levels of macular fluid in patients with neovascular AMD and even improve visual 
acuity, rather than just limit further vision loss, providing an advantage over Macugen 
and PDT (Bashshur et al., 2006; Brown et al., 2006; Rosenfeld et al., 2006; Fung et 
al., 2007).
Studies have also shown beneficial effects of combinations of PDT and VEGF 
inhibition (Heier et al., 2006), also with the addition of anti-inflammatory drugs 
(Augustin et al., 2007). These combinations enhance results of individual drugs and 
often require fewer treatment cycles, and therefore potentially have a lower cost and 
lower risk of negative side-effects.
The treatments described here are only relevant to neovascularization which occurs in 
“wet” AMD. No treatment or cure for “dry” AMD or geographic atrophy has yet been 
found. There is some potential in the field of cell transplants, although this has only 
reached the stage of initial experiments in animal models. RPE cell transplants have 
been carried out and successfully recovered phenotypes of rodents with dysfunctional 
RPE, such as for example the Royal College of Surgeons rat (Lavail et al., 1992; 
Jiang and Hamasaki, 1994) and the RPE65(/) mouse (Gouras et al., 2002). 
Additionally, iris pigment epithelial cells have been used to regenerate RPE cells, as a 
potential route for autologous transplantation (Abe et al., 2007).
In light of the fact that there is limited opportunity to cure or treat AMD, the effects of 
antioxidants as preventative agents have been investigated. Several longitudinal
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studies of antioxidant protection against AMD have been carried out. These suggest 
beneficial effects of certain combinations of antioxidants. For example, the Age- 
Related Eye Disease Study (AREDS) showed that combined high dose vitamins C 
and E and P-carotene, in conjunction with zinc, reduced the probability of developing 
advanced AMD. However, this was only observed in a subgroup of participants with 
the highest risk of progression to advanced AMD (i.e. extensive intermediate drusen, 
large drusen, or non-central geographic atrophy in one or both eyes, or advanced 
AMD or vision loss due to non-advanced AMD in a single eye). Subjects with earlier 
or later stages of AMD did not appear to benefit (AREDS Research Group, 2001; 
Bartlett and Epeijesi, 2003). The Carotenoids in Age-Related Eye Disease Study 
(CAREDS) has also shown possible protective effects against AMD in certain age 
groups of women with diets supplemented with lutein and zeaxanthin (Moeller et al., 
2006). It is important to note in studies using carotenoids, however, that p-carotene 
has been shown to have a detrimental effect in smokers, increasing the risk of lung 
cancer and cardiovascular disease (Omenn et al., 1996). A further study (AREDS2) is 
currently being undertaken to investigate the effects of dietary supplementation with 
lutein, zeaxanthin and omega-3 LC-PUFAs on development of AMD, and whether p- 
carotene and zinc -  used in the original AREDS study -  are in fact necessary (Huang 
et al., 2008)
1.4 Docosahexaenoic acid
1.4.1 DHA structure, synthesis and distribution
DHA is a long chain polyunsaturated omega-3 fatty acid (22:6n-3; Figure 1.5) found 
in abundance in animal tissues, with particularly high levels in the brain and retina 
(Tinoco, 1983). It is required for development and normal function of tissue, 
particularly of the nervous system and retina, but it is not synthesized de novo in 
humans or other animals due to the inability to synthesize the n-3 structure 
(Yamanaka et al., 1980; Tinoco, 1983). DHA must, therefore, be taken up directly 
from the diet (e.g. from oily fish) or it may be synthesized from the plant-derived 
dietary precursor a-linolenic acid (18:3n-3), by the actions of elongase and desaturase
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enzymes in the liver (Tinoco, 1983; Scott and Bazan, 1989; Nakamura and Nara, 
2003; Das, 2006).
Dietary DHA or DHA converted from a-linolenic acid is released from the liver into 
blood lipoproteins and transported to the brain and retina where it is selectively taken 
up and incorporated into cell membranes (Scott and Bazan, 1989; Wang et al., 1992; 
Bazan et al., 1993). In rod outer segments, LC-PUFA make up approximately 50% of 
total membrane fatty acids. Approximately 80% of these are accounted for by DHA, 
which is the dominant fatty acid in both phosphatidylserine and 
phosphatidylethanolamine (Fliesler and Anderson, 1983; Wang and Anderson, 1992). 
The presence of multiple double bonds in DHA makes it extremely susceptible to 
peroxidation -  especially in the pro-oxidant conditions found in the retina. This 
process is discussed in greater detail below.
o
Figure 1.5 Chemical structure o f  DHA (22:6n-3) demonstrating the 22 carbons, 6 cis 
double bonds and n-3 conformation.
(From: http://www. neuroinformation, org/about this site. htm)
1.4.2 DHA insertion into POS membranes
The RPE plays two important roles relating to DHA levels in the rod POS -  it allows 
transport of new DHA (from diet or the liver) from the choriocapillaris to the 
photoreceptors to be incorporated into newly formed discs, and it recycles DHA from 
phagocytosed POS and returns it to photoreceptor cells (Wang and Anderson, 1992; 
Bazan et al., 1993). Uptake of new DHA into POS functions predominantly to 
establish the high disc concentrations of DHA during development of the POS. In the 
mature retina most POS DHA is obtained from the RPE mediated recycling process, 
but some of this DHA may be lost by p-oxidation or peroxidation, necessitating 
further uptake of new DHA from the diet (Wang and Anderson, 1992). This loss of 
DHA, however, occurs very slowly in normal circumstances so prolonged dietary
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deprivation of n-3 fatty acids would be needed to significantly reduce retinal DHA 
content (Mukheijee et al., 2004).
1.4.2.1 DHA uptake from blood
DHA levels in the RPE are higher than circulating blood levels but much lower than 
in POS. This is due to a mechanism which allows the RPE to selectively take up DHA 
from plasma lipoproteins from the choriocapillaris. It may then accumulate transiently 
in RPE oil droplets, and/or be released into the interphotoreceptor matrix before being 
taken up by photoreceptor cells. (Wang and Anderson, 1992; Bazan et al., 1993; 
Gordon and Bazan, 1993). The mechanism of uptake is not currently known but 
appears to occur via a lipid uptake mechanism which is specific for carbon chain 
length and level of unsaturation, as other fatty acids are not taken up at the same rate. 
Because this uptake is so selective, it may involve a specific carrier protein, rather 
than passive diffusion of DHA through the lipid bilayer (Wang and Anderson, 1992; 
Wang et al., 1992).
1.4.2.2 RPE mediated recycling of DHA
Similar to the experiments described above which tracked movement of proteins from 
insertion into the POS up to phagocytosis by RPE cells, DHA movement has been 
visualized using [3H]DHA (Gordon and Bazan, 1990; Gordon et al., 1992; Gordon 
and Bazan, 1993). In these experiments, DHA is shown to be taken up by rod 
photoreceptors and initially localized in the inner segments. Some is transported to 
synaptic terminals, and a small amount spreads diffusely throughout the POS. The 
majority, however, accumulates at the base of the outer segments where it is 
incorporated into newly formed POS discs and can be seen to migrate along the length 
of the POS. It is then taken up by the RPE as the POS tips are phagocytosed (Gordon 
and Bazan, 1990).
Studies in the frog have shown that DHA is released from phagocytosed POS 
membranes. Some DHA is then incorporated into phospholipids but the majority is 
rapidly esterified into newly synthesized triglycerides (TG). Because of the large 
amount of DHA released in POS phagocytosis, this results in an increase in cellular 
lipids and formation of oil droplets, containing predominantly TG, which act as a fatty
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acid reservoir. This storage process also protects DHA from oxidation and release into 
the choriocapillaris (Chen and Anderson, 1993b,a). In vitro studies using rat RPE cells 
have shown synthesis of DHA-TG after phagocytosis (Rodriguez de Turco et al., 
1999). However, there appeared to be no increase in accumulation of DHA-TG in in 
vivo studies (Baker et al., 1986), leading to speculation that although cells are capable 
of producing TG, in the normal situation, DHA is preferentially exported from RPE 
cells, either to the liver or to be returned to photoreceptor outer segments (Baker et 
al., 1986; Rodriguez de Turco et al., 1999). Incorporation of DHA into TG differs 
from the processing of arachidonic acid (AA). This LC-PUFA is also taken up by 
RPE cells but is incorporated into TG at a slower rate, and by fatty acid exchange 
rather than synthesis of new TG. This difference could explain how DHA is 
preferentially taken up and enriched in the photoreceptor POS, while other PUFA are 
not (Chen and Anderson, 1993b).
1.4.3 Normal role o f native DHA
DHA has several important functions in the retina. It appears to be essential for 
development of photoreceptor cells -  addition of DHA to immature photoreceptor 
cells in culture leads to enrichment of DHA in phospholipids, and enhanced 
differentiation of these cells. This was shown by increased opsin expression and 
advancement of formation of apical processes, which later form the outer segments 
(Rotstein et al., 1998). DHA-enriched phospholipids and rhodopsin are both formed 
in the endoplasmic reticulum in the inner segment of photoreceptors and are co­
transported to the POS for formation of new discs (Rodriguez de Turco et al., 1997).
DHA also appears to be essential for normal function of rhodopsin in the visual 
response, as DHA deficiency causes a decrease in rhodopsin activation, and also a 
decrease in downstream protein interactions in the rhodopsin G-protein mediated 
cascade that normally occur to produce photoreceptor cell hyperpolarization and the 
visual signal (Niu et al., 2004). DHA appears to interact directly with rhodopsin, 
altering local membrane properties and, in doing so, enhancing activation kinetics of 
rhodopsin. In contrast, cholesterol and saturated fatty acids appear to have the 
opposite effect due to their effects on membrane properties (Litman et al., 2001; 
reviewed in Stillwell and Wassail, 2003; Grossfield et al., 2006). In dietary deficiency
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of DHA and other n-3 fatty acids, these are eventually replaced by n-6 
docosapentaenoic acid which is less flexible and has been thought to affect the 
function of integral membrane proteins, and their movement within the membrane 
(Eldho et al., 2003). DHA is also able to protect photoreceptor cells from oxidative 
stress-induced apoptosis, seemingly via a different mechanism, by acting as a trophic 
factor and causing upregulation of Bcl-2 to inhibit apoptosis via the mitochondrial 
pathway (Rotstein et al., 2003).
In addition to these direct effects of DHA, cells may also be protected indirectly by a 
DHA-derived mediator, 10,175-docosatriene (neuroprotectin D l; NPD1). NPD1 is 
produced in the RPE by a lipoxygenase-type enzyme from DHA previously released 
from the membrane by phospholipase A2 (PLA2), and appears to be able to modulate 
signalling pathways responsible for cell survival, thereby reducing oxidative-stress- 
induced apoptosis (Mukheijee et al., 2004). In fact, NPD1 has been shown to protect 
cells from A2E-induced damage, and it is also involved in the signalling pathway of 
PEDF, which upregulates its synthesis and release ffom RPE cells (Mukheijee et al., 
2007a).
In vivo studies of dietary intake or supplementation with DHA have also shown 
beneficial effects. Stereoacuity appears to be improved in infants when maternal pre­
natal diet was high in oily fish and DHA, and in those infants who were breastfed, 
apparently due to increased DHA intake compared with non-breastfed infants 
(Williams et al., 2001). Benefits have also been shown in neurological function of 
breastfed or dietary DHA-supplemented infants compared with non-supplemented 
formula fed infants (Salem et al., 2001).
Several animal studies on DHA deficiency have been carried out but it has been found 
that a significant decline in neural DHA requires more than one generation of dietary 
deprivation, with a reduction of 50-80% required for impairment of neural function 
(Salem et al., 2001).
Studies have also indicated broader roles for n-3 LC-PUFA, in protecting against 
colorectal cancer mortality in males, possibly through alterations of prostaglandin 
signalling pathways (Caygill and Hill, 1995). Overall, however, studies on the
2 7
1. Introduction
preventative effects of n-3 fatty acids against cancer and in protection against 
cardiovascular disease show conflicting results (Hooper et al., 2006).
1.4.4 DHA peroxidation
Lipid peroxidation is known to occur in situations of oxidative stress. In the past, 
many studies have been carried out on peroxidized metabolites of AA as this fatty 
acid is found in abundance in many tissues. It has been found that measurement of 
AA metabolites can give an accurate measurement of levels of oxidative stress, and 
that some of these metabolites actually have a distinct biological effect and can act as 
mediators of oxidative injury (Morrow and Roberts, 1997). The similarities between 
the structure of AA and DHA -  they are both long chain polyunsaturated fatty acids -  
and the more specific localization of DHA in neural and retinal tissue, suggests that 
DHA metabolites could be used to specifically measure oxidative stress in these 
tissues, and that they may also have downstream pathological effects on the tissue 
(Reich et al., 2000; Musiek et al., 2004).
LC-PUFA, such as DHA, are particularly susceptible to peroxidation due to the 
multiple carbon-carbon double bonds. The process of lipid peroxidation is detailed in 
Figure 1.6. Singlet oxygen reacts with the double bonds in PUFA, resulting in lipid 
hydroperoxide formation (Foote and Clennan, 1995). For initiation of the peroxidation 
cascade, these hydroperoxides must first be decomposed by metal ions, to produce 
alkoxyl radicals. Alternatively, free radicals can cause hydrogen abstraction from lipid 
molecules, forming carbon-centred radicals. The bond energy of hydrogen to the lipid 
carbon atom is weaker in the presence of double bonds, particularly in the case of 
double bonds on both sides of the carbon (i.e. bis-allylic hydrogen), as is the case in 
DHA with its 6 double bonds, making it highly oxidizable compared with more 
saturated fatty acids (Wagner et al., 1994). The rapid reaction of oxygen with the lipid 
radical allows propagation of the cascade as the newly formed peroxyl radical reacts 
readily with further unoxidized lipids, and thus the cycle continues until a termination 
step is provided (Buettner, 1993; Walling, 1995).
Termination involves either production of non-radical products through coupling with 
other radicals, or through hydrogen abstraction from another compound by the lipid
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radical to give a non-radical lipid species and a new radical of the other compound 
which is less reactive (Porter et al., 1995; Yin and Porter, 2005).
LH
+ 10
LOOH
LH
LOH RH
Initiation
+ 0
+ o
LOO* LH
LOOHPropagation
+ ROH
LOOH 
+ R*Termination
Figure 1.6 Simplified diagram o f the stages o f  lipid peroxidation: initiation by singlet 
oxygen or free radicals, propagation, and termination. L = lipid; R = other molecule; 
L*/R• = lipid/other radical; 10 2  = singlet oxygen; H  = weakly bonded hydrogen 
atom; LOOH lipid hydroperoxide; LO*/RO• = alkoxyl radical; LOO• = lipidperoxyl 
radical.
In addition to the cyclic propagation of lipid peroxidation described above, oxidized 
PUFA may undergo further structural and chemical changes. Initially, after hydrogen 
abstraction and oxygen addition to the carbon-centred lipid radical, rapid double-bond 
rearrangement leads to conjugated diene formation (Porter et al., 1995). Possible 
further reactions of the lipid radicals include cyclization, reduction, further oxidation
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and scission (Porter et al., 1995; Bemoud-Hubac and Roberts, 2002; Yin and Porter, 
2005). Different peroxidation products which may be produced from DHA include 
neuroprostanes (NPs) with different ring conformations (A4 and J4), (Fam et al.,
2002), and highly reactive neuroketals (y-ketoaldehydes) by rearrangement of 
intermediates of the NP pathway (Bemoud-Hubac et al., 2001). Additionally, a 
number of truncated phospholipids are produced by free radical-induced cleavage of 
DHA phospholipids (Gu et al., 2003b). Due to the number of sites where hydrogen 
abstraction and downstream reactions can occur on DHA, the non-specific nature of 
autoxidation results in formation of a large, complex mixture of products and isomers 
thereof, as indicated in Figure 1.7 (Porter et al., 1995; Walling, 1995; Yin et al., 
2005).
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Figure 1.7 Simplified scheme o f the chain o f  peroxidation products o f  DHA, 
indicating the families o f  products which may be form ed after initial radical 
formation, followed by multiple additions o f  molecular oxygen, with an end-point o f  
neuroketal (NK; a y-ketoaldehyde derived from DHA) formation (Bemoud-Hubac and 
Roberts, 2002). Many more products are possible depending on the precise location 
o f  the initial radical formation and subsequent oxygen addition.
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1.4.5 Biological effects o f non-enzymatic lipid peroxidation
1.4.5.1 Effects of lipid peroxidation in general
Various studies have been carried out in the past to study the direct effects of different 
lipid peroxidation products on RPE cells. These have included exposure of cells to the 
polyunsaturated fatty acid linoleic acid and its hydroperoxides, with hydroperoxides 
shown to be toxic, causing damage to lysosomes, and leading to formation of 
undegradable intracellular granules (Akeo 1996). Exogenous lipid hydroperoxides are 
also able to cause peroxidation of mitochondrial membranes in vitro (Terrasa et a l ,
2003). Sub-retinal injection of linoleic acid hydroperoxides can result in 
neovascularization as described above, but at higher concentrations they are also 
directly toxic to RPE and photoreceptor cells (Tamai et al., 2002).
Lipid peroxidation products may also have an indirect effect on cell viability by 
causing increased lipofuscin accumulation. This is thought to occur due to interactions 
with other molecules including proteins -  in particular, through Schiffs base 
interactions -  which may result in undegradable material. Lipid aldehydes may also 
act as second messengers, to transmit oxidative damage (reviewed in Esterbauer et 
al., 1991). In summary, there are many possible ways in which lipid peroxidation 
products may cause damage or interfere with normal cell function.
1.4.5.2 Specific effects of peroxidized DHA
As native (unperoxidized) DHA has many beneficial and essential functions, an 
immediate effect of peroxidation would be loss of these functions. Additionally, 
products of non-enzymatic peroxidation of DHA have several specific detrimental 
effects.
Products of DHA peroxidation have been shown to mediate photo-induced oxygen 
uptake, and singlet oxygen and hydroxyl radical generation in vitro (Rozanowska et 
al., 2002b).
Neuroprostanes, like isoprostanes, are formed while DHA is esterified in 
phospholipids. They can then be released by PLA2 (Reich et al., 2000). While still
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attached to the phospholipids, neuroprostanes may have an important effect on 
membrane fluidity and function (Fam et a l , 2002), which could alter the function of 
membrane proteins such as rhodopsin which, as discussed above, are reliant on 
interaction with DHA. It has been found that A4/J4 neuroprostanes readily conjugate 
to glutathione, which would rapidly inhibit the negative effects of these reactive 
compounds, but when they are present in high concentrations, it could result in 
depletion of cellular glutathione and perhaps other antioxidants (Fam et al., 2002).
Neuroketals have been shown to rapidly form lysine adducts in a pathway similar to 
that of isoketals (the peroxidized AA equivalent metabolite), with initial reversible 
formation of SchifTs base adducts, followed by irreversible formation of pyrroles, 
then lactam or hydroxylactam products (Bemoud-Hubac et al., 2001). This may result 
in similar downstream effects to that of isoketal-protein adducts which have been 
shown to inhibit normal membrane protein function (Brame et a l , 2004), and inhibit 
proteasome function, which could explain the formation of lipofuscin (Davies et a l , 
2002). Reactive aldehyde products such as 4-hydroxy-2(£)-hexenal (4-HHE) are also 
known to interact with proteins and also amine groups on phosphatidylethanolamine 
(Bacot et a l,  2003; Bacot et a l,  2007). Additionally, CEP-protein adducts are found 
in drusen, and apparently have a pro-angiogenic effect (Ebrahem et a l,  2006). These 
adducts with proteins could form products which are resistant to lysosomal 
degradation, which has important implications for the POS phagocytosis process. 
They may also be involved in oxidative damage in the retina which is rich in DHA 
and its degradation products (Crabb et a l,  2002; Gu et a l,  2003a; Kawai et a l,  2006).
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1.5 Summary
This introduction has summarised the importance of the RPE in helping to maintain 
normal function of retinal photoreceptors and, therefore, the visual response. It is easy 
to understand, therefore, how dysfunction of the RPE which occurs in age-related 
macular degeneration could lead to loss o f photoreceptor function and downstream 
loss of vision.
The full mechanisms of this pathway, such as the specifics of lipofuscin formation 
and molecules which cause its toxicity, are not yet fully understood. A greater 
understanding is therefore vital to better understand the disease process and 
potentially develop therapeutic or preferably preventative measures to reduce the 
prevalence of AMD.
DHA has many beneficial and essential functions in the retina, particularly in the 
photoreceptor outer segments. Loss of these functions by peroxidation of DHA could 
in itself result in important detrimental effects. However, DHA is present in high 
concentrations and recycled fairly quickly through the POS disc-shedding process, 
such that this may only form a minor pathway of cell dysfunction. More important, 
perhaps, are the various peroxidized DHA metabolites which appear to have similar 
deleterious effects to some AA metabolites in other tissues, and may, therefore, cause 
direct damage to both photoreceptor and RPE cells.
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1.6 Aims of this project
The overall aim of this project is to gain insights into the effects of DHA peroxidation 
products on RPE cell function and lipofuscin formation, and 0f  its possible role in 
age-related RPE dysfunction. To achieve this, the study is divided into several 
specific objectives:
• determine the susceptibility of DHA to oxidation undei physiologically 
relevant conditions, in preparation for experiments with cultuired cells,
• investigate the effects of peroxidized DHA (pDHA) on RPE cell function and 
viability, and identify the pathway of cell death involved (j.e. apoptosis vs. 
necrosis)
• investigate whether selected antioxidants and detoxifying agents can protect 
RPE cells from pDHA toxicity
• examine the mechanisms by which PE protects from pDHA ( photo)toxicity by 
monitoring reactive oxygen species production in its presence
• study the effects of pDHA on lysosomal integrity and enzyme* activity
• determine the effect of pDHA on levels of accumulation of fluorescent 
material and lipofuscin-like granules
It is hoped that these investigations will help to develop a greater understanding of the 
initial processes which may be involved in the development of age-related macular 
degeneration and related blindness.
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Chapter 2:
Materials and methods
2. Materials and methods
2.1 DHA peroxidation
All experiments in this thesis which involved the use of DHA used this fatty acid 
as a component of phospholipids in the form of 1,2-didocosahexaenoyl-s«- 
glycero-3-phosphocholine, not as the free fatty acid form. For simplicity, it is 
referred to as DHA throughout.
2.1.1 Liposome preparation
A lipid film of DHA, as l,2-didocosahexaenoyl-s«-glycero-3-phosphocholine 
(Avanti Polar lipids, Alabaster, AL, USA; cat # 850400C; supplied in 
chloroform), was formed using a rotary vacuum evaporator (Buchi, Flawil, 
Switzerland). The sample flask was maintained at 37 °C and rotated under argon 
(Pureshield, BOC, UK), and the pressure was gradually decreased to 40 mbar as 
the solvent evaporated. To ensure the lipid film was dry and solvent-free, waste 
chloroform was removed from the system, and the pressure was again reduced to 
40 mbar then left for 90 minutes (dark, under argon, room temperature, no 
rotation). To form liposomes, phosphate buffered saline (PBS) was added 
gradually to the flask containing the lipid film, and the film was rehydrated using 
a combination of rotation, vortexing and warming to 37 °C. The final DHA 
concentration was 50 mM. Samples that were to be kept unperoxidized were 
saturated with argon for at least 30 minutes to remove air/oxygen then stored 
under argon at -80 °C. To ensure formation of uniformly-sized liposomes, freshly 
prepared liposomes were put through 5 freeze/thaw cycles (frozen in liquid 
nitrogen then thawed in a 37 °C water bath).
Prior to use in experiments with cultured cells, liposomes were extruded using a 
Liposofast 100J extruder (Glen Creston, UK) with two 200 nm filters, powered 
by compressed argon, to ensure sterility.
2.1.2 DHA peroxidation
DHA films or liposomes to be peroxidized were left on a heating block at 37 °C, 
in the dark, with containers opened weekly to allow replenishment of oxygen. To 
ensure that peroxidation occurred as evenly as possible within each liposome
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batch, equal aliquots were put into identical tubes. The lipid film was kept in a 
dry environment on the inner surface o f a spherical rotary evaporator flask. After 
peroxidation, the lipid film was made into liposomes and analysed and used as 
for the other liposomes. Progress of peroxidation was monitored by extracting 
lipids from the liposome suspension then measuring decay of native lipid and 
formation of oxidation products using absorption and fluorescence spectroscopy, 
with or without initial high performance liquid chromatography (HPLC) 
separation (Kim and LaBella, 1987). These processes are described in greater 
detail below.
In total, 3 sets of lipids were allowed to peroxidize: two sets were peroxidized as 
liposomes, and one was peroxidized as a lipid film and subsequently made into 
liposomes. The first batch of liposomes and the film were allowed to peroxidize 
simultaneously for a total of 175 days. The second batch of liposomes was 
peroxidized for 18 days.
The first batch of liposomes (peroxidized for 175 days) was used for monitoring 
the time-course of lipid peroxidation by absorption spectroscopy, and formation 
of fluorescent products. Lipids peroxidized as a dry film were used to produce 
liposomes and were subsequently used for all the DHA phototoxicity 
experiments in Chapter 4 and lysosomal enzyme activity assays in Chapter 7. 
Finally, the second batch of liposomes (peroxidized for 18 days) was used for 
experiments with antioxidants (all experiments in Chapters 5 and 6), and other 
phagocytosis and lysosomal function experiments (all experiments in Chapter 7 
except for enzyme activity assays).
Concentrations of pDHA stated in methods and results sections below indicate 
starting DHA concentration, i.e. “2 mM pDHA” indicates 2 mM of DHA which 
has been allowed to peroxidize.
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2.1.3 Monitoring o f  peroxidation
2.1.3.1 Extraction of lipids
Lipids were extracted from liposomes using a modified Folch’s procedure (Folch 
et al., 1957; Rozanowska et al., 2004): 0.5 ml liposome suspension in PBS 
(50 mM DHA) was added to 0.8 ml chloroform/methanol (2:1 v/v; both Fisher 
Scientific, UK) and vortexed briefly, then centrifuged. This resulted in formation 
of an upper polar phase enriched with methanol/PBS, and a lower chloroform- 
enriched phase, as shown in Figure 2.1. The two phases were removed and 
analysed separately. Although these phases are likely to be slightly contaminated 
with components of the other phase (i.e. small amounts of chloroform in the 
upper phase and methanol and water in the lower phase), they are referred to 
from this point as the “methanol/PBS” and “chloroform” phases, to indicate the 
predominant solvents present.
Methanol/PBS phase
Interphase 
Chloroform phase
Figure 2.1 Diagrammatic representation o f  the layers formed in chloroform/ 
methanol extraction o f  highly per oxidized pDHA liposomes.
2.1.3.2 UV-visible absorption spectroscopy
For sample components solubilized in the chloroform phase, 2 ml of chloroform 
were added to 450 pi of extracted sample and absorption spectra measured in a 
quartz cuvette with a 1 cm path length for wavelengths from 200 to 700 nm (U- 
2800 UV-VIS Spectrophotometer (Hitachi) with Hitachi UV Solutions software). 
Chloroform was then evaporated off by passing argon gas over the sample while
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heating to 37 °C on a heating block in the dark. The dried lipid film was then 
dissolved in 2 ml acetonitrile (Aldrich, UK) + 100 pi methanol, and spectra 
measured. Methanol/PBS phase samples (500 pi) were initially diluted in 2 ml 
methanol + 250 pi PBS for measurement o f spectra.
When removing extracted samples as described above, a small amount of each 
phase was left in the tube to prevent contamination from the other phase during 
removal. To maximize the total amount o f sample extracted, repeat extractions 
were carried out for certain experiments (as stated in results below): the 
appropriate volume removed from each phase was replaced with “clean” 
methanol/PBS or chloroform phases obtained by mock extraction of PBS using 
the same method described for liposomes above (i.e. using PBS instead of 
liposome suspension). Samples were vortexed and centrifuged again, further 
samples removed, then the process was repeated. For spectral measurements after 
repeat extraction of the chloroform phase, the samples were dried under argon as 
above and re-dissolved in acetonitrile + methanol (20:1, v/v). For the 
methanol/PBS phase, repeat extraction samples (500 pi each) were combined in 
a single cuvette and initial spectra measured without further addition of solvent.
For spectral measurements of both phases, multiple 1 in 10 dilutions of the 
samples were carried out and the spectra re-measured to ensure the upper limit of 
absorbance was below 1.5 at the wavelengths of interest. This allowed the same 
sample to be used to monitor absorption at >400 nm (in the more concentrated 
samples), and to monitor the upper limit of the remaining unperoxidized DHA 
and formation of markers of peroxidation in more dilute samples.
Baseline measurements were carried out by the spectrophotometer across the 
same spectrum for each of the relevant solvents to allow automatic background 
subtraction. The solvents used consisted of: fresh solvents (either chloroform or 
20:1 acetonitrile/methanol as appropriate) for samples extracted in the 
chloroform phase, and an aliquot of the methanol/PBS phase from “mock” PBS 
extraction for spectral measurements of the extracted methanol/PBS phase.
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2.1.3.3 Fluorescence spectroscopy
Fluorescence emission spectra were measured using a F4500 Fluorescence 
Spectrophotometer (Hitachi) with Hitachi FL Solutions software. Samples were 
excited at wavelengths selected from peaks in the absorption spectra (i.e. 230 and 
270 nm) and also the wavelength commonly used to measure fluorescence 
properties of oxidized lipids and lipofuscin (360 nm) (Gutteridge et a l , 1982; 
Kim and LaBella, 1987). Emission intensity was monitored over a spectrum of 
wavelengths starting above the excitation wavelength. For all measurements, 
samples were used at a suitable dilution where absorbance was <0.1 (1 cm 
pathlength) at the excitation wavelength. Solvent backgrounds were measured 
separately. Spectra were not corrected for variations in photomultiplier 
sensitivity over the spectral range in the spectrophotometer.
2.1.3.4 High performance liquid chromatography
For analysis using HPLC, DHA fatty acids were hydrolyzed from the 
phospholipid headgroup (DeMar et al., 1996). After repeat chloroform/methanol 
extractions and drying under argon, samples were saponified by re-suspending in 
2 ml of argon-saturated potassium hydroxide in ethanol, and heating at 100 °C 
for 30 minutes. After cooling to room temperature, 1 ml of argon-saturated dH20 
and 100 pi of concentrated hydrochloric acid were added. The free fatty acids 
were extracted twice with 3 ml of argon-saturated hexane and dried under argon. 
Samples were then solubilized in 3:1 methanol/acetonitrile (v/v), filtered using 
Vectaspin micro filters (0.45 pm, polypropylene; Whatman, UK), then analysed 
by reverse phase HPLC using a Waters 2695 Separations Module with 
Millennium software (Waters, UK). Separation was carried out isocratically 
using an Ace 5 C8 column (150 x 4.6 mm, 5 pm particle size; Hichrom Limited, 
UK), with mobile phase consisting of acetonitrile/HPLC-grade water/HCl 
(90/10/0.05%, v/v/v) at a flow rate of 1 ml.min'1. The elution profile was 
monitored using a Waters 996 Photodiode Array Detector (Waters). Prior to 
running samples, the column was equilibrated with mobile phase solvent until 
absorption of the eluent at 210 nm stabilized, then 10 pi of sample was injected, 
and elution monitored for 10 minutes at 190-600 nm.
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2.1.4 Preparation o f lipid samples containing antioxidants
To produce liposomes containing pDHA and lipophilic antioxidants, previously 
peroxidized pDHA liposomes were extracted by the modified Folch’s method 
described above. After addition of selected antioxidants (described below), the 
lipid-antioxidant mixtures were dried using a rotary evaporator. Liposomes were 
then produced by hydration with Dulbecco’s PBS (D-PBS; GIBCO), and 
saturated with argon for 20 minutes and put through 5x freeze/thaw cycles prior 
to use. Samples were stored at -80 °C under argon.
2.1.4.1 Zeaxanthin and a-tocopherol
Zeaxanthin (a generous gift from DSM Nutritional Products (Switzerland)), was 
solubilized in ethanol and absorbance at 454 nm measured to calculate the 
concentration using the molar absorption coefficient of 1.52 x 105 M^.cm*1 
(Wrona et al., 2004). a-Tocopherol (Sigma) was weighed and solubilized in 
chloroform. Antioxidants in their respective solvents were then added to the 
extracted pDHA.
Alternatively, zeaxanthin was added to liposomes immediately prior to cell 
exposure by making a stock solution in dimethyl sulfoxide (DMSO; Sigma), and 
adding this directly to pDHA liposome solutions. In these experiments, all wells 
contained 0.2% (v/v) DMSO either as a solvent for zeaxanthin or as a carrier 
control.
2.1.4.2 Phosphatidylethanolamine
Phosphatidylethanolamine (PE) as l-palmitoyl-2-oleoyl-s«-glycero-3-phospho- 
ethanolamine (POPE; Avanti Polar lipids, USA; cat # 850757c; supplied in 
chloroform), was added directly to extracted pDHA lipids. 1 -Palmitoyl-2-oleoyl- 
s«-glycero-3-phosphocholine (POPC; Avanti Polar lipids, USA; cat # 850457c) 
was used as a control in these experiments, with liposomes formed as for POPE.
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2.1.4.3 Glutathione, glutathione 5-transferase and A-acetylcysteine
Solutions of glutathione (GSH; Sigma), glutathione 5-transferase (GST; equine 
liver; Sigma) and A-acetylcysteine (NAC; Sigma) were prepared in D-PBS and 
added to pDHA liposomes immediately prior to cell exposure, either individually 
or in combination.
2.2 Cell culture
The ARPE-19 cell line (American Type Culture Collection (ATCC), through 
LGC Promochem, UK), a human RPE cell line, was used to test the effects of 
pDHA and rose bengal.
2,2.1 Standard cell culture
Cells were grown in a 1:1 mixture of Dulbecco’s modified Eagle’s medium and 
Ham’s F12 medium (DMEM:F12; GIBCO, UK). This medium was 
supplemented with antibiotics (100 pg.ml'1 streptomycin, 100 pg.ml'1 kanamycin 
and 60 pg.ml*1 penicillin; Sigma, UK), Fungizone (1.25 (xg.ml'1 Amphotericin B; 
GIBCO), and 10% v/v heat-inactivated fetal calf serum (FCS; Bio-West, UK) 
until the cells reached confluence (after approximately two days). FCS was then 
reduced to 2% until cells were required for experiments. Cells were maintained 
at 37 °C in a humidified incubator containing 5% CO2 and 95% air, and medium 
was changed every 3 days. Cell populations were initially built up in 75 cm 
flasks, then split into 25 cm2 flasks, or 12- or 24- well plates as required for 
experiments.
To subculture cells, culture medium was aspirated and cells were rinsed with 
sterile PBS. Cells were detached by adding 0.25% (w/v) trypsin + 0.02% EDTA 
(both Sigma) in PBS and incubating at 37 °C for 2 minutes. Trypsin was then 
deactivated by adding growth medium with 10% FCS, and cells were transferred 
to new flasks or multi-well plates (at an approximate surface area ratio of 1:3).
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2.2.2 Long-term storage
For storage, cells were trypsinized as described above. After addition of medium 
with 10% FCS, cells were transferred to 15 ml centrifuge tubes and centrifuged 
at 700 x g  for 5 minutes. The supernatant was removed and cells were re­
suspended in FCS with 10% v/v dimethylsulphoxide (DMSO; Sigma). Cells 
were then put in cryovials and frozen, initially in an isopropanol cryostorage box 
at -80 °C before being transferred to liquid nitrogen storage.
2.2.3 Confirmation o f cell identity
An antibody against cytokeratin 18, a protein expressed by RPE cells both in vivo 
and in vitro (McKechnie et al., 1988; Hunt and Davis, 1990) was used to 
positively identify cells used here as RPE cells, rather than any of the non- 
epithelial neuronal cell types present in the retina, which would not express this 
marker.
Cells were grown on sterile glass coverslips in 24-well plates until nearly 
confluent. Medium was aspirated and the cells were washed with PBS. The cells 
were fixed by immersion in 70% ethanol for 5 minutes, followed by PBS washes, 
then permeabilized with 0.1% Triton X-100 (v/v in PBS; Sigma) for 10 minutes 
and washed again with PBS. Cells were then incubated simultaneously with anti- 
cytokeratin 18 antibody (FITC conjugated; Sigma F4772) at a 1:100 dilution in 
PBS, and Hoechst 33342 (bisBenzamide; Sigma), which stains AT-rich regions 
of double-stranded DNA and should therefore label nuclei of all cells (3 pg.m r1 
final concentration in the antibody solution). Incubation was carried out for 2 
hours in the dark. After washing with PBS, coverslips were mounted on slides in 
Hydromount (National Diagnostics) and slides were stored (4 °C, dark) until 
required. Cells were visualized using appropriate filters (Hoechst: 340-380 nm 
excitation, 450-490 nm emission; cytokeratin-FITC: 450-490 nm excitation, 
>515 nm emission) on a Leica DMRA2 upright microscope, and images obtained 
using a Leica DC500 CCD camera and Leica QFluoro software (Leica, UK).
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2.3 Exposure of cells to (p)DHA or rose bengal, and light
Rose Bengal stock solution was made in D-PBS, and diluted further to 
concentrations between 0.05 and 1 jxM as required. (p)DHA liposomes, 
previously prepared as a stock solution o f 50 mM in PBS, were further diluted to 
required concentrations (see individual chapters) in D-PBS. ARPE-19 cells 
grown in either multi-well plates or 25 cm flasks were rinsed twice with PBS, 
then (p)DHA liposomes or rose bengal were added.
Light exposure was carried out with a Sol lamp (Honle UV Ltd, Birmingham; see 
Figure 2.2 for description of setup). Heat and UV filters (Lee Heat Shield and 
#226 Lee U.V. respectively; Lee Filters, UK) were placed above the lamp in all 
experiments. Additionally, a green filter was used for rose bengal experiments 
(#090 “dark yellow green” filter; Lee Filters, UK). Irradiance spectra of the light 
to which cells were exposed are shown in Figure 2.3.
Cell culture plate(s) 
m— UV/colour filter(s) 
G lass plate 
(adjustable height)
t
.e e  heat shields
Honle Sol 
light source
Figure 2.2 Experimental setup for light exposure experiments, with cells 
illuminated from below. Irradiance and temperature measurements were taken at 
the position on the glass plate where the cell culture plates were subsequently 
put fo r  each experiment.
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Plates or flasks were placed above the lamp for 1 hour. For dark experiments, 
plates were wrapped in black foil and placed above the lamp to mimic 
temperature and air conditions experienced by light-exposed cells. Silver foil was 
placed between the black foil and the glass plate to prevent excess heat 
absorption. Spectral irradiance of the light source between 380 and 780 nm was 
measured in each experiment using a handheld spectroradiometer (Specbos 1201 
with JETI LiMeS software; Glen Spectra, UK) to ensure consistency. 
Temperature was also monitored. If required, the light intensity was altered 
initially crudely by adjusting the height of the glass plate relative to the lamp, 
then more subtly by adding individual UV filters to act as additional neutral 
density filters.
After 1 hour exposure, liposome or rose bengal solutions were aspirated, cells 
washed twice with D-PBS, then either used immediately for further experiments, 
or returned to the incubator with normal growth medium containing 2% FCS for 
a further incubation period prior to processing.
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Figure 2.3 Irradiance spectra o f  light to which cells were exposed. (A) White 
light with Lee UV and heat filters, adjusted to 15 mW.cm2 for pDHA 
experiments. (B) Lee UV and heat filters with 090 “Dark Yellow Green” filter, to 
produce predominantly green light at 2.8 mW .cm2 fo r rose bengal experiments.
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2.4 Cytotoxicity assays
2.4.1 Microscopy for cell morphology
Cells were visualized using an Olympus 1X70 inverted microscope configured 
for phase contrast imaging, and images obtained using a Spot RT colour CCD 
camera and Spot Advanced software (Diagnostic Instruments Inc, UK).
2.4.2 MTT assay
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) is reduced 
to formazan crystals by active mitochondria in living cells. Crystals can be 
dissolved and absorbance measured to provide a rapid assay of cell viability 
(Mosmann, 1983).
After exposure of cells to DHA or rose bengal in 24-well plates with or without 
post-incubation in fresh medium, cells were washed with PBS, and 250 pi MTT 
(Sigma; 0.5 m g.m f1 in PBS) was added to each well. Plates were incubated at 
37 °C for 1 hour. MTT solution was aspirated and formazan crystals dissolved by 
addition of 250 pi acidified isopropanol (isopropanol with 0.04 M HC1). Samples 
were transferred to 96-well plates and absorbance was measured at 590 nm in a 
microplate reader (Multiskan Ascent, Labsystems). Background measurements 
were carried out in cells exposed only to acidified isopropanol (i.e. no rose 
bengal/DHA, no MTT), or in later experiments, a reference filter at 690 nm was 
used, with absorbance values at this wavelength automatically subtracted off the 
absorbance at 590 nm.
For rose bengal experiments, which used multiple timepoints, mitochondrial 
viability after treatment was calculated as a percentage of control (i.e. 0 mM rose 
bengal from the same plate, and after identical incubation periods as the treated 
cells), after background subtraction. For pDHA experiments, mitochondrial
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viability was calculated as a percentage of dark control (i.e. 0 mM pDHA in the 
dark-maintained plate of paired light/dark exposures).
2.4.3 Monitoring o f membrane integrity
Propidium iodide (PI) can not normally cross the intact cell membrane of live 
cells, therefore, it is only taken up by cells showing loss of membrane integrity 
and is commonly used as a marker of necrotic cell death. Uptake could also 
indicate alteration in membrane structure or function due to direct interaction 
with peroxidized lipids. After entering the cell, PI binds to DNA thus labelling 
nuclei of cells with compromised membranes.
Following exposure to pDHA and light at 15 mW.cm' , cells were washed then 
labelled immediately, or put in fresh medium for 2 hours first then labelled. Cells 
were incubated for 15 minutes at 37 °C in 1 pg.m f1 PI in PBS. Cells were co­
labelled with 3 pg.m f1 Hoechst 33342 to allow total cell numbers to be counted. 
Cells were washed and imaged immediately using the Olympus 1X70 inverted 
microscope described above, using filter sets optimized for blue emission (for 
Hoechst; excitation: 330 -  385 nm; longpass emission filter: > 420 nm) and red 
emission (for PI; excitation: 510 -  550 nm; longpass emission filter: > 590 nm).
2.4.4 TUNEL assay for cleavage o f DNA
One of the biochemical changes of apoptosis is the non-random cleavage of 
DNA into 180 base pair fragments. This cleavage results in exposure of free 3’- 
OH termini which can be enzymatically labelled with the TUNEL (Terminal 
dUTP Nick-End Labelling) assay (Gavrieli et al., 1992).
TUNEL was carried out using the ApopTag® Plus Rhodamine In Situ Apoptosis 
Detection Kit (Chemicon International, USA), according to the instructions 
supplied with the kit. Cells were grown in 4-well chamber slides, and used after 
at least 1 week in 2% FCS medium. After exposure to pDHA +/- 15 mW.cm '2 
light, cells were incubated in medium for 12 hours, then rinsed in PBS. Cells 
were then fixed in 1 % paraformaldehyde for 1 0  minutes at room temperature,
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then washed with PBS twice. Post-fixation was carried out with 2:1 
ethanol:acetic acid for 5 minutes at -20 °C. After washing with PBS, 
equilibration buffer (supplied with kit) was applied for 10 seconds. This was 
removed and cells were incubated with working strength TdT enzyme (prepared 
according to kit instructions) for 1 hour at 37 °C. Working strength stop/wash 
buffer (from kit) was added and left to incubate for 1 0  minutes at room 
temperature after 15 seconds of agitation. Cells were washed with PBS, and 
working strength anti-digoxigenin-rhodamine conjugate (affinity purified sheep 
polyclonal antibody) was added and left for 30 minutes at room temperature, in 
the dark. Cells were again washed with PBS. Vectashield mounting medium 
containing Hoechst 33342 (to label all cell nuclei; 3 pg.m f1) was added and a 
coverslip applied. Cells were imaged using a Leica DMRA2 upright microscope 
and images obtained using a Leica DC500 CCD camera and Leica QFluoro 
software (Leica, UK).
2.5 Effects of PE on production of reactive oxygen species by 
pDHA
2.5.1 Singlet oxygen production
Photogeneration and decay of singlet oxygen was monitored by time-resolved 
detection of phosphorescence at 1270 nm by a nitrogen-cooled germanium 
detector (Applied Detector Co., Fresno, CA, USA) coupled to an Agilent 
digitizing scope (Infiniium 54830B DSO, Agilent, Santa Clara, USA) interfaced 
with a Rise computer (Acom, Swadlincote, UK) (Rozanowska et a l , 1998). 
Photoexcitation of the sample was induced by a 5 ns laser pulse at 420 nm from a 
Q-switched Nd:YAG laser (Continuum Surelite II; Santa Clara, USA) equipped 
with an optical parametric oscillator (Panther OPO; Continuum, Santa Clara, 
USA). Apparatus is shown in Figure 2.4. The laser intensity reaching the sample 
was reduced by insertion of neutral density filters into the light path. The 
transmission spectra of these filters were measured using a spectrophotometer to 
calculate the reduction in laser intensity caused by insertion of one or more filters 
into the light path.
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Singlet oxygen decay was fitted to an exponential curve (excluding the initial 
contribution from laser scatter and fluorescence), extrapolated to time zero 
(corresponding to the laser pulse) to calculate initial emission intensity as a 
function of laser intensity (see Figure 2.5). The relative laser energy of each 
pulse was measured by a photodiode (positioned before the neutral density 
filters) and used to normalize the emission intensity values obtained. Normalized 
initial emission intensity values were then plotted as a linear function of laser 
intensity (i.e. intensity of the laser beam reaching the sample after passing 
through the neutral density filters). In concentration-matched samples, slopes of 
the fitted straight lines gave the relative singlet oxygen yield. Quantum yields of 
singlet oxygen generation (i.e. the number of singlet oxygen molecules generated 
per photon absorbed) were calculated using measurements obtained after 
matching sample absorbances to that of all-rra«s-retinal (ATR; quantum yield of 
0.30 ± 0.04 (Rozanowska et al., 1998)), using Equation 2.1 below.
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Figure lASchematic diagram o f singlet oxygen detection apparatus. OPO: 
optical parametric oscillator; Qz: quartz plate, PhD: photodiode -  for  
measuring relative laser pulse energy; PB: Pellin Broca prism; Sh: shutter; FI: 
neutral density filters (0-16) for regulation o f  laser intensity; L: diverging lens 
(optional); S: sample in a quartz cell; F2: Si filter cutting o ff stray light below 
1100 nm and an interference filter with transmission maximum at 1260 nm; blue 
line = laser light path.
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Equation for fitting:
y = A0e"kt + A b
A0 = initial em ission intensity 
Am = emission intensity at t—►«> 
k = rate constant 
t = time 
t  = lifetime = 1/k
Figure 2.5 Hypothetical curve fi t  by an exponential equation to model the decay 
o f  singlet oxygen (monitoring signal intensity at 1270 nm over time), showing the 
equation o f  the curve and values used in further analysis.
^  _ O a t r  ’ S l o p e ,  
s lop eATR 
O = quantum yield 
slope = slope of fitted initial em ission intensity values  
x = sam ple 
ATR = all-frans-retinal
Equation 2.1 Equation for calculation o f  quantum yield o f  singlet oxygen 
production, using ATR as a standard singlet oxygen producer.
2.5.2 Laser flash photolysis to monitor transient formation
Laser flash photolysis experiments (Bensasson et al., 1993a) were carried out 
with a Q-switched Nd:YAG laser (Continuum Surelite II; Santa Clara, USA) as 
the excitation source (Rozanowska et al., 1998). Samples were exposed to a 5 ns 
laser pulse at 420 nm and absorbance of transient species was monitored between 
300 and 660 nm (at 10 nm intervals) using a xenon lamp as a monitoring light 
source, two monochromators (Spectra Kinetics Monochromators, Applied 
Photophysics, UK), and a photomultiplier coupled to a digitizing scope 
(Infiniium 54830B DSO Agilent, Santa Clara, USA) interfaced with a Rise 
computer (Acom, Swadlincote). See Figure 2.6 for a diagram of the apparatus. 
Transient difference spectra were produced by plotting averaged absorbance at
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selected time points in the kinetic measurements at each wavelength (multiple 
adjacent data points surrounding each selected time point were averaged).
To determine the effect of oxygen on the rate of decay of the observed transient 
species and recovery to the ground state, measurements were repeated at key 
wavelengths (i.e. wavelengths corresponding to maxima and minima in the 
transient difference spectra), in both argon-saturated (oxygen-depleted) and air- 
equilibrated (oxygen present) conditions. The bimolecular rate constant of 
quenching of the transient by oxygen in air-equilibrated benzene was calculated 
using the rate constants obtained after fitting to an exponential equation, and 
Equation 2.2 below.
_ ^air ^Ar 
°  [ 0 2]benz
kQ = rate of quenching by oxygen (M'1s'1) 
kajr = rate constant in air-saturated sam ple  
kAr = rate constant in argon-saturated sam ple  
[ 0 2]benz = [ 0 2] in air-saturated ben zen e  
= 1.91x10'3 M *
Equation 2.2: Equation for calculation o f  the bimolecular rate constant o f  
quenching o f  the transient(s) by oxygen in air-saturated benzene at room 
temperature. *(Murov, 1973).
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Figure 2.6 Schematic diagram o f flash photolysis apparatus. OPO: optical 
parametric oscillator; Qz: quartz plate, PhD: photodiode -  for measuring 
relative laser energy; PB: Pellin Broca prism; Sh: shutters; S: sample in a 
quartz cell; PhM: photomultiplier; L: lenses forming analysing beam; blue line: 
laser light path; green line: analysing light path.
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2.5.3 Superoxide assay
Superoxide production was measured using a previously published assay which 
monitors superoxide-mediated reduction of cytochrome C (Boulton et al., 1993). 
The assay medium consisted of Hank’s balanced salt solution (HBSS pH 7.6; 
Sigma), 50 pM cytochrome C (Sigma) and 0.05% cetyltrimethylammonium 
bromide (CTAB; Sigma), with or without liposomes containing 0.1 mM pDHA 
in the presence of 40 mol% POPE or POPC. Selected samples also contained 
superoxide dismutase (SOD: 250 U.ml'1; Sigma) or catalase (250 U.m f1; Sigma) 
Stock solutions of each reagent were made in HBSS.
Samples were prepared in cuvettes with an optical path length of 1 cm, and were 
stirred throughout. Initial measurements were taken at t = 0 minutes, immediately 
after the reagents were combined, then samples were exposed to light and 
spectral measurements were repeated every 10-15 minutes, as indicated. Controls 
consisted of: (a) assay buffer without liposomes, and (b) assay buffer with 
liposomes, dark-maintained throughout (except for the monitoring light during 
spectral measurements). Absorbance increases at 550 nm were used to calculate 
reduction of cytochrome C using the extinction coefficient of 21 mM '1.cm' 1 
(Boulton et al., 1993). These values indicate concentrations of superoxide 
responsible for the observed cytochrome C reduction. Where necessary, due to 
variations in background scattering, the absorbance at 680 nm was first 
subtracted off the spectra, and samples were normalized at the isosbestic points 
at 542 and 556 nm.
Results for samples with pDHA in the light, pDHA in the dark and pDHA + 
catalase in light were compared by nonlinear regression, fitting data to an 
exponential curve (Figure 2.7), followed by statistical comparisons of k and Aoo 
values. This allowed comparison of pDHA + POPC and pDHA + POPE.
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Equation for fitting:
y = y0+ A*>(1-e " k')
y0 = initial value at t=0 
A . = value a tt— 
k = rate of product formation 
t = time
Time
Figure 2.7 Hypothetical curve fi t  by exponential equation to model increase in 
levels o f  reduced cytochrome C, showing the equation o f  the curve and values 
used in further analysis
As other data sets (i.e. no pDHA, pDHA + SOD) did not fit to an exponential 
curve, further comparisons were carried out on levels of cytochrome C reduction 
at 60 minutes for all samples, within their respective groups i.e. pDHA + POPC 
or pDHA + POPE.
2.6 Lysosomal function studies
2.6.1 Isolation o f bovine photoreceptor outer segments
Retinas were isolated from fresh bovine eyes. Muscle and fat were removed from 
the orbit, and eyes put into Betadine solution (AAH, UK). Eyes were transferred 
to a tissue culture hood for the remainder of the process. An incision was made in 
the orbit, posterior to the cornea, using a scalpel, and scissors were used to 
remove the anterior segment and vitreous. The retina was gently detached from 
the eye cup and cut at the optic nerve. Retinas were either refrigerated and used 
within 24 hours or frozen at -80 °C and thawed as required.
POS isolation was carried out following a modified version of the procedure 
published by Papermaster (Papermaster, 1982). Sterile conditions were 
maintained throughout. All solutions were filtered and pre-chilled and ice was 
used to ensure samples were maintained at a temperature of ~4 °C. 
Homogenization medium (see Table 2.1) was added to retinas (15 ml per 25
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retinas) and a Teflon hand-held homogenizer was passed through the mixture 
three times. The homogenate was transferred to a cold centrifuge tube then back 
into the homogenizer tube, and homogenization repeated. The homogenate was 
centrifuged at 1500 x g for 4 minutes at 4 °C (U-32R; Hettich Zentrifugen, 1617 
rotor; Boeco, Germany).
Fresh retina 
(34% w/w)
Frozen retina 
(30% w/w)
42% sucrose 191 g 162 g
1 M NaCl 13 ml 13 ml
0.1 M MgCl2 0.4 ml 0.4 ml
1 M Tris-acetate 1 ml 1 ml
Add ddH2Q to obtain: 230 g 226 g
Table 2.1 Composition o f  homogenization media fo r  POS isolation from fresh or 
frozen bovine retinas.
The supernatant was decanted into centrifuge tubes, and the pellet was re­
homogenized as above with a further 15 ml homogenization buffer, and re­
centrifuged. The total volume of supernatant after the 2 centrifugations was 
determined before transferring to a cold 500 ml conical flask. Two equivalent 
volumes of 0.01 M tris-acetate buffer (ice cold, pH 7.4) were added gradually 
while stirring. The POS were then pelleted by centrifugation at 1500 x g  for 4 
minutes at 4 °C. The pellet was re-suspended in 1.10 g.ml' 1 sucrose solution (see 
Table 2.2) and repeatedly passed through an 18- then 21-gauge needle, rapidly 
ejecting the solution against the wall of the plastic tube each time.
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Density (g.ml'1)
1.10 1.11 1.15
42% sugrose (g) 31.2 34.2 46.5
0.1 M MgCl2 (pi) 50 50 50
1 M tris-acetate (pi) 50 50 50
Add ddH20  to obtain: 55 55.5 57.5
Table 2.2 Composition o f  sucrose solutions used fo r  sucrose gradient during 
POS isolation from bovine retinas.
Sucrose gradients were prepared using 1.15 and 1.11 g.ml' 1 sucrose solutions 
carefully layered into centrifuge tubes to ensure negligible mixing at the 
interface. The crude POS suspension in 1.10 g.ml' 1 sucrose was then carefully 
layered onto the gradient. After centrifugation at 50000 * g  for 30 minutes at 
4 °C in an ultracentrifuge (Sorvall Ultra-Pro 80, Sorvall Products, L.P., 
Newtown, Connecticut), POS were carefully removed from the 1.11/1.15 g.ml*1 
interface using a sterile Pasteur pipette. POS were recovered by dilution in 
0.01 M tris-acetate and centrifugation in the ultracentrifuge at 45000 * g  for 20 
minutes. The resultant POS pellet was then re-suspended in D-PBS and yield 
counted using a haemocytometer. After each isolation procedure a small amount 
of POS suspension was added to a cell culture flask with medium and monitored 
for at least 24 hours to ensure no bacterial contamination. Prior to experimental 
use, POS were diluted to the required concentration in normal cell culture 
medium.
2.6.2 Feeding cells with POS + pDHA
For feeding experiments, controls were fed with medium only (DMEM:F12 
medium containing 2% FCS), and other treatments included POS, pDHA or POS 
with pDHA. POS were fed at lx l0 7 POS.ml' 1 (Mukheijee et a l , 2007b) and 
multiple pDHA liposome concentrations were used, as indicated in the results 
section. After preparation of different combinations of medium/POS/pDHA, all
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samples were sonicated for 15 minutes, with the aim of aiding insertion of pDHA 
lipids from liposomes into POS. The solutions were applied to cells and medium 
was changed every two days, with POS/pDHA included in each feed. Each 
treatment was carried out in duplicate or triplicate wells of a 24-well cell culture 
plate, with “n” indicating total number of separate plates.
2.6.3 Acridine orange labelling to monitor lysosomal integrity
After feeding with pDHA +/- POS for 2 weeks, cells were detached from 24-well 
plates as described in Section 2.2.1 and either kept in the dark or exposed to light 
(15 m W .cm ') for 1 hour. Cells were then incubated with 5 pg.ml' acridine 
orange for 15 minutes at 37 °C to allow uptake (Brunk et al., 1997). After 
labelling, cells were centrifuged at 700 x g  then re-suspended in PBS to remove 
excess acridine orange. Acridine orange uptake and distribution in the cell was 
then monitored by either flow cytometry or microscopy.
2.6.3.1 Microscopy of acridine orange loaded cells
To allow for quick localization of cells using the microscope, thus reducing the 
photosensitizing effects of acridine orange, cell nuclei were labelled using 
Hoechst 33342 (3 pg.ml'1) simultaneously with acridine orange labelling. Cells 
were rinsed then put on a microscope slide and covered with a coverslip 
immediately prior to imaging using a fluorescence microscope (Leica DM 6000B 
with a Leica DFC 350 FX camera; Leica, UK).
2.6.3.2 Flow cytometry of acridine orange loaded cells
For flow cytometry, cells were transported to the flow cytometer (BD 
FACSCalibur with CellQuest software, BD Life Sciences, UK) on ice, in a dark 
container. Cells were taken up by the flow cytometer and passed through a laser 
beam at 488 nm and forward and side scatter (to determine size and granularity 
of the cells respectively) and fluorescence emission data were collected. 
Detectors and filters allowed separation of emitted fluorescent light into three 
channels with different peak wavelengths: FL1 = 530 nm emission, FL2 = 
585 nm and FL3 = 650 nm. Sensitivity of the detectors was altered to ensure that 
the fluorescence signal of unlabelled cells was limited to the lowest decade of the
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fluorescence intensity histogram, and that labelled cells did not exceed the limits 
of the 4 decade scale.
Prior to data collection, a gate was set on the forward scatter (FSC) vs. side 
scatter (SSC) plot to exclude cell debris in the bottom left hand comer. For each 
sample, data was collected until 1 0 , 0 0 0  “events”, assumed to be cells, were 
counted within this gate. For acridine orange labelling experiments, FSC and 
SSC data was collected for each sample, as were FL1 (green emission) and FL3 
(red emission). Data analysis and presentation was carried out using WinMDI 2.8 
software (The Scripps Research Institute, USA).
2.6.4 Lysosomal enzyme assays
To determine whether pDHA affects RPE lysosomal enzyme function, 
phosphatase and glucosaminidase activities were assayed using p-nitrophenyl 
phosphate or /?-nitrophenyl p-D-glucosaminide substrates (Sigma, UK) 
respectively, with active enzymes expected to release p-nitrophenol which can be 
measured spectrophotometrically (Shamsi and Boulton, 2001).
Cells were lysed in 0.2% Triton X-100 (Sigma) in dFUO for 5 minutes at room 
temperature on a rocker. 25 pi of cell lysate was combined with 25 pi pDHA in 
D-PBS, or D-PBS alone, in 96-well plates. Alternatively, purified acid 
phosphatase enzyme (from wheat germ; Sigma, UK) was used instead of cell 
lysate. Light (or dark) exposure was then carried out, then plates were removed 
from the lamp and enzyme activity assays were carried out as described below.
For all assays, controls were carried out with no cell lysate/enzyme (but with all 
concentrations of pDHA) to monitor background absorbance, and also with no 
substrate. A standard curve was created using 100 pi p-nitrophenol (Sigma, UK) 
at a range of concentrations in 0.1 M acetate buffer (pH 4.5), plus 100 pi of 
0.2 M NaOH. The Pierce BCA Protein Assay (Section 2.6.4.3) was carried out in 
parallel in each experiment to allow normalization of enzyme activity to protein 
levels.
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2.6.4.1 Phosphatase enzyme activity
After light treatment, 50 pi of 10 mM p-nitrophenyl phosphate in acetate buffer 
(0.2 M, pH 4.5) was added to the pDHA + lysate/enzyme mixture. Samples were 
incubated for 30 minutes at 37 °C. The reaction was then stopped by addition of 
100 pi NaOH (0.2 M). Absorbance at 405 nm was measured in a plate reader.
2.6.4.2 Glucosaminidase enzyme activity
After light treatment, 50 pi of 10 mM /?-nitrophenyl P-D-glucosaminide in citrate 
buffer (0.2 M, pH 4.5) were added to the pDHA + lysate/enzyme mixture. 
Samples were incubated for 45 minutes at 37 °C. The reaction was stopped by 
addition of 100 pi of 0.8 M glycine-NaOH. Absorbance at 405 nm was read in a 
plate reader.
2.6.4.3 Measurement of protein concentration
Protein concentration in cell lysates was measured using the commercially 
available Pierce BCA Protein Assay kit (Thermo Scientific, UK). This 
colorimetric assay measures reduction of Cu2+ to Cu1+ by proteins using 
bicinchoninic acid (BCA). The microplate procedure was followed, according to 
the kit instruction booklet. Briefly, 25 pi of each standard or sample was put in a 
96-well plate and combined with 200 pi of freshly made working reagent: a 50:1 
combination of BCA reagent A (containing sodium carbonate, sodium 
bicarbonate, BCA and sodium tartrate in 0.1 M sodium hydroxide) : BCA 
reagent B (4% cupric sulphate). Incubation was carried out at 37 °C for 
30 minutes. Plates were then cooled to room temperature and absorbance at 
570 nm was measured using a plate reader. A standard curve was carried out 
simultaneously for each experiment using 0 - 2  m g.m f1 bovine serum albumin 
(BSA). All samples were assayed in triplicate wells.
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2.6.5 Intracellular deposit formation
2.6.5.1 Flow cytometry analysis of changes in fluorescence
After long-term feeding of ARPE-19 cells with POS and/or pDHA, cells were 
washed with PBS then detached with trypsin as described in Section 2.2.1. They 
were then transported on ice to the flow cytometer immediately and data 
collected as for acridine orange experiments described in Section 2.6.3.2 above, 
but with detectors optimized for unlabelled cells used in this experiment. Data 
was collected for FSC, SSC and FL1 channels.
2.6.5.2 Transmission electron microscopy for monitoring deposit formation
All reagents for preparation of transmission electron microscopy (TEM) 
specimens were purchased from Agar Scientific (UK) unless stated otherwise.
After long-term feeding, cells were detached by trypsinization then centrifuged 
to form pellets, as described in Section 2.2.1. Pellets were fixed for 1 hour at 4 °C 
in a mixture of glutaraldehyde and osmium tetroxide buffered with 0.05 M 
imidazole (Sigma, UK), pH 7.4 (1 part 2.5% glutaraldehyde + 2 parts of 1% 
osmium tetroxide, both in 0.05 M imidazole). The pellet was scraped from the 
side periodically to enable full penetration of the fixative. After fixation, the 
pellet was broken up and samples were centrifuged. Samples were then 
embedded in 3% (w/v) agar (Difco Laboratories, MI, USA) which was first 
dissolved by heating then allowed to cool prior to embedding of samples. Pellets 
were scraped from the side to ensure total immersion in the agar. After 
solidification of the agar, the samples were removed from the tubes and cut to 
remove excess agar from around the specimens, and to provide several small 
pieces of agar-embedded pellet for each treatment. These were then washed 4 
times for 1 0  minutes each in dH2 0  to remove excess fixatives, then stained with 
0.5% aqueous uranyl acetate for 60 minutes in the dark at 4 °C.
Specimens were dehydrated in a graded series of ethanol concentrations (Fisher 
Scientific, UK) for 10 minutes each: 30%, 50%, 70%, 80%, 90% and 3 x 100%. 
They were then incubated in propylene oxide for 2 x 10 minutes. Samples were
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infiltrated with resin overnight at room temperature in a fume hood -  in a 1 : 1  
mixture of propylene oxide and araldite mix (composed of 5g araldite CY 212: 
5g DDSA : 0.15g BDMA). The following day samples were transferred into 
fresh resin (i.e. araldite mixture without propylene oxide) in plastic moulds and 
embedded at 60 °C for 48 hours, after which the resin had become polymerized 
and solid.
Blocks were sections using an Ultracut microtome (Reichert-Jung E, Austria) -  
with ultrathin sections (60 -  90 nm) collected on pioloform coated copper grids. 
Each block was sectioned at three different depths i.e. superficial, intermediate 
and deep; with each block derived from one POS-feeding-treatment. Sections 
were counterstained first in 2% uranyl acetate for 1 0  minutes, washed briefly 
twice in dELO, then in Reynold’s lead citrate for 5 minutes, again followed by 
two brief washes in dfUO. Sections were examined using a transmission electron 
microscope (Philips EM400T; Eindhoven, Netherlands) operated at 80 kV 
accelerating voltage. Intracellular granules were then counted in 10 whole cells 
for each treatment (with the 1 0  cells distributed over the three depths of the same 
block). These were counted on the microscope during imaging, allowing 
magnification as required to differentiate between mitochondria and other 
granules. Representative images were taken for each treatment. Two types of 
granules were encountered: granular and homogeneous (more lipofuscin-like). 
These were counted separately.
2.7 Statistical analysis
Normalization of data and calculation of means and SD/SEM were carried out 
using Microsoft Office Excel 2003. Linear and non-linear regression were 
carried out using GraphPad Prism 3.02 and SigmaPlot 9.0. All further statistical 
analyses were carried out using GraphPad Instat 3.06, GraphPad Prism 3.02 or 
SigmaStat 3.5. Tables of P-values for all post-tests carried out after significant 
ANOVA tests and for one-sample t-tests and selected other comparisons are 
included in Appendices 1 -4.
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Chapter 3:
Peroxidation of DHA
3. Peroxidation o f DHA
3.1 Introduction
Photoreceptors and RPE cells contain high levels of known photosensitizers, 
including all-/raws-retinal in photoreceptors, and lipofuscin in the RPE. In 
conjunction with the regular high fluxes of light reaching the retina and high 
levels of oxygen due to the high metabolic requirements of visual transduction, 
these are able to photosensitize singlet oxygen and free radical production 
(Delmelle, 1978; Boulton et a l , 1993; Rozanowska et al., 1995). Additionally, 
photoreceptors depend on several iron-containing enzymes for normal function 
of phototransduction, photoreceptor disc renewal and retinoid recycling 
(referenced in He et a l , 2007), therefore iron is readily available in the retina. In 
fact, levels of iron (including easily chelatable iron) have been shown to increase 
in retinas with AMD (Hahn et al., 2003). In addition to the Fenton reaction 
which results in formation of the highly reactive hydroxyl radical, iron can 
induce decomposition of lipid hydroperoxides to form lipid alkoxyl radicals 
(Halliwell and Gutteridge, 1984). This is an important step, in conjunction with 
singlet oxygen and free radical production, in initiation and propagation of the 
lipid peroxidation cascade, as shown in Figure 1.6 (Buettner, 1993; Yin and 
Porter, 2005).
These factors are all conducive to DHA peroxidation, especially taking into 
account its polyunsaturated structure. Indeed, DHA peroxidation products have 
been found in photoreceptors and RPE cells, and also in drusen and inter/intra- 
laminar deposits on the basolateral surface of the RPE cell layer, particularly at 
the level of Bruch’s membrane (Crabb et al., 2002; Gu et al., 2003a; Ng et al., 
2008). Additionally, it previously been demonstrated that DHA peroxidizes 
readily by exposure to air, resulting in formation of blue-light absorbing 
chromophores which are able to photosensitize production of singlet oxygen and 
superoxide (personal communication: M.B. Rozanowska).
The aim of this chapter is to compare two methods of DHA oxidation, and 
determine optimal conditions for accumulation of lipophilic blue-light absorbing 
chromophores. Due to the difficulties of identifying specific individual molecules 
or markers of lipid peroxidation, the time-course and final end-points of
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peroxidation were monitored in different lipid preparations (dry film vs. aqueous 
liposome suspension) by observing degradation of native DHA and formation of 
key markers of peroxidation (conjugated dienes, conjugated trienes, and 
carbonyls), and absorbance of visible light. This was carried out in preparation 
for the study of potential effects of pDHA in cells of the retina, investigated in 
further chapters of this thesis.
3.2 Experimental design
3.2.1 Peroxidation of DHA
Two different sample types were used for producing peroxidized lipids: lipids in 
liposomes (two batches), and lipids as a dry film in a glass flask (one batch). 
Those peroxidized as liposomes would be physiologically similar to lipid 
peroxidation in membranes, with access to water which could result in hydrolysis 
reactions. DHA peroxidized as a film could follow other pathways of 
peroxidation, and be more similar to lipids inside lipophilic deposits such as 
lipofuscin and lipid-rich Bruch’s membrane deposits.
3.2.2 Monitoring of peroxidation
Many natural lipids show an absorption peak in UV light close to 200 nm 
(Recknagel and Glende, 1984). In this thesis, the DHA absorption was monitored 
at 2 1 0  nm, to prevent any overlap with absorption by the solvents used. 
Peroxidation of DHA can result in formation of products with conjugated diene 
structures which absorb light at approximately 230 nm (Pryor and Castle, 1984; 
Recknagel and Glende, 1984; Corongiu et al., 1989), and also trienes and ketone 
dienes which can be observed as additional absorption shoulders/peaks at 260- 
280 nm (Recknagel and Glende, 1984; Kim and LaBella, 1987; Butovich, 2005; 
Butovich et al., 2006). For analysis here, wavelengths of 240 and 270 nm were 
selected for monitoring, with 240 nm expected to indicate conjugated diene 
formation, but offset slightly from 230 nm to reduce overlap with the DHA 
absorption peak at 210 nm. Therefore, reduction in the size of the peak at 210 nm
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and increases at 240 and 270 nm may be used to monitor increases in the level of 
peroxidation.
When observed by UV-visible spectroscopy, however, these peaks can not be 
clearly separated -  with the absorbance value for 2 1 0  nm likely to be partially 
overlapped by the 230/240 nm conjugated diene peak/shoulder. Furthermore, 
conjugated diene levels may in fact decrease with prolonged duration of 
peroxidation due to further degradation and formation of other products (Kim 
and LaBella, 1987), and the absorbance shoulder of conjugated trienes and other 
products at 270 nm may overlap with that of conjugated tetraenes, which show a 
broad characteristic absorbance peak at -300 nm (Knight et al., 1999; Kuklev 
and Smith, 2004). Thus, quantification of these changes is difficult but should 
still provide an indicator of changes that have occurred with time. Absorption at 
210 nm can be assumed to indicate the upper limit of unperoxidized DHA 
present in samples, and may overestimate the value if contaminated by the 
absorbance of species exhibiting a peak/shoulder at 230 nm. In an attempt to 
overcome this problem, HPLC was used as this method allows separation of 
most peroxidation products from the unperoxidized DHA.
In addition to monitoring changes in absorption of UV light as an indicator of 
peroxidation, absorption spectroscopy was used to monitor absorption of visible 
light at wavelengths >400 nm in concentrated pDHA samples. As the anterior 
eye in the adult human blocks shorter wavelengths, observation of products able 
to absorb at >400 nm would be required to validate any theory that pDHA may 
act as a photosensitizer in the adult retina.
3.3 Results
3.3.1 General observations
Over time, both the lipid film and liposomes changed colour from light yellow to 
darker yellow/orange.
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At the earlier time points of lipid peroxidation for the first batch of liposomes, 
absorption spectra were only measured for the chloroform-soluble fraction of the 
extracted liposomes. With time, however, a change in colour in the upper 
methanol-soluble phase was noticed, becoming yellow rather than colourless as 
observed earlier, so from the 132 day time point onwards absorption spectra were 
also measured for this phase.
In the same batch of liposomes, in addition to the colour change in the upper 
phase, increased duration of peroxidation resulted in the formation of an 
apparently insoluble brown interphase between the upper methanol/PBS phase 
and the lower chloroform phase (as indicated in Figure 2.1). This layer appeared 
to increase in quantity as peroxidation of the samples progressed. However, it 
was found to gradually disappear and dissolve into the upper methanol/PBS 
phase when repeat extractions were carried out. For the lipids allowed to 
peroxidize as a dry film, there was very little material observed between the two 
main extraction phases.
Following these observations in the first batch of liposomes, the second batch of 
liposomes, which was to be used in further experiments in this thesis, was 
allowed to peroxidize for a considerably shorter period (18 days vs. 175 days), to 
minimize the formation of polar products and loss of pDHA into the upper 
methanol/PBS phase, and therefore to maximize levels of blue-absorbing 
chromophores in the lower chloroform phase.
3.3.2 Analysis o f chloroform-soluble phase
3.3.2.1 UV-visible spectroscopy
Figure 3.1 A shows absorption spectra of the chloroform-soluble component of 
the lipid extraction from the first batch of liposomes, dissolved in acetonitrile + 
methanol (20:1 v/v). Changes in absorbance values over time of the 
peaks/shoulders at selected wavelengths are shown more clearly in Figure 3.IB. 
These results show that with time, absorbance at 210 nm decreases representing a 
loss of native DHA as it becomes peroxidized. Conversely, there is a slight initial 
increase in absorbance at 240 and 270 nm, and thus levels of peroxidation
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products, but this reaches a plateau and does not increase further to account for 
the loss of unperoxidized DHA. This could be counteracted by the formation of 
polar products extracting in the methanol/PBS phase as discussed above. Even at 
the earliest time points there is absorption at longer wavelengths, indicating that 
the DHA is already (unintentionally) partially peroxidized, demonstrating how 
readily this process occurs.
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Figure 3.1 Monitoring o f DHA peroxidation with UV/visible absorption 
spectroscopy. (A) Absorption spectra for the chloroform soluble component o f  
extracted pDHA liposomes, measured in acetonitrile + methanol (20:1 v/v). 
Measurements were taken at time points up to 175 days o f peroxidation, and 
maximum extracted (p)DHA concentration was 0.12 mM. (B) Graph showing 
changes in absorbance at key wavelengths (210, 240 and 270 nm) over time, 
taken from the spectra in (A).
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Figure 3.2 shows different comparisons of absorption spectra of the three 
different batches of DHA at matched concentrations. The three samples were: 
two batches peroxidized as liposomes, and DHA peroxidized as a lipid film and 
later made into liposomes. All samples were freshly extracted and diluted as 
described above.
Figure 3.2A indicates that over the same length of time, DHA peroxidized in 
liposomes showed considerably lower levels of native DHA compared with the 
lipid film (A2 ionm = 0.085 vs. 0.436), thus indicating a higher degree and 
therefore rate of peroxidation when lipids are in an aqueous environment. The 
lower levels of absorption at 240 and 270 nm are consistent with the findings in 
Figure 3.1 above that these levels actually decrease slightly with increased extent 
of peroxidation, indicating further degradation of these products.
Comparison of the two liposome batches at similar time points (23 and 18 days 
for the first and second batch of liposomes, respectively; Figure 3.2B) shows 
very similar spectra. The samples are difficult to compare directly, however, as 
only a single extraction was carried out for the first batch, whereas repeat 
extractions were carried out during extraction of the second batch of liposomes. 
This explains the overall slightly lower absorbance for the first batch.
Despite different durations of peroxidation, absorbance spectra of the second 
batch of liposomes and the lipids allowed to peroxidize as a film compared very 
favourably as shown in Figure 3.2C -  although the absorbance at 210 nm was 
slightly higher for the liposomes (liposomes: 0.567 vs. film: 0.436), absorbance 
at 240 and 270 nm was very similar (240 nm: 0.076 vs. 0.079; 270 nm: 0.035 vs. 
0.032). Figure 3.2C also shows the absorption spectrum for unperoxidized DHA 
indicating, as expected, greater absorbance at 210 nm (A = 0.769) compared with 
the peroxidized samples, and lower absorbances at 240 and 270 nm (0.040 and 
0 . 0 2 1  respectively).
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Figure 3.2 Comparison o f absorption spectra after DHA peroxidation in 
liposomes or as a dry lipid film. Spectra are shown for the chloroform soluble 
phase o f extracted liposomes measured in acetonitrile + methanol (20:1 v/v), and 
graphs compare key wavelengths. (A) Comparison o f  the end-point o f DHA 
peroxidation as liposomes (first batch) vs. a lipid film after 175 days (max. 
0.012 mM DHA); (B) comparison o f two sets o f  liposomes at similar times: after 
23 days o f  peroxidation for the first liposomes, and the 18 day end-point for the 
second liposomes (max. 0.12 mM DHA); (C) comparison o f peroxidation end­
points o f lipids used in further experiments; DHA peroxidized as either a lipid 
film or as liposomes (second batch), and unperoxidized DHA (max. 0.012 mM  
DHA).
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The results from the diluted samples above confirm that peroxidation of DHA 
has occurred, resulting in alterations in distinctive peaks of absorption of UV 
light. Figure 3.3 shows less dilute samples than those used to monitor UV 
absorption, allowing monitoring of absorption of visible light (>400 nm). These 
demonstrate that for DHA used in further experiments, DHA peroxidized as a 
film for 175 days produced more products capable of absorbing visible light than 
the second batch of liposomes after 18 days (A400 = 0.115 vs. 0.078; integration 
of absorbance >400 nm: 9.13 vs. 3.56). “Unperoxidized” DHA, as expected, 
showed less absorbance above 400 nm than either of these samples (A400 = 
0.026; integration of absorbance >400 nm: 1.21).
3.3.2.2 HPLC
Monitoring elution of the pDHA sample at 210 nm after HPLC separation 
demonstrated a sharp peak in the chromatogram between 3.5 and 4 minutes, as 
shown in Figure 3.4A. The size of this peak was smaller for pDHA than DHA. 
Additionally, when the full spectrum was monitored for the peak observed in the 
210 nm chromatogram (Figure 3.4C), a reduction in absorbance at 200 nm was 
seen. Compared with the absorption spectra shown in Section 3.3.2.1, there was 
less absorption at longer wavelengths in the HPLC spectrum, suggesting 
effective separation of peroxidized products from the main DHA peak through 
the process of HPLC. This is confirmed by the presence of greater numbers of 
smaller peaks at shorter elution times in the pDHA sample compared with DHA, 
as shown in Figure 3.4B. Figure 3.4D shows that the DHA peak area (from the 
210 nm chromatogram) initially reduced between 0 and 2 days of peroxidation 
but did not reduce further with increased duration of peroxidation.
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Figure 3.3 Comparison o f absorption o f  visible light by (p)DHA samples to be 
used in future experiments, at peroxidation end-points. (A) Absorption spectra o f  
concentrated samples, corresponding to 1.2 mM intact DHA, with duration o f  
peroxidation (days) indicated. (B) Comparison o f absorbance at 400 nm. (C) 
Comparison o f integrated total absorbance between 400 and 700 nm.
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Figure 3.4 Representative data for HPLC analysis o f  (p)DHA samples. (A) 
HPLC chromatogram (monitored at 210 nm) for DHA and pDHA after 18 days 
o f peroxidation (second liposome batch). (B) The same chromatogram with the y- 
axis amplified to show smaller peaks. (C) Spectra at the elution time o f the main 
DHA elution peaks. (D) Graph showing peak areas for the main DHA peak in 
HPLC chromatograms monitored at 210 nm. Each injection corresponded to 
275 nmol (p)DHA.
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3.3.2.3 Fluorescence spectra
Fluorescence spectroscopy showed the presence of fluorescing products in 
pDHA samples after 175 days o f peroxidation (first batch of liposomes), as 
shown in Figure 3.5. Emission peaks were observed at 437 nm after excitation at 
360 nm, and at 310 and 440 nm after excitation at 270 nm. Fluorescence 
emission was also observed after excitation at 230 nm, with a shoulder at 
-330 nm, but the fluorescence is considerably less intense than at the longer 
wavelengths and there is interference in the spectrum due to Raman scattering of 
the solvent.
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Figure 3.5 Fluorescence emission spectra o f DHA samples (first liposome batch, 
peroxidized for 175 days) extracted in the chloroform phase, dissolved in 
acetonitrile/methanol, after excitation at (A) 360 nm: peak at 437 nm; (B) 
270 nm: peaks at 310 nm and 440 nm; (C) 230 nm: shoulder: ~330nm. Note 
differences in scale between spectra.
400 450 500 550 600
7 5
3. Peroxidation of DHA
Variations in DHA concentrations for the samples, shown in Table 3.1, were due 
to the requirement of absorbance at the relevant excitation wavelength to be 
below 0.1 as described above.
Aex (nm) concentration (mM) absorbance at Aex
360 1.2 0.036
270 0.12 0.073
230 0.012 0.026
Table 3.1 Concentrations and absorbances o f  samples used for fluorescence 
measurements. 1 in 10 dilutions were carried out to ensure absorbance below 0.1 
at the stated excitation wavelength. Xex = excitation wavelength.
3.3.3 Analysis o f methanol-soluble fraction
3.3.3.1 UV-visible spectroscopy
Figure 3.6A shows that the general shape of the absorption spectra of the 
methanol-soluble component is similar to that of the chloroform-soluble 
component at later stages of peroxidation, with peaks occurring at approximately 
230 and 270 nm. Figure 3.6B shows there is an increase in absorbance at these 
wavelengths over time. Multiple extractions were carried out during preparation 
of these samples to ensure complete dissolving and removal of the 
“intermediate” layer described above. The absorption spectrum for the sample 
allowed to peroxidize as a film is included for comparison (Figure 3.6C). Despite 
a considerably longer duration of peroxidation, the spectrum is similar to the 
end-point for the second liposome batch. All the absorption spectra were 
truncated at 220 nm due to interference from the solvents used. Although 
methanol and PBS do not absorb at these wavelengths, absorption was observed 
in the solvent indicating contamination by chloroform during the extraction 
process, as discussed in Section 2.1.3.1.
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Figure 3.6 Absorption spectra o f the methanol/PBS phase o f pDHA liposome 
extracts. (A) Absorption spectra and (B) graph showing changes at 240 and 
270 nm for the second liposome batch, diluted 1:10 (after multiple extractions); 
(C) Comparison o f absorption spectra at end-points fo r lipids peroxidized as a 
lipid film and in the second batch o f liposomes (extracted and diluted 1:10).
3.3.3.2 Fluorescence spectra
When running background samples (i.e. methanol + PBS, but no lipids), it was 
found that this solvent combination showed considerable levels o f fluorescence 
at excitation wavelengths of 230 and 270 nm (possibly due to chloroform content 
retained in the upper phase during the extraction process, as for the absorption 
spectra Section 3.3.3.1 above). Therefore, for methanol/PBS phase extracts, only 
360 nm was used for fluorescence excitation. Figure 3.7 shows a sample 
spectrum, demonstrating similar fluorescence to the chloroform-soluble sample
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(Section 3.3.2.3) excited at 360 nm, with a peak at the slightly longer wavelength 
of 458 nm. Absorbance of this sample at the excitation wavelength was 0.032.
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Figure 3.7 Fluorescence spectrum fo r  the methanol/PBS-soluble component o f  
extracted pDHA liposomes (first liposome batch, peroxidized fo r  175 days), with 
360 nm excitation (1:100 dilution; peak = 458 nm).
3.3.4 Analysis o f DHA peroxidation product partitioning into upper 
and lower phases
Results described above show that products of DHA peroxidation are found in 
both the chloroform and the methanol/PBS phases during extraction. To calculate 
the ratio of products in these two phases, absorption spectra were integrated to 
calculate total absorbance above either 300 or 400 nm, then normalized to equal 
volume (Figure 3.8A and B and Table 3.2). This analysis shows that 
approximately 10% of molecules which absorb light at >300 nm separate into the 
methanol/PBS phase, compared with 90% which extract in the chloroform phase. 
This ratio is approximately equal for both the samples. In contrast, when 
comparing absorbance >400 nm, i.e. visible light, which was used in later 
experiments in this thesis, the percentage of absorbing molecules in the lipid film 
preparation which extracts to the methanol/PBS phase is reduced to only 3% 
(compared with 11% for the liposome preparation).
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Figure 3.8 Comparison o f  partitioning into chloroform and methanol/PBS 
phases after peroxidation as liposomes (second batch, 18 days) or lipid film  (175 
days). (A) Comparison o f  integrated absorbance between 300 and 600 nm; (B) 
comparison o f  integrated absorbance between 400 and 600 nm.
integrated
region
absorbance ratio
liposom es lipid film
>300 nm 89%:11 % 90:10
>400 nm 89:11 97:3
Table 3.2 Comparison o f ratios o f  chloroform phase to methanol/PBS phase 
absorption after correcting for extraction volume, fo r  wavelengths longer than 
either 300 or 400 nm.
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3.4 Discussion
The observations in this chapter confirm that DHA autoxidation occurs readily in 
vitro and that the rate thereof varies depending on the microenvironment of the 
lipids.
Absorption spectroscopy showed that even “unperoxidized” DHA samples, 
which have been carefully prepared under argon throughout and stored under 
argon immediately after preparation of liposomes, exhibited absorbance at longer 
wavelengths. This is indicative of the presence of peroxidation products. Thus, 
the samples, although not allowed to peroxidize, were not 100% unperoxidized. 
This could be due to contamination of lipids, glassware or PBS with metal ions, 
for example iron, which would promote lipid peroxidation as described in 
Chapter 1. Similarly, it can not be assumed that all DHA in the “peroxidized 
DHA” samples was completely peroxidized, as shown by a clear absorbance 
peak still evident at -210 nm.
An unexpected observation in monitoring peroxidation of DHA was the 
formation of the “interphase” during lipid extraction, which increased with 
duration of peroxidation. In the second liposomes, a gradual increase in 
absorbance in the methanol/PBS phase was observed (up to 18 days of 
peroxidation), indicating increased formation of polar products with time, with 
limited amount of material in the interphase. At later stages of peroxidation, as 
monitored in the first liposomes (up to 175 days), a thick, dark layer formed, 
apparently consisting of polar products, as they dissolved into the upper layer 
after repeat extractions. This indicated an excess of these products, saturating the 
methanol/PBS layer until “fresh” methanol/PBS mixture was added during 
subsequent repeat extractions.
In contrast, DHA allowed to peroxidize as a film for 175 days appeared more 
similar in appearance to the second liposomes, peroxidized for only 18 days, than 
the first liposomes which were peroxidized for the same length of time (i.e. 175 
days). There was similar absorbance in the methanol/PBS phase, and very little 
interphase material. This indicates lower levels of peroxidation compared with
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the first liposomes, a finding which correlates with absorbance measurements of 
the extracted chloroform phase. Here, the first liposome batch showed 80% 
lower absorbance at 210 nm compared with the lipid film samples peroxidized 
for the same length of time, indicating greater degradation of native DHA. 
Again, the lipid film sample was more similar to the second liposomes which 
were peroxidized for 10% of the duration o f the first liposomes, as these showed 
similar absorption spectra for the chloroform phase.
As the lipid film and the first liposomes were allowed to peroxidize 
simultaneously, on the same heating block and in the same environment, the only 
difference was the microenvironment of the lipids: i.e. the presence of water and 
also possibly redox active metal ions in the liposome preparation. As the phase 
transition for DHA-PC is very low (approximately -70 °C; Kariel et al., 1991), 
the lipids in the film should be mobile and able to interact freely with each other, 
with no added benefit with the addition of water. The hydration state could, 
however, be a crucial variable as it could facilitate hydrolysis of the lipids, and 
would aid with diffusion of metal ions between liposomes. Obviously the 
liposome model for lipid peroxidation appears more physiologically relevant to 
retinal lipid membranes, as cell membranes, like lipid bi-layers in liposomes, are 
in contact on both surfaces with aqueous solutions. However, peroxidation as a 
film is relevant to lipofuscin and lipid deposits in Bruch’s membranes, as lipids 
contained within these may be isolated from water.
The formation of chloroform-insoluble degradation products has implications for 
further experiments in this thesis: in those experiments involving antioxidants 
(Chapters 5 and 6), peroxidized liposomes were extracted and only the 
chloroform phase was used for addition of antioxidants and re-forming of 
liposomes. It is possible that in this process a large number of DHA peroxidation 
products were removed, which could result in lower toxicity compared with the 
original starting pDHA prior to extraction. However, removal of those polar 
hydrophilic products found in the methanol/PBS phase may in fact make the 
samples more representative of any likely drusen or lipofuscin-like substances in 
the retina. In both of these lipid-rich components of the aged retina, hydrophilic 
degradation products of lipids are unlikely to be retained as they would more
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likely diffuse away. Indeed, after Folch’s extraction of human lipofuscin 
samples, no absorption of light above 200 nm is detectable in the upper 
methanol/PBS phase, suggesting they do not contain equivalent products (Pawlak 
et al., 2002; Rozanowska et al., 2004).
Loss of DHA products into the methanol/PBS phase rather than retention in the 
chloroform phase could explain the plateau in formation of conjugated dienes 
and trienes seen in the first liposome batch, as these products may have been 
formed then degraded further into polar products. This is similar to findings with 
free fatty acids (Kim and LaBella, 1987).
Fluorescence of peroxidized DHA was consistent with previous findings, that 
formation of fluorescent compounds increases with the extent of peroxidation 
(Gutteridge et al., 1982; Kim and LaBella, 1987). The fluorescence emission 
peak of pDHA from the chloroform phase of extraction is measured here as 
437 nm (i.e. blue) upon excitation at 360 nm. This is consistent with data for 
homogenized retina samples which have been allowed to oxidize in vitro (Eldred 
and Katz, 1989). In contrast, lipofuscin -  both in situ and when isolated -  shows 
yellow fluorescence with emission peaking at 570-605 nm, increasing in 
intensity with age (Eldred and Katz, 1989; Boulton et al., 1990; Docchio et al., 
1991). The difference between peroxidized lipid and lipofuscin fluorescence has 
led to debate on the validity of the theory that lipofuscin formation is induced by 
lipid peroxidation (Eldred and Katz, 1989,1991; Sharma and James, 1991). 
Lipofuscin has however been shown to contain DHA (Bazan et al., 1990). The 
observed change in fluorescence from blue to yellow may be caused by 
interaction and cross-linking of peroxidized lipids with other components of 
lipofuscin, or due to the actions of lysosomal enzymes (Eldred and Katz, 1989). 
Alternatively, it has been suggested that as yet unidentified blue-absorbing 
chromophores(s) may transfer energy to A2E, an important component of 
lipofuscin which in fact shows yellow emission properties similar to lipofuscin 
(Haralampus-Grynaviski et al., 2003). From data shown here, pDHA could be 
proposed as a candidate for this absorbing chromophore.
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Results here have clearly shown the potential for DHA peroxidation products to 
absorb light above 400 nm. This is vital to this project as the phototoxicity of 
pDHA is investigated in later chapters using visible light, above -400 nm, and in 
the intact adult human eye, very little light below 400 nm reaches the retina as it 
is blocked by the lens and cornea. Only in the very young eye there is a small 
transmission band peaking at 320 nm (Boettner and Wolter, 1962).
Similarities between the lipids peroxidized as a film and the second liposomes 
justify the use of both of these preparations in further experiments described in 
the rest of this thesis. As there is still some variation between these two, their use 
has been kept to separate sets of experiments.
In summary, DHA autoxidation has led to formation of products which are 
capable of absorbing blue light, providing liposomes which are suitable for use in 
further experiments to monitor pDHA (photo-)toxicity.
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4. Cytotoxicity studies
4.1 Introduction
As discussed in Chapters 1 and 3, DHA is present in high levels in the outer 
retina (i.e. photoreceptors and RPE), and is easily peroxidized, as demonstrated 
in Chapter 3, and DHA peroxidation products have been identified in and around 
the RPE cell layer -  in photoreceptor outer segments, in the RPE including in 
lipofuscin granules, and in drusen deposits found beneath the RPE cell layer 
(Crabb et al., 2002; Gu et al., 2003a; Ng et al., 2008). pDHA has also been 
shown to be photoexcitable in vitro (personal communication, M.B. 
Rozanowska) resulting in production of reactive oxygen species. Thus, 
considering the high light fluxes in the retina it is possible that pDHA could be 
phototoxic to RPE cells. The increase in pDHA levels observed with age and 
progression of AMD (Gu et al., 2003a) could therefore play a role in the age- 
related RPE cell dysfunction observed.
Toxicity due to reactive oxygen species may culminate in either of two forms of 
cell death: apoptosis or necrosis. Key features of these two processes are shown 
in Figure 4.1. Apoptosis, also known as programmed cell death, can be induced 
by a multitude of internal or external triggers, leading to a tightly controlled 
cascade of events, shown in Figure 4.2, culminating in cell death. This process is 
often essential during normal development. In vivo, waste products of apoptotic 
cells are usually efficiently removed by phagocytic cells meaning neighbouring 
cells remain unaffected. In contrast, necrosis often occurs due to “accidental” 
insult, and due to its rapid culmination with permeabilized and effectively burst 
cells, and the nature of the toxic insult, it is prone to affect groups of cells. In 
certain situations, such as in vitro cell culture environments where phagocytic 
cells are not present to remove apoptotic residues, apoptosis does not resolve 
properly, and cells begin to show apparently necrotic attributes such as loss of 
membrane integrity -  a process sometimes called secondary necrosis. This is not, 
however, a valid form of cell death when studying toxicity of an agent, as this 
would not occur in most tissues in vivo.
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In this thesis, multiple assays were used to monitor the pathways of cell death 
involved in pDHA (photo-)toxicity. Different time points were tested initially 
during optimization of the assays, as the rate of the apoptotic cascade can vary 
depending on the insult. Additionally, multiple assays were carried out to ensure 
signals were not missed and to try to monitor which pathway was involved.
It is believed that reactive oxygen species induced apoptosis occurs via the 
mitochondrial, or intrinsic, pathway (Dumont et al., 1999). At high levels of 
insult, it is possible for some species, for example hydrogen peroxide, to cause 
necrosis rather than apoptosis due to oxidation of caspase enzymes (Hampton 
and Orrenius, 1997). Additionally, reactive oxygen species may simply cause 
extensive lethal damage to the cell membrane. The pathway of cell death induced 
by pDHA therefore warrants investigation.
The aim of this chapter was to quantify levels of (photo-)toxicity induced by 
pDHA in different conditions, and then to further understand the pathways by 
which the observed cell death occurred.
4.2 Experimental design
4.2.1 Exposure of cells to DHA
Cells were exposed to (p)DHA in the form of externally applied liposomes. The 
aim of this procedure was to mimic the situation in vivo where pDHA is found in 
close contact with RPE cells -  either in photoreceptor membranes which 
normally lie adjacent to and in intimate contact with the apical surface of the 
RPE, or Bruch’s membrane deposits which are in close contact with the basal 
surface of the RPE cell layer.
4.2.2 Light exposure and subsequent analysis o f cell viability
Initially, the effects of a known photosensitizing agent, rose bengal, on ARPE-19 
cells were monitored to observe the cellular response to phototoxic insult. 
Following peroxidation of DHA, its phototoxicity was also studied.
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To monitor cell viability, the MTT assay of mitochondrial activity was used 
initially. This measures the reductive capacity of mitochondria. MTT assay was 
carried out either immediately or 24 hours later, allowing cells to either recover, 
or for the apoptotic cascade to continue resulting in cell death. Loss of activity 
therefore indicates overall levels of cell death. Cells were then imaged using 
phase contrast microscopy to monitor changes in gross morphology. Other 
indicators of apoptosis were then monitored: nuclear condensation (using 
Hoechst labelling) and DNA cleavage (using TUNEL). Additionally, propidium 
iodide was used to monitor membrane integrity. Loss of integrity at initial stages 
of cell death would indicate necrosis.
After exposure to rose bengal +/- light for 1 hour, cells were “post-incubated” in 
fresh medium with 2% FCS for different durations, as stated in the results. All 
MTT results were normalized to control for the same cell culture plate deemed to 
be 100% mitochondrial activity i.e. 0 mM RB with identical light exposure 
conditions and post-incubation period.
DHA exposure +/- light was carried out for 1 hour, then for the MTT assay, cells 
were washed and either tested immediately or put in fresh medium for 24 hours 
first. For other apoptosis assays following DHA exposure, duration of post­
incubation was varied to ensure that crucial steps in the cascade of cell death 
events were not missed. Times are stated in the relevant results sections.
4.3 Results
4.3.1 Confirmation of ARPE-19 cell identity
As expected, positive labelling of cultured ARPE-19 cells with cytokeratin 18 
was observed as shown in Figure 4.3, confirming a pure epithelial cell culture 
without contamination by other retinal cell types.
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Figure 4.3 Cytokeratin 18 labelling o f  ARPE-19 cells. (A) Cells labelled with 
both cytokeratin (green) and Hoechst 33342 (blue); (B) control slide showing 
labelling with only Hoechst. Bar = 100 fim.
4.3.2 R ose  B en g a l cytotoxicity
4.3.2.1 Cell morphology
Cells exposed to the lower concentrations o f rose bengal (< 0.1 pM) showed no 
major morphological changes when observed by phase contrast microscopy (see 
Figure 4.4). At increasing concentrations, considerable changes in morphology 
were evident, with cell shrinkage (causing bright areas in images due to 
increased thickness of samples and difficulties in focussing on the full depth) and 
some cell detachment observed. At the highest concentration o f 1 pM, however, 
the cells appeared to remain attached, although they were completely different in 
appearance to unaffected cells -  with cells becoming more spindly, and often 
with visible nuclei.
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Figure 4.4 Phase contrast images o f  ARPE-19 cells 17 hours after exposure to 
light and rose bengal at indicated concentrations. Bar represents 50 pm.
4.3.2.2 MTT assay
Rose bengal had a concentration-dependent effect on cell viability in the 
presence o f light, as measured by MTT assay (see Figure 4.5A), with all 
concentrations > 0.2 pM at all time points showing statistically significant 
reduction in mitochondrial function compared with control (0 pM rose bengal 
with matched light exposure/post-incubation conditions; P-values for 
comparisons are shown in Appendix 1). The cytotoxic effect of rose bengal 
increased with increased time after exposure (in the presence of light). Cells
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exposed to rose bengal in dark conditions showed no significant changes in 
mitochondrial activity compared with control. Figure 4.5B shows that light and 
post-incubation alone had no significant effect on MTT absorbance values in 
0 pM rose bengal controls (one-way ANOVA P-value = 0.9652).
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Figure 4.5 Results o f  MTT assay after rose bengal exposure. (A) MTT assay was 
carried out at the indicated time after 1 hour rose bengal exposure, with 
2.8 mW.cm'2 green light except where labelled as 11 dark”. Mitochondrial activity 
was calculated as percentage o f  control (i. e. 0 pM  rose bengal with same light 
conditions). (B) Raw MTT absorbance values at 590 nm for control cells (0 pM  
rose bengal) at different time points after exposure. Error bars indicate SEM; n 
= 3 or 4.
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4.3.3 pDHA cytotoxicity
4.3.3.1 Cell morphology
As shown in Figure 4.6, cell morphology did not appear to have altered greatly 
24 hours after exposure to 1 mM pDHA in the dark, although 2 mM pDHA 
appeared to increase the occurrence of smaller cells on the surface. When cells 
were exposed to pDHA in light conditions, morphology was severely altered, 
with appearance of spindles extending from cells and eventually no clearly 
distinguishable cell outlines. Cell detachment did not appear to be as severe as 
after treatment with rose bengal.
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Figure 4.6 Effects o f pDHA on cell morphology. Phase contrast images taken 24 
hours after exposure to pDHA at the indicated concentrations. (A) Cells exposed 
to pDHA in dark conditions; (B) cells exposed to pDHA with light. Bar = 
100 pm.
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4.3.3.2 MTT assay
The effects of 1 hour DHA and pDHA exposure on mitochondrial activity of 
ARPE-19 cells are shown in Figure 4.7.
When the MTT assay was carried out immediately after exposure, 2 mM DHA 
(i.e. unperoxidized) caused a slight but significant decrease in mitochondrial 
activity compared with control in all treatment conditions i.e. light and dark at 
both light intensities (P-values shown in Appendix 1). 24 hours later, however, 
only DHA treated cells exposed to light at 9 mW.cm'2 showed a significant 
reduction in mitochondrial activity (P = 0.0176), while cells exposed to 
15 mW.cm' or maintained in the dark showed no significant difference to 
control (.P > 0.05 for all).
The effect of DHA on mitochondrial activity was smaller than the effect of 
pDHA. After exposure to 2 mM (p)DHA, in each of the four conditions (either 9 
or 15 mW.cm'2, with MTT carried out either after 0 hs or 24 hs), pDHA 
produced a significantly greater effect on mitochondrial activity than the same 
concentration of DHA (P-values shown in Appendix 1). Light did not 
significantly alter effects on mitochondrial activity of either peroxidized or 
unperoxidized DHA compared with dark, at this maximal 2 mM concentration.
Increasing the length of time between the exposure of cells to DHA and carrying 
out the MTT assay from 0 to 24 hours significantly increased the observed effect 
on mitochondrial activity at 2 mM pDHA, in both light exposed and dark 
maintained experiments. Tukey's post-tests revealed P-values of <0.001 for all 
comparisons of equivalent samples (i.e. 2 mM pDHA, either 9 or 15 mW.cm'2 
experiments, in light-exposed or dark-maintained samples) at 0 hs vs. 24 hs.
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Figure 4.7 Effects o f  pDHA and irradiance levels on mitochondrial activity, 
measured by MTT assay at different time points after exposure. Mitochondrial 
activity is expressed as a percentage o f  control (i.e. 0 mM DHA). Bars = SEM; n 
= 3-6.
Further comparisons of data collected 24 hours after DHA exposure was enabled 
by fitting data to a sigmoidal curve. This allowed calculation of EC50 values, 
indicating the pDHA concentration which induced a 50% reduction in 
mitochondrial activity. Curve fits are shown in Figure 4.8. Comparisons of these 
values using F-tests showed that light did not significantly increase the effect of 
pDHA at 9 mW.cm'2 (EC50: 1.36 mM (dark) vs. 1.06 mM (light), P = 0.506). At
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15 mW.cm'2, however, light did significantly decrease the EC50 value, thus 
indicating an increase in toxicity o f pDHA (EC50: 0.94 mM vs. 0.26 mM dk vs. 
It; P < 0.0001). Data also showed that in light-exposed cells, increasing the light 
intensity from 9 mW.cm'2 (EC50: 1.06 mM) to 15 mW.cm'2 (EC50: 0.26 mM) 
significantly increased the effects o f pDHA (P < 0.0001)
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Figure 4.8 Sigmoidal curve-fits o f  mitochondrial activity data fo r  MTT assays 
carried out 24 hours after exposure o f  cells to pDHA in dark or light, at 9 or 
15 mW.cm2.
4.3.3.3 Propidium iodide labelling for membrane integrity
Minimal uptake and nuclear labelling o f PI was observed in ARPE-19 cells 
treated with pDHA + light for 1 hour either immediately or 2 hours after 
exposure (Figures 4.9 and 4.10). This confirms that these cells do not undergo 
necrotic cell death within this time period, and that pDHA did not interfere with 
membrane integrity in a way that altered permeability to PI. This is confirmed by 
lack of significant difference between numbers of Pi-labelled nuclei after 
different treatments (ANOVA: P = 0.291).
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A 0 hours B 2 hours
Figure 4.9 Representative images o f  propidium iodide labelling o f cells after 
exposure to indicated concentrations o f  pDHA + 15 mW.cm2 light. (A) Labelled 
immediately after exposure; (B) labelled after 2 hours post-incubation in fresh 
medium. Blue = Hoechst; pink = dual labelling with Hoechst and PI. Bar = 
50 pm.
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Figure 4.10 Effects o f  pDHA treatment on membrane integrity as indicated by PI 
labelling o f  nuclei. Cells were labelled immediately after exposure or after 2 
hours ofpost-incubation in fresh medium. Bars = SEM; n = 3.
4.3.3.4 Apoptotic changes: nuclear condensation and DNA cleavage
After 12 hours of post-incubation in fresh medium following exposure to pDHA 
and light, changes in cell nuclei were observed, with increased incidence of 
condensed nuclei and labelling with the TUNEL assay. Additionally, cell density 
appeared to decrease with increased pDHA concentration (Figures 4.11 and 
4.12). However, there was no statistically significant change in total cell number 
per slide, or prevalence of TUNEL stained nuclei (ANOVA: P > 0.05 for both). 
The number of cells with condensed nuclei did, however, increase significantly 
(ANOVA: P = 0.0004), from <1%  with 0 mM pDHA to -25%  with 1 mM 
pDHA (P < 0.001), and to 14.5% after treatment with 2 mM pDHA (P < 0.05). 
Additionally, the total number of cells showing no indicators of apoptosis (i.e. 
“normal nuclei” in 4.12A) did change significantly (ANOVA: P = 0.021), from 
approximately 150 cells in control slides to 103 after 1 mM pDHA (31% 
reduction; P < 0.05) and to 82 after 2 mM pDHA (45% reduction; P < 0.05).
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Figure 4.11 Images showing the effects o f  pDHA on DNA cleavage and nuclear 
condensation. Cells were exposed to (A) 0 mM, (B) 0.5 mM, (C) 1 mM or (D) 
2 mM pDHA in 15 mW.cm'2 light. All cells were fixed and processed 12 hours 
after exposure. Blue = Hoechst; red/pink = TUNEL. Bar = 50 pm.
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Figure 4.12 Effects o f pDHA on cell nuclei and cell attachment 12 hours after 
exposure to pDHA. (A) Effects o f  pDHA on nuclear condensation and (B) DNA 
cleavage. Total height o f stacked bars indicates the average number o f  adherent 
cells in each image. As data from the two graphs is from the same images, the 
cell totals for each concentration are identical in both. Bars = SEM; n = 3-4.
4.4 D iscussion
Cytokeratin 18 labelling confirmed the identity o f RPE cells as epithelial cells. 
Although the antibody used was not specific for RPE cells, the lack of other 
epithelial cells in the retina allowed the use o f this antibody to ensure there was 
no contamination by other retinal cells. Contamination would be unlikely as 
ARPE-19 is a well established cell-line, and it was purchased after identification 
by the supplier using more specific markers (RPE65 and CRALBP).
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The use of the ARPE-19 cell line instead of primary cell cultures has certain 
implications. ARPE-19 is a spontaneously arisen cell-line derived from primary 
cultures of a human 19-year-old donor. Cells are structurally and functionally 
similar to RPE cells in vivo. They grow as an adherent polarized monolayer, and 
form tight junctions with similar barrier properties to native RPE cells. They also 
accumulate pigment with increased time in culture (Dunn et al., 1996). Several 
studies have been carried out, however, which indicate important differences in 
the RNA and protein expression profiles between primary RPE cells and ARPE- 
19 cells, and the effects of culture conditions on these profiles. The most notable 
differences include down-regulation in ARPE-19 of proteins involved in retinoid 
metabolism (resulting in inability o f the cells to regenerate 11 -czs-retinal from 
all-/ra«s-retinol) and changes in expression of cytoskeleton-related elements 
(Alge et al., 2003; Tian et a l , 2005; Alge et a l , 2006).
Despite the differences compared with primary RPE cells, the use of ARPE-19 
cells provides an overall advantage: they are readily available and divide rapidly 
to provide uniform and stable cultures with which to carry out experiments. 
Thus, there are no requirements to obtain fresh donor eyes and carry out isolation 
and purification on a regular basis in order to maintain a supply of high numbers 
of cells. Variation in ages and pathology in donor human eyes would cause 
further issues, particularly in light of the fact that most experiments in this thesis 
involved investigation of the effects of light on cells -  variation in levels of 
intrinsic light-absorbing and potentially photosensitizing agents, such as 
lipofuscin, would increase baseline variability between cell cultures. Thus, the 
use of the ARPE-19 cell line was chosen instead.
The main purpose of this chapter was to further understand the response of 
ARPE-19 cells to photosensitizer-induced toxicity. As expected, rose bengal 
proved to be a potent inducer of ARPE-19 cell death causing gross changes in 
cell morphology and reduction in mitochondrial activity measured by the MTT 
assay. There was no effect of rose bengal in the dark, showing its specific light- 
induced effects. In contrast, pDHA caused cell death in light and dark conditions. 
The toxicity of pDHA was, however, greater after light treatment suggesting that 
pDHA does have photosensitizing properties.
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Normal light levels to which the retina is exposed in indirect outdoor daylight 
range from approximately 0.01 to 0.1 mW.cm'2, which is similar to the irradiance 
of indoor light sources on the retina (Sliney, 1983). Light doses used in DHA 
experiments here were 1 hour at 9 or 15 mW.cm’2, which are therefore equivalent 
to 90 or 150 hours of exposure at the maximum likely retinal irradiance in 
normal daylight This shows one o f the limitations of the model used here, in 
which the response to an acute light exposure is monitored rather than the long­
term exposure to normal daylight levels more likely to be encountered by the 
average adult human being. However, it should be noted that the light intensities 
used here were significantly lower than those of direct sunlight focused on the 
retina, or optometnc equipment such as ophthalmoscopes (~70 mW.cm* for
o • oindirect, 30 mW.cm' for direct) and slit lamps (>200 mW.cm*), or surgical 
lamps used in operating theatres (25 mW.cm'2) (Calkins et al., 1980; Sliney, 
1983). Cytotoxicity of pDHA is already observed after 1 hour exposure to the
"j
lower irradiance of 9 mW.cm' , which is equivalent to only 2.7 minutes of 
exposure to a slit lamp.
Using variables measured for rod outer segments (Lamb and Pugh, 2004): i.e. 
dimensions of photoreceptors (length: 25 pm, diameter 2 pm) and spacing of 
discs (1 disc (i.e. 2 membranes) per 0.03 pm), rhodopsin density in disc 
membranes (25,000 p m '), and numbers o f outer segments in contact with each 
RPE cell (-25), in addition to relative levels of lipids to proteins (480 nmol per 
mg total protein in young and 716 in old retinas; Bazan et al., 1990), the 
molecular weight of rhodopsin (-38800) and rhodopsin levels as a percentage of 
total protein in outer segments (-80%; Fliesler and Anderson, 1983), the amount 
of DHA to which RPE cells are exposed in vivo can be estimated. Calculations 
give values from 1 .3 x 1 0 '13 to 1 .9 x 1 0 '13 moles of DHA per RPE cell (from 
young to old retinas), if total DHA from each whole photoreceptor is taken into 
account. This does not take into account any DHA contained within RPE cells or 
at the basolateral surface in Bruch’s membrane. By comparison, ARPE-19 cells
IT 10grown in culture were exposed to a DHA range of 2.3 x 10’ to 2.3 x 10" mol 
DHA per cell (based on the concentration range used in MTT experiments of 
0.2 mM to 2 mM and an average count of cells contained within a cell culture 
well). Although the maximal in vitro levels and the in vivo values differ by more
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than 10 times, the in vivo value is close to the lowest concentration used. 
Obviously the conditions and environment of the DHA in vivo vs. in vitro differ 
greatly, particularly in that in intact retinas, RPE processes extend into the POS 
layer, increasing the surface area o f contact and possible interactions. However, 
this comparison of exposure levels shows the concentrations used in experiments 
are meaningful.
MTT results show clear increases in death of ARPE-19 cells with increased 
pDHA concentration, particularly when MTT assay was carried out 24 hours 
after exposure. This delay (indicating initial maintenance of active 
mitochondria), in addition to the lack of PI labelling at short time points, strongly 
suggests a role for apoptotic cell death in the loss of cell viability observed. 
Significant increases in cell numbers showing condensed nuclei support this 
finding. Quantification of DNA cleavage by TUNEL assay showed no significant 
change. This finding could, however, be compromised by the large numbers of 
cells detached in the processing o f these samples, as further analysis did show a 
significant decline in non-apoptotic cells.
Although pDHA causes cell dysfunction in the dark, the finding that light 
exacerbates pDHA toxicity is extremely important for a tissue such as the retina. 
The level of toxicity observed in the dark would be unlikely to fluctuate greatly 
or suddenly over short time periods if darkness is maintained, thus allowing the 
retina to adapt to the conditions e.g. by providing and replenishing intrinsic 
antioxidants. Exposure to light, however, produces rapid temporal variations in 
conditions to which the retina would need to respond at onset of the “insult”. The 
finding that light exacerbates pDHA toxicity is, therefore, extremely important 
for a tissue such as the retina.
In summary, pDHA causes delayed cell death in ARPE-19 cells, probably via the 
apoptotic pathway of cell death, with a greater toxicity observed with higher light 
intensities.
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5. Effects of antioxidants on pDHA toxicity
5.1 Introduction
As described in Chapter 3, DHA peroxidation may occur readily in the retina, 
due to the structure and abundance of DHA itself, and the presence of 
photosensitizers, iron and high levels of oxygen. To end the propagation of the 
peroxidation chain of events, a termination step is required. Antioxidants play an 
important chain-breaking role to terminate lipid peroxidation and prevent further 
damage that may occur through the species produced. Thus, they may limit direct 
damage by lipid peroxidation products to other cellular components or formation 
of conjugates with other cellular molecules such as proteins, potentially leading 
to undegradable material such as lipofuscin -  a matter which is investigated 
further in later chapters of this thesis.
As discussed in Chapter 1, there is an important role for antioxidants in 
maintenance of cellular homeostasis in the retina and various antioxidants have 
been used clinically in attempts to reduce or delay the onset of AMD, with 
varying levels of success. In addition to providing a basis for potential 
therapeutic pathways, the in vitro use of different antioxidants with known 
mechanisms of action may aid in further identification of pathways of toxicity of 
different agents, as in this chapter, in which pDHA phototoxicity to ARPE-19 
cells is studied. The antioxidants used in this thesis and their known mechanisms 
of action are discussed in greater detail here.
5.1.1 Zeaxanthin and a-tocopherol
a-Tocopherol is a lipid-soluble free radical scavenger. Hydrogen donation from 
the phenol group in a-tocopherol to a lipid peroxyl radical results in formation of 
an a-tocopherol phenoxy radical which is relatively unreactive with other lipids 
and oxygen (Burton and Ingold, 1984).
LOO' + TOH -»  LOOH + TO'
The reaction can act as a chain breaking termination step in the cycle of lipid 
peroxidation, as the rate constant for this reaction, ~8xl04 M ^.s'1, is almost 4
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orders of magnitude faster than the interaction between the lipid peroxyl radical 
and lipids: ~10 N f'.s’1, with both constants estimated for biological membranes 
(Burton and Ingold, 1981; Buettner, 1993; Mukai et a l,  1993a; Mukai et a l,  
1993b). It is also possible for a-tocopherol radicals to adduct to lipid peroxyl 
radicals:
LOO* + TO' -*  TO-OOL
In addition to these antioxidant actions, a-tocopherol radicals are thought to play 
a pro-oxidant role if they accumulate to high concentrations, by interacting with 
lipids, resulting in lipid radical formation (Mukai et a l,  1993a; Mukai et a l , 
1993b).
TO’ + LH —► TOH + L’
TO’ + LOOH -+ TOH + LOO’
Use of additional antioxidants which can repair the tocopherol radical reduces 
this problem. Previous in vitro studies using a-tocopherol in conjunction with 
carotenoids and ascorbic acid showed a synergistic protective effect against 
photosensitizer-induced lipid peroxidation and cell death (Bohm et a l, 1998; 
Wrona et a l,  2003; Wrona et a l,  2004).
Zeaxanthin is a member of the carotenoid family. Carotenoids, in addition to 
their ability to repair a-tocopherol as described above and interact with other 
radicals, are able to quench singlet oxygen by energy transfer (Burton and 
Ingold, 1984; Liebler and McClure, 1996; Edge et a l,  1997; Young and Lowe, 
2001). This is an efficient process due to the lower triplet state energy of 
carotenoids compared with singlet oxygen. Following the transfer of energy, 
singlet oxygen returns to its triplet state, and zeaxanthin dissipates the transferred 
energy to its surroundings and returns to its ground state (Britton, 1995; Foote 
and Clennan, 1995). An additional property of zeaxanthin is its ability to alter 
membrane structure and function. It aligns perpendicularly within the membrane, 
and may affect water and oxygen movement through the membrane and thus 
slow down propagation of lipid peroxidation (Snodderly, 1995; Young and
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Lowe, 2001). As with a-tocopherol, it has been suggested that carotenoids may 
be pro-oxidant in certain situations, particularly in high oxygen conditions and in 
the presence of high carotenoid concentrations. Carotenoid pro-oxidant actions 
have been attributed to formation of carotenoid radicals and autoxidation 
resulting in formation of aldehyde and ketone products (Handelman et al., 1991; 
Young and Lowe, 2001; Hurst et al., 2005).
5.1.2 Phosphatidylethanolamine
The phosphatidylethanolamine (PE) polar head group has a free primary amine 
(Figure 5.1). Various studies have demonstrated that lipid peroxidation products, 
namely lipid aldehydes, may interact with the free amine, leading to formation of 
Schiff base and Michael adducts (Jain, 1984; Guichardant et a l , 1998; 
Guichardant et a l, 2002; Bacot et a l ,  2003; Bacot et a l,  2007), and that PE- 
aldehyde adducts form in low density lipoproteins (Heller et a l,  2000; Zieseniss 
et a l,  2001). Considering the large number of different products potentially 
formed during peroxidation of DHA, PE may provide a pathway for deactivation 
or stabilization of these products, or at least a number of them.
On
R, — C — OCH,
I
R ,— C — O — CH O
..............................................
O c h 2 — O — P — o — c h 2 — c h 2— n h 3
Ethanolamine phosphate
Figure 5.1 Phosphatidylethanolamine structure, indicating the polar 
ethanolamine phosphate headgroup containing a free primary amine. Rj and R2 
indicate fatty acid side chains (Halliwell and Gutteridge, 2007b).
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5.1.3 Glutathione, glutathione S-transferase and N-acetylcysteine
Glutathione (GSH) is able to conjugate with certain lipid peroxidation products, 
resulting in less toxic adducts. Specifically, lipid-derived aldehydes such as 4- 
hydroxynonenal (4-HNE, derived from arachidonic acid) and 4-HHE (derived 
from DHA), the breakdown products o f lipid hydroperoxides, are electrophilic 
and therefore readily react with thiol groups, including that in GSH (Esterbauer, 
1993; Choudhary et al., 2003; Guichardant et a l , 2004; Choudhary et a l, 2005). 
The aldehyde may then be further metabolised for example by reduction. This 
process may be enhanced in the presence of glutathione-S-transferase (GST), 
which catalyzes the conjugation o f aldehydes with GSH (Esterbauer, 1993; 
Choudhary et al., 2003). It has also been shown that other DHA peroxidation 
products such as the family of neuroprostanes are able to form conjugates with 
GSH (Fam et a l , 2002). GSH can also react with and deactivate free radicals and 
singlet oxygen (Halliwell and Gutteridge, 2007c). It is also a specific co-factor 
for glutathione peroxidase which is able to reduce peroxides (e.g. hydrogen 
peroxide and lipid peroxides which have been freed from membranes) by 
producing water and oxidizing reduced GSH (Halliwell and Gutteridge, 2007c):
H20 2 + 2GSH -*• GSSG + 2H20  
LOOH + 2GSH — GSSG + H20  + LOH
Aldehydes may also react directly with another low molecular weight thiol 
compound, N-acetylcysteine (NAC), also by forming a thio-ether linkage 
(Esterbauer et al., 1991). Thus, excesses of thiols such as NAC and GSH can 
overcome binding of lipid aldehydes to thiols on cellular proteins in addition to 
binding free lipid aldehydes (Esterbauer et al., 1991). Additionally, NAC is taken 
up by cells more readily than GSH. In the cytoplasm, NAC can be metabolized to 
the GSH precursor, cysteine. Thus, in addition to its direct actions as a thiol 
antioxidant, NAC may be used to replenish cellular GSH levels (Tanito et al., 
2002; Franco et al., 2007).
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The aim of this chapter is to determine the effects of various antioxidant agents 
on the effects of pDHA, in order to further understand the pathways by which 
pDHA is toxic.
5.2 Experimental design
For all experiments in this chapter, MTT assay was carried out 24 hours after 1 
hour of exposure to DHA +/- antioxidants, +/- light (15 mW.cm'2).
5.2.1 Zeaxanthin and a-tocopherol
Initial experiments were carried out with separate pDHA liposomes with either 
zeaxanthin or a-tocopherol incorporated. Later experiments used zeaxanthin 
dissolved in DMSO to avoid zeaxanthin degradation during liposomal 
preparation. To monitor potential degradation of zeaxanthin, liposome samples 
were removed from the individual wells after cell + light exposure and extracted 
in chloroform/methanol by the modified Folch’s method described in Section
2.1.2.1 above. Absorbance spectra were then measured, and compared to spectra 
of freshly prepared zeaxanthin in PBS (i.e. not exposed to cells or light) which 
was also extracted via the same procedure.
Zeaxanthin was used at concentrations o f 1, 2 and 4 pM, and a-tocopherol at 10, 
20 and 40 pM. These concentrations are equivalent to or higher than those 
previously shown to be protective in combination to ARPE-19 cells exposed to 
photodynamic damage (Wrona et al., 2004). The zeaxanthin concentrations used 
are considerably higher than measured plasma concentrations of 0.09 pM (SD
0.04) (Curran-Celentano et al., 2001), yet the presence of a regulated uptake 
mechanism results in accumulation of zeaxanthin and lutein in the retina to levels 
which are higher than xanthophyll levels in any other tissue (Bhosale et al., 
2004; Whitehead et al., 2006). DHA was used at either 0.5 or 1.5 mM depending 
on observed toxicity in each set o f experiments. The reduction in toxicity of 
pDHA observed in the second set of experiments, and therefore the need for a 
higher concentration, could be due to the presence of DMSO which has been 
shown to have antioxidant effects (Santos et al., 2003).
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5.2.2 Phosphatidylethanolamine
To study the effects of PE on pDHA toxicity, liposomes were made using pDHA 
and POPE at a concentration o f 40 mol%. This is based on published PE levels in 
the retina: 34.5 mol% of total rod outer segment (ROS) phospholipids in young 
and 35.9% in old samples (Bazan et al., 1990), and 43.2% of total retinal 
phospholipids (Fliesler and Anderson, 1983). In an attempt to control for any 
dilution or other effect of adding 40 mol% phospholipids, liposomes were also 
made using 40 mol% POPC with pDHA. As addition of these phospholipids 
would alter liposome properties, initial experiments were carried out to check 
pDHA toxicity in these new liposomes, with 3 mM chosen to ensure sufficient 
levels of toxicity to be able to monitor any changes induced by POPE.
5.2.3 Glutathione, glutathione S-transferase and N-acetylcysteine
To study the effects of GST and related antioxidants, pDHA was used at a 
concentration of 2 mM. GSH and NAC were both used at 0.5 mM and GST at 
4 ll.m f1 (all Sigma, UK). These concentrations were based on the expected 
activity of GST: assuming maximal lipid peroxidation and aldehyde formation
i.e. 2 aldehydes per DHA-PC, with 1 U o f GST able to conjugate 1 pmol to 
reduced glutathione per minute, 4 U.ml'1 should theoretically be able to catalyze 
reactions to bind and inactivate all the aldehyde groups within one minute. GSH 
and/or NAC were not used at concentrations high enough to fully facilitate this 
inactivation as these concentrations affected pH of the medium used, therefore a 
lower concentration was used.
5.3 Results
5.3.1 Zeaxanthin and a-tocopherol
Figure 5.2 below shows results for MTT assay carried out with either zeaxanthin 
or a-tocopherol incorporated into pDHA liposomes. pDHA caused a reduction in 
mitochondrial activity to 80% and 61% in dark and light exposed cells 
respectively. Zeaxanthin showed no protective effect against pDHA (photo-)
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toxicity, and in fact showed a significant reduction in mitochondrial activity at 
the highest concentration, with mitochondrial activity reduced to 66% and 41%, 
in dark and light, respectively (4 pM zeaxanthin; P <0.05). In contrast, a- 
tocopherol was able to reduce pDHA toxicity in a dose-dependent manner, with 
20 and 40 pM able to significantly improve mitochondrial activity compared 
with pDHA alone {P <0.01 and <0.001 respectively) to greater than 90%, such 
that they were no longer significantly different to control levels (P >0.05). Full 
tables of P-values are contained in Appendix 2.
pDHA (0.5 mM) + + + +
Zeaxanthin (pM) 1 2 4
pDHA (0.5mM) + + + +
a-Tocopherol (pM) - - 10 20 40
Figure 5.2 MTT results fo r  ARPE-19 cells exposed to pDHA liposomes with (A) 
zeaxanthin or (B) a-tocopherol, and either light-exposed or dark-maintained. All 
data were normalized to dark control. n=3.
I l l
5. Effects of antioxidants on pDHA toxicity
As previous studies have shown that the presence of multiple antioxidants is 
important, further experiments were carried out using both zeaxanthin and a- 
tocopherol in combination, with zeaxanthin added after dissolving in DMSO 
rather than incorporated into liposomes, to minimize its degradation prior to 
exposure to cells. Figure 5.3 shows a significant reduction in mitochondrial 
activity due to pDHA in light treatment only {P <0.001), with no significant 
positive effect of either antioxidant, either alone or in combination.
Dark 
I I Light
Bars = SEM
I
pDHA (1.5 mM) - + + + + + + +
a-Tocopherol (pM) - 20 20 40 40
Zeaxanthin (pM) - - -  4 -  4 1 4
Figure 5.3 MTT results fo r  ARPE-19 cells exposed to pDHA liposomes with a-
tocopherol and/or zeaxanthin. All treatments included 0.2% DMSO as carrier or
carrier control. All data were normalized to dark control, n = 3 for dark, n = 4
for light exposed.
Figure 5.4 shows absorption spectra measured to monitor potential changes in 
zeaxanthin after exposure to cells and light. These results show that the 
distinctive absorption peaks of zeaxanthin (at -450 and 480 nm) in the presence 
of a-tocopherol closely matched that of untreated zeaxanthin even after exposure 
to light for 1 hour. In contrast, absorption decreased for zeaxanthin alone (i.e. 
without a-tocopherol) in the dark, and decreased further after light treatment. 
This indicates degradation of zeaxanthin and could explain lack of positive 
effects when zeaxanthin was added alone without a-tocopherol in the 
experiments described above.
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Figure 5.4 Absorption spectra o f  extracted liposomes after cell exposure, 
compared with freshly prepared zeaxanthin diluted in PBS prior to extraction. 
AT = a-tocopherol; ZX  = zeaxanthin.
5.3.2 Phosphatidylethanolamine
Figure 5.5 compares the effects of pDHA with and without POPE on 
mitochondrial activity. An overall ANOVA P-value of <0.0001 indicates 
significant difference between these values. Post-tests indicate that pDHA (in 
liposomes with 40 mol% POPC) decreased mitochondrial activity significantly 
compared with controls (P <0.001 for light and dark): by 46% in dark- 
maintained (P <0.001 vs. control) and 83% in light-exposed cells (P <0.001 vs. 
control) and with a significantly greater effect in light vs. dark (P <0.01). The 
pDHA induced toxicity was significantly reversed in the presence of 40 mol% 
POPE instead of POPC (pDHA-POPC vs. pDHA-POPE: P <0.01 in dark, P 
<0.001 in light), and caused mitochondrial activity to return to levels which were 
no longer significantly different to their respective light/dark controls. There was 
no significant difference between dark- and light-maintained control cells (i.e. no 
pDHA).
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Bars = SEM 
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Control pDHA + pDHA + 
40mol% 40mol%
POPC POPE
Figure 5.5 MTT results fo r  ARPE-19 cells exposed to pDHA liposomes with 
40 mol% POPE or POPC. All data were normalized to dark control, n = 4.
5.3.3 Glutathione, glutathione S-transferase and N-acetylcysteine
Figure 5.6 shows, in agreement with previous experiments, that 2 mM pDHA 
had a significant effect on mitochondrial activity, with reductions to 56% in dark 
(P <0.001) and 20% in light (P <0.001). For light-exposed cells, addition of GSH 
or NAC separately to pDHA significantly increased mitochondrial activity 
compared with cells treated with pDHA alone (P <0.001 and <0.05 respectively), 
with activity in the presence of GSH no longer significantly different to control 
(i.e. no pDHA). GST, however, had no protective effect, either singularly or 
when added to either GSH or NAC. Adding all 3 reagents -  GSH, NAC and GST 
-  to pDHA had no further protective effect than adding either GSH or NAC in 
combination with GST.
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Figure 5.6 MTT results fo r  ARPE-19 cells exposed to pDHA with or without 
GSHZGST/NAC. All treatments were normalized to dark control. n>  3.
5.4 Discussion
This chapter has demonstrated that several agents are effective in protecting cells 
from (photo-)oxidative damage induced by pDHA.
The free radical scavenger a-tocopherol had a positive effect in one set of 
experiments with 0.5 mM pDHA, however it had no effect at the higher 
concentration of 1.5 mM pDHA. It should be noted that these experiments used 
different liposomes, with the latter having undergone additional intermediate 
steps in preparation during addition of antioxidants (as liposomes from the first 
experiments were “recycled” and used to make further liposomes). Also, in the 
second set of experiments, pDHA exposure was carried out in the presence of 
DMSO, either as a solvent for zeaxanthin or as a carrier control in all other wells. 
DMSO may act as an antioxidant (Santos et al., 2003), and could therefore 
decrease overall toxicity of pDHA, and additionally, could alter the pathways of 
oxidative reactions induced by pDHA, thus altering the efficacy of different 
antioxidants, as was observed here. Nevertheless, results suggest that in the
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presence of more lipid peroxides a-tocopherol appears less effective — possibly 
due to the balance of its antioxidant vs. pro-oxidant effects altering, or perhaps 
due to different modes of action of products found in more heavily peroxidized 
DHA samples, or increased probability of radicals reacting with other pDHA 
molecules instead of a-tocopherol, due to higher pDHA levels.
Surprisingly, considering that pDHA is known to produce singlet oxygen (MB 
Rozanowska personal communication; see also Chapter 6), zeaxanthin was not 
able to reduce toxicity, and appeared unable to salvage a-tocopherol and amplify 
its antioxidant effects. Evidence from UV-visible spectroscopy showed that 
zeaxanthin degraded during these experiments. This explains the lack of 
antioxidant activity. It has previously been shown for p-carotene that aldehyde 
degradation products absorb at shorter wavelengths than the unoxidized form, 
and that these products are toxic to cells (Hurst et al., 2005), thus it could be 
postulated that this is also possible for zeaxanthin, and indeed occurred in these 
experiments. As described in Chapter 4, retinal light irradiance would be lower 
than the acute model used here -  with cells here exposed to a dose of light (1 
hour at 15 m W .cm ') equivalent to 150 hours of continuous retinal exposure to 
maximal normal daylight. In more physiological light exposures, zeaxanthin 
would be less prone to photodegradation, and could be protected by further 
antioxidants, such as water-soluble ascorbate, which would normally be present 
but are not included in the in vitro situation studied here. It is also more likely 
that zeaxanthin and other antioxidants could be replenished from the circulation 
over this time period.
Experiments with GSH showed that this thiol antioxidant was able to almost 
completely prevent the cell death caused by pDHA, as could NAC, a precursor to 
GSH which also contains a thiol group. As discussed above, these molecules 
could act as free radical scavengers, as a co-factor for GSH peroxidase (GSH) or 
by adducting with lipid aldehydes and other degradation products. The latter 
would prevent subsequent adduction of these products to other cellular 
components, which would otherwise have a detrimental effect on cell function, 
potentially leading to cell dysfunction and death observed in these results. 
Surprisingly, GST had no effect on cell viability. In these experiments,
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antioxidants were combined with pDHA prior to applying to cells. Perhaps in the 
several minutes between these two steps the GSH and NAC are able to bind to 
aldehydes or other derivatives within the lipid mixture, thus, no further change 
would occur in the presence o f GST -  if GSH and NAC have fully interacted 
with lipids, the enzyme can have no further effect. It is not surprising that GST 
alone had no effect as the liposomes are applied to the cells externally where 
there would not be GSH for the GST to catalyze the reaction of. It is of course 
possible that some pDHA is internalized -  either by phagocytosis or 
incorporation into the cell membrane. For the former, GST could enter too but as 
these components will then be contained within a phagosome there is still likely 
to be an issue of access to GSH. If DHA incorporates into the cell plasma 
membrane, this would not necessarily allow access of GST into the cytoplasm.
Phosphatidylethanolamine also successfully reduced the toxic effects of pDHA. 
As it is known the amine group o f PE can interact with lipid aldehydes, these 
results suggest a crucial role for lipid aldehydes in the toxicity of pDHA. 
However, as PE is not a well defined traditional antioxidant, further work has 
been carried out in Chapter 6 to further elucidate the mechanisms by which it 
acts as an antioxidant in protecting cells from pDHA-induced damage.
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Chapter 6:
Pathways of pDHA (photo-)reactivity
6. Pathways of pDHA (photo-)reactivity
6.1 Introduction
Although it has been shown in Chapter 4 that pDHA is phototoxic to ARPE-19 
cells, the precise pathways by which this toxicity occurred were not discussed. In 
Chapter 5, however, various antioxidants and detoxifying agents were shown to 
have protective effects on cell viability in the presence of pDHA (measured by 
MTT assay). Although several o f these antioxidants have known mechanisms of 
action, POPE does not. The large protective effect seen in experiments in 
Chapter 5 therefore warrants further investigation.
It has previously been demonstrated that photoexcitation of pDHA as 
16:0;22:6PC or as a free fatty acid results in an increase in O2 uptake, and 
formation of superoxide (measured by spin-trapping) and singlet oxygen 
(personal communication: MB Rozanowska). To further understand the potential 
relevance of these pathways to this project, and to better understand the 
mechanism by which POPE was protective to cells, experiments were carried out 
to monitor singlet oxygen production and transient formation, and also 
superoxide production via an alternative assay in which reduction of cytochrome 
C by superoxide was monitored. These experiments were carried out using 
pDHA phospholipid, with 40 mol% of either POPE or POPC.
6.2 Experimental design
6.2.1 Singlet oxygen production
Singlet oxygen production was measured in two separate sets of experiments:
(1) Relative yield of singlet oxygen measured in samples containing equal 
concentrations of pDHA in the presence of 40 mol% POPE or POPC
(2) Quantum yield o f singlet oxygen measured in samples with matched 
absorbances at the excitation wavelength (420 nm) to ensure equal 
numbers of absorbed photons, with ATR as a standard of known quantum 
yield
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Liposomes containing 60 mol% pDHA and 40 mol% of either POPC or POPE 
were extracted in chloroform/methanol as described in Section 2.1.3.1 above. 
Chloroform-enriched phases were then dried under argon and dissolved in 
benzene prior to measurement of absorption spectra.
The same initial samples were used for both sets of experiments, but diluted as 
required. To ensure that the incident laser energy was uniform across the 
irradiated surface area and to reduce the irradiance of the samples a diverging 
lens was put in the path of the laser beam for the second (quantum yield) set of 
experiments (see Figure 2.4)
Transmission spectra of the neutral density filters (used to reduce laser intensity 
in singlet oxygen measurements) were measured to calculate the average 
reduction in light intensity caused by the filters (Figure 6.1 A). The mean 
reduction in transmission at 420 nm, the laser excitation wavelength in these 
experiments, was 8.92% (SD 0.26%) per filter. Figure 6.IB shows expected 
relative laser intensity over the range of filter numbers used in these experiments.
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Figure 6.1 Effects o f  neutral density filters on light transmission. (A) 
Transmission spectra with either air only or with 1 filter; (B) calculated relative 
laser energy at 420 nm with 0 to 16 filters in the light path.
6.2.2 Laser flash  photolysis
Liposomes containing pDHA, with POPE or POPC, were extracted and prepared 
as for singlet oxygen measurement. Absorption spectra in benzene were then
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measured to ensure optical densities at 420 nm were matched, at approximately 
0.2. Samples were depleted o f oxygen by bubbling for 20 minutes with argon 
prior to measurement, then passing argon over the samples throughout 
measurement. Where required, samples were bubbled with air to obtain air- 
saturated (oxygen present samples), containing 1.91 mM oxygen (Murov, 1973).
6.2.3. Super oxide production
Initial experiments were carried out to find an optimal concentration of pDHA at 
which to carry out monitoring o f superoxide production -  ensuring that 
saturation levels o f cytochrome C reduction were not reached, and that 
background absorbance levels due to light scattering caused by pDHA liposomes 
was not too high to allow accurate measurement o f changes in absorbance at 
550 nm. Based on these results, subsequent experiments were carried out with 
liposomes containing 0.1 mM pDHA in liposomes, with 40 mol% POPC or 
POPE.
6.3 Results
6.3.1 Singlet oxygen production
6.3.1.1 Relative singlet oxygen yield: concentration-matched samples
Figure 6.2 below shows absorbance spectra o f pDHA samples prior to singlet 
oxygen measurements. Although the concentrations were matched, absorbance at 
420 nm for pDHA + POPC was 0.231, which was less than 0.389 measured for 
pDHA + POPE.
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Figure 6.2 Absorbance spectra fo r  matched concentrations o f pDHA + POPE 
and pDHA + POPC in benzene, prior to singlet oxygen measurement.
Singlet oxygen kinetic traces are shown in Figure 6.3A with linear regression of 
the initial intensity values (normalized to laser pulse energy) shown in Figure 
6.3B. A comparison of signal lifetime values and slopes (indicating yields of 
singlet oxygen production) of pDHA + POPE and pDHA + POPC is shown in 
Table 6.1. This shows a large difference in lifetime of singlet oxygen: 31.2 ps in 
the POPC sample, compared with only 17.4 ps in the POPE sample. The results 
of the linear regression indicate a slightly shallower slope and therefore lower 
yield o f singlet oxygen in samples containing POPE. However, the 95% 
confidence intervals for the slopes o f the two samples overlap, suggesting a non­
significant difference.
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Figure 6.3 Singlet oxygen production in samples o f matched concentration o f  
pDHA in the presence o f  POPC or POPE. (A) Singlet oxygen phosphorescence 
kinetics for pDHA + POPC and pDHA + POPE at 39% laser intensity (with 
similar laser pulse energy). (B) Linear regression o f initial signal intensity 
values, based on single measurements over a range o f  laser intensities. 95% 
confidence intervals o f  the linear regression are indicated by dashed lines.
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A420 r  (m^s) Regression slope Slope: 95% Cl
pDHA + POPC 0.231 31.2 (9.1 ± 0.3) xlO"4 8.6x1c4 -9 .7 x 1 0 “'
pDHA + POPE 0.389 17.4 (8.3 ± 0.3) xlO-4 7.8x104 -8 .8 x10'4
Table 6.1 Summary o f  singlet oxygen formation in concentration-matched 
samples, showing absorption at 420 nm prior to experiment, lifetime o f the 
observed signal (x), slope o f  the linear regression ± SD (from data in figure 
6.5B) -  directly proportional to singlet oxygen yield, and 95% confidence 
interval o f the slope.
6.3.1.2 Singlet oxygen quantum  yields: absorbance-matched samples
Figure 6.4 shows absorbance spectra for ATR, pDHA + POPC and pDHA + 
POPE, diluted as required to give matching absorbances at 420 nm, adjusted to 
0.189.
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Figure 6.4 Absorbance spectra fo r  ATR, pDHA + POPC and pDHA + POPE 
samples, with absorbances matched to the arbitrary value o f 0.189 at 420 nm.
When absorbances at 420 nm were matched, the yield o f singlet oxygen 
production in pDHA + POPC was greater than for pDHA + POPE as indicated 
by the initial phosphorescence intensities in Figure 6.5A and the steeper slope of 
the fitted data in Figure 6.5B. When compared to the slope of ATR it was 
possible to calculate quantum yields for singlet oxygen production, summarized 
in Table 6.2. Results show a higher quantum yield o f singlet oxygen production
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by pDHA + POPC (0.14 ± 0.02) compared with pDHA + POPE (0.08 ± 0.01). 
Measured intensities o f singlet oxygen phosphorescence were lower in this 
experiment compared with those presented in Figure 6.3 above due to the 
insertion of the diverging lens into the laser pathway.
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Figure 6.5 Singlet oxygen production in samples o f  matched absorbance. (A) 
Singlet oxygen phosphorescence kinetics for A TR, pDHA + POPC and pDHA + 
POPE, at 39% laser intensity (with similar laser pulse energy). (B) Linear 
regression o f  initial signal intensity values, based on single measurements over a 
range o f laser intensities. 95% confidence intervals o f the linear regression are 
indicated by dashed lines.
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Q uantum  yield
ATR 0.30 ± 0.04 *
pDHA + POPC 0.14 ±0.02
pDHA + POPE 0.08 ± 0.01
Table 6.2 Quantum yields o f  singlet oxygen production by ATR, pDHA + POPC 
and pDHA + POPE in benzene. *(Rozanowska et al., 1998).
6.3.2 Laser flash photolysis to monitor transient formation
After exposure to a 5 ns laser pulse at 420 nm, deoxygenated samples showed 
formation of a transient species followed by decay of transient(s) at wavelengths 
longer than -440 nm, and initial photobleaching, then recovery of the ground 
state at wavelengths shorter than -440 nm (see Figure 6.6). It can be seen, 
however, that recovery from photobleaching does not appear to be complete 
within the time-span of the recordings shown. This effect is more pronounced in 
pDHA + POPE than pDHA + POPC.
To determine whether the transient formation and its lifetime are affected by 
molecular oxygen, initial yields and decays were compared in air- and argon- 
saturated samples. The absorbance changes were monitored at wavelengths 
corresponding to the maxima and minima in the transient absorption spectra 
(Figure 6.6 A-D). The kinetics were fitted to exponential curves and lifetimes of 
the transients were calculated as shown in Table 6.3. The lifetime of the transient 
in pDHA + POPC samples was greatly reduced by oxygen (6.4 to 0.7 ps), giving 
a bimolecular rate constant for quenching of the transient by oxygen (indicating 
rates of interaction of the formed transient(s) with oxygen) of 6.8 x 108M '1.s’1. 
For pDHA + POPE, the transient lifetime reduce from 16.7 to 0.9 ps with a rate 
constant for interaction with oxygen of 5.8 x 108M '1.s‘1. Comparing the two 
samples, the transient lifetime in argon-saturated samples was 2.6-fold longer in 
the presence of POPE (16.7 ps) compared with POPC (6.4 ps), but oxygen- 
saturated samples showed similar lifetimes. The rate constant for quenching by 
oxygen was, however, 17% greater for the pDHA + POPC samples compared 
with pDHA + POPE.
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Figure 6.6 Laser flash photolysis o f  pDHA. (A-D): Kinetics o f absorbance 
change for pDHA + POPC (A+C) and pDHA + POPE (B+D), showing initial 
formation then decay (A+B) and photobleaching (C+D) o f the transient(s), in 
argon and air saturated samples. Kinetics are shown for indicated wavelengths, 
representing maximal absorbance/photobleaching for each sample. Vertical 
interval = 0.005 absorbance change (AU); horizontal interval = 15ps. (E) 
Transient difference spectra fo r pDHA + POPC and (F) for pDHA + POPE for  
data averaged around three selected time points.
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pDHA + POPC pDHA + POPE
t  (ns): argon 6.4±0.1 16.7±1.9
t  (m s): air 0.7±0.04 0.9±0.09
ko (M 's'1) 6.9 x10s 5.5 x10s
Table 6.3 Lifetimes (t) o f  transient(s) form ed after flash photolysis o f  argon- or 
air-saturated samples containing pDHA + POPC or pDHA + POPE, and rates 
o f quenching o f  transient formation by oxygen ( I cq ) .
6.3.3 Superoxide production
Cytochrome C reduction took place in the presence of pDHA, demonstrated by 
an increase in absorbance at 550 nm over time (Figure 6.7 and 6.8). Inhibition by 
SOD indicates that the observed reductive effect was at least partly attributable to 
production of superoxide. Although there was a considerable amount of 
superoxide production in the dark, production increased upon exposure to light.
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Figure 6.7 Spectral changes in absorbance over time. Increase in absorbance at 
550 nm indicates cytochrome C reduction by superoxide. (A) Samples containing 
liposomes with pDHA + POPC and (B) pDHA + POPE, with or without 
250 U.mL'1 catalase or SOD, and irradiated with light or incubated in dark, as 
indicated. Representative data shown were obtained in a single experiment.
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Figure 6.8 Graphs showing changes in reduced cytochrome C levels in 3 
independent experiments for samples containing (A) pDHA + POPC liposomes 
and (B) pDHA + POPE liposomes, with or without 250 U.mL'1 catalase or SOD, 
and irradiated with light or incubated in dark, as indicated. Red lines indicate 
nonlinear regression curve fits. Other data sets which did not f it  the equation are 
joined by dotted lines.
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Non-linear regression allowed comparison of kinetics for samples with pDHA + 
light, pDHA + catalase + light and pDHA + dark by fitting data to a single 
exponential equation. This provided values for the rate of cytochrome C 
reduction (k), and the maximal level of cytochrome C expected (Aoo). These 
values are compared in Figure 6.9. For the k-value, t-tests to compare the light 
treated liposome samples (without enzyme) in the pDHA + POPC group vs. 
pDHA + POPE indicated no significant difference (P = 0.255). Separate 
ANOVA tests within the pDHA + POPC and pDHA + POPE liposome groups 
showed no significant difference in k-values between light treated (no enzyme), 
light treated + catalase or dark treated (P = 0.614 for pDHA + POPC and 0.543 
for pDHA +POPE).
There was no significant difference in Aoo between the two light exposed 
(without enzyme) samples (P = 0.199, with Welch correction for unequal 
variances). Furthermore, there was no overall difference in A® within the pDHA 
+ POPC group (ANOVA: P — 0.198). There was however a very significant 
difference within the pDHA + POPE group (P = 0.004), with dark causing a 
significant 47% reduction in A® (P < 0.01), from 15.4 to 8.2 pM.
To allow further comparison of all samples, including those which could not be 
analysed using non-linear regression, mean levels of cytochrome C observed 
after 60 minutes were compared. Results are shown graphically in Figure 6.10. 
There was no significant difference between light exposed (without enzyme) 
pDHA + POPC and pDHA + POPE samples (P = 0.245). Separate ANOVA tests 
showed that within both of these sample groups there was significant variation 
(P < 0.0001 for both). Separate comparisons with the “control” (i.e. light 
exposed, no enzymes) within each of these groups showed no significant effect 
of catalase, but extremely significant reduction in final cytochrome C levels in 
the presence of SOD, in the absence of pDHA, and in dark maintained samples 
(P < 0.01 for all).
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Figure 6.9 Comparison o f  non-linear regression values fo r  cytochrome C 
reduction assay showing: (A) rate offormation o f  reduced cytochrome C (k); (B) 
maximum levels o f reduced cytochrome C as time approaches oo (Af). Bars 
indicate mean o f  3 experiments. Error bars = SEM.
1 3 2
6. Pathways of pDHA (photo-)reactivity
10 i
■ooo
3■o
2
o
<D
E
2£Oo
*o
I I 1
pDHA, light 
pDHA + catalase, light 
pDHA + SOD, light 
pDHA, dark 
no pDHA, light
pDHA + POPC pDHA + POPE
Figure 6.10 Levels o f  reduced cytochrome C after 60 minutes incubation, fo r  
samples containing pDHA + POPC or pDHA + POPE, with or without 
250 U.mL'1 catalase or SOD, and irradiated with light or incubated in dark, as 
indicated. Bars indicate mean o f  3 experiments. Error bars = SEM.
6.4 Discussion
This chapter has attempted to investigate the mechanism responsible for 
reduction of phototoxicity of pDHA in the presence of POPE, as observed in cell 
culture experiments in Chapter 5.
Photoexcitation of pDHA, in the presence of either POPC or POPE, resulted in 
formation of singlet oxygen. Although the quantum yield of singlet oxygen 
production is greater in the presence of POPC, this could be counteracted by an 
increased absorption of samples with POPE, thereby still giving equal yields. 
The expected ratio of singlet oxygen yields of concentration-matched samples 
(excited at 420 nm) may be calculated, based on their respective quantum yields 
(measured in Section 6.3.1.2) and absorbance values (Section 6.3.1.1) which 
allow estimation of the ratio of absorbed photons by each sample, as shown in 
Figure 6.11. This gives a calculated ratio of 1.22, which compares well with the 
measured ratio, 1.10, calculated using relative yields measured in Section 6.3.1.1.
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A = absorbance
l0 = incident light (equal for all samples) 
lA = absorbed light 
4* = yield
O = quantum yield
PC = pDHA + POPC samples
PE = pDHA + POPE samples
Figure 6.11 Equations and calculations to compare calculated yield ratios, using 
quantum yield and absorbance values, and measured yield ratios. Equation lb  is 
derived as a rearrangement o f  la. 3 a is derived from  2, and 3 b is derived from  
incorporation o f  lb  into 3a.
These experiments, therefore, do not show a role for POPE in reducing the yield 
of singlet oxygen produced by pDHA. There does, however, seem to be a 
difference in lifetime of the singlet oxygen produced. Without POPE, singlet 
oxygen lifetime was comparable with the published expected lifetime of singlet 
oxygen in benzene: 30 ps (Bensasson et al., 1993b; Foote and Clennan, 1995). In 
the presence of POPE the singlet oxygen lifetime decreased, indicating efficient 
quenching of singlet oxygen by POPE and/or POPE-pDHA adducts. To confirm 
whether POPE is able to quench singlet oxygen, further experiments could be 
carried out in which singlet oxygen production by another photosensitizer such 
as rose bengal is monitored, and increasing concentrations of POPE or a mixture 
of pDHA and POPE are added to monitor any quenching ability.
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To investigate the possible mechanisms by which singlet oxygen was formed, 
laser flash photolysis was carried out to monitor formation of transient excited 
states in pDHA samples, in the presence of either POPE or POPC. 
Photoexcitation of the samples resulted in formation of transient(s), and also 
photobleaching, followed by decay and recovery respectively. Recovery from 
photobleaching was not complete within the time-span of the recordings, 
particularly in the presence of POPE. In argon-saturated (oxygen depleted) 
samples, the presence of POPE resulted in a longer transient lifetime. In air- 
saturated (oxygen present) samples, however, POPE did not affect the lifetime of 
the transient. The precise identity o f the transient formed in these experiments 
has not been elucidated. However, singlet oxygen formation occurs via energy 
transfer from an excited triplet state molecule (e.g. excited photosensitizer), 
therefore, the observed quenching of the transient by oxygen, and formation of 
singlet oxygen already described above imply that the transient observed here is 
likely to be a triplet state species. To confirm this, further experiments could be 
carried out using a triplet energy acceptor, for example P-carotene or related 
carotenoids. These compounds have a low triplet energy level (e.g. <95 kJ.mol'1 
for P-carotene) and can therefore be excited to a triplet state by most other triplet 
states. This results in a shift in the absorption maximum of the carotenoid to a 
longer wavelength (compared with the singlet state), with a high absorption 
coefficient, thus allowing straightforward detection of its formation (Bensasson 
e ta i ,  1993a).
Light exposure of pDHA liposomes containing either POPC or POPE resulted in 
increased levels of reduced cytochrome C. There was, however, no difference 
between pDHA + POPC and pDHA + POPE liposome samples. The formation of 
reduced cytochrome C did not occur linearly with time, but instead appeared to 
reach a plateau. This indicates either a limiting factor in the formation of 
superoxide or the reduction of cytochrome C, or loss of reduced cytochrome C 
through re-oxidation. Potential pathways are summarized in Figure 6.12.
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Figure 6.12 Schematic diagram o f  actual and speculated pathways involved in 
the cytochrome C reduction assay used in this chapter. Dotted arrows = 
speculated pathways; OxCytC = oxidized cytochrome C; RedCytC = reduced 
cytochrome C; H2O2 = hydrogen peroxide; OfT = hydroxyl radical. * 
dismutation o f  superoxide may also occur spontaneously.
It is difficult to confirm the role of any of these factors: oxygen supply is 
plentiful due to stirring of samples throughout the experiments; the substrate, 
cytochrome C, is available in excess (starting concentration was 50 pM 
compared with maximal reduced cytochrome C levels observed after 60 minutes 
of approximately 9 pM). Other alternatives include depletion of the 
photosensitizer, pDHA, over the time-span of the experiment, or alternative 
routes of degradation of superoxide which could occur more quickly than the rate 
at which it interacts with and reduces cytochrome C. These could include 
dismutation to hydrogen peroxide (spontaneous or via SOD where included) or 
interaction with pDHA. An additional factor not controlled for in these 
experiments is metal ion levels: if  superoxide is formed and dismutates to 
hydrogen peroxide, this could cause re-oxidation of cytochrome C. However, 
catalase, an enzyme which degrades hydrogen peroxide, showed no effect on 
cytochrome C reduction in these experiments so hydrogen peroxide is unlikely to 
play a direct role here. In the presence of metal ions however, Fenton reactions 
may result in rapid formation of hydroxyl radicals which could instead re-oxidize 
cytochrome C. These pathways are summarized in Figure 6.12 (Halliwell and 
Gutteridge, 2007a).
1 3 6
6. Pathways of pDHA (photo-)reactivity
Addition of SOD resulted in lower levels of reduced cytochrome C at 60 
minutes. To confirm that this was due to direct enzyme actions in dismutating 
superoxide rather than the protein acting as an alternative substrate for pDHA or 
(photo-)generated reductive species, results can be compared with catalase 
experiments: catalase was present in a similar absolute concentration 
(0.85 mg.ml'1 catalase vs. 0.96 mg.ml'1 SOD), thus providing similar levels of 
amino acid residues as potential targets. Yet catalase caused no alterations in 
reduced cytochrome C levels. Therefore, the positive effect of SOD confirms that 
superoxide is responsible for the observed reduction of cytochrome C. Kinetics 
of cytochrome C reduction in the presence of SOD is, however, very different to 
the samples without SOD. Graphs suggest that SOD initially protects cytochrome 
C, causing a lag period before cytochrome C reduction commences, between 10 
and 20 minutes after the start o f light exposure. This could be due to inactivation 
of SOD -  potentially by the light exposure -  or by interaction with pDHA, 
neither of which was investigated here.
In summary, although pDHA samples appear to produce both singlet oxygen and 
superoxide, POPE does not reduce the production of these compounds to a level 
which could explain its protective effect observed in MTT cell culture 
experiments in Chapter 5. POPE does, however, shorten the lifetime of singlet 
oxygen, but because the yield of production is the same as without POPE, the 
effects of this shortening would depend on the rate of interaction of singlet 
oxygen with other targets in the cell experiments and their concentrations relative 
to PE. The presence of PE reduced singlet oxygen lifetime to -17 ps, almost half 
the lifetime of singlet oxygen produced by pDHA without PE. These 
measurements were carried out in benzene, where the expected lifetime of singlet 
oxygen is 30 ps (Bensasson et a l , 1993b; Foote and Clennan, 1995). In lipid 
suspensions in water (using pure phosphatidylcholine), and cell membranes, 
singlet oxygen lifetime is decreased by two thirds (compared with benzene) to 
-10 ps (Baier et a l , 2005). The lifetime in water is even shorter: 3.5-4 ps 
(Bensasson et al., 1993b; Baier et a l , 2005). If the quenching ability of PE is 
similar in these other situations and can halve the singlet oxygen lifetime, this
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could have a large impact on the likelihood of singlet oxygen produced by pDHA 
interacting with other molecules to cause toxicity.
Another potential pathway of POPE-mediated protection is via the interaction of 
PE with lipid aldehydes. Peroxidation of LC-PUFA leads to the production of a 
large number o f products and includes the formation of lipid aldehydes which 
have previously been shown to form Schiff base adducts with amines (Boutaud et 
al., 1999; Bemoud-Hubac et al., 2001; Gu et al., 2003b), and are able to form 
Michael adducts with ethanolamine phospholipids (Bacot et al., 2007). 
Therefore, PE may act as a substrate for this reaction when combined with 
pDHA, thereby potentially deactivating pDHA, or at least a large number of the 
peroxidation products present in the mixture. This could prevent further 
phototoxic reactions, or prevent interaction of pDHA aldehydes with proteins 
during cell exposure experiments. Changes in absorbance observed in samples 
containing pDHA + POPE compared with pDHA + POPC suggest that formation 
of adducts between pDHA and POPE do, in fact, occur. To further investigate 
this matter, pDHA-PE adducts and adducts with cellular proteins could be 
identified using tandem mass spectroscopy, and the protective effects of POPE 
could be compared with other known (natural and synthetic) lipid aldehyde 
scavengers. This could at least provide an indication of whether or not this 
mechanism is important in the observed toxicity of pDHA, and may better 
explain the protective role of POPE.
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7. Effects of pDHA on RPE degradative functions
7.1 Introduction
As discussed in Chapter 1, RPE cells play a vital support role to photoreceptor 
cells. One of the important processes carried out by RPE cells is the phagocytosis 
of spent photoreceptor outer segments, to remove peroxidized lipids and other 
waste materials. Lipid peroxidation may in fact result in increased phagocytosis 
by providing tags for CD36 mediated phagocytosis (Sun et a l , 2006). To aid 
with this process, RPE are in very close contact with POS (Gu et al., 2003a). 
After internalization, material needs to be degraded prior to complete removal 
from the RPE, either through Bruch’s membrane and removal via the blood 
supply, or via a recycling process to be re-incorporated into newly formed POS 
discs. It has previously been shown that normal components of the (aged) retina, 
e.g. lipofuscin and A2E, as well as oxidized POS fed to cells, are able to reduce 
the degradative capacity of lysosomes via various pathways (Wihlmark et al., 
1996; Bermann et al., 2001; Shamsi and Boulton, 2001; Finnemann et al., 2002; 
Bergmann et al., 2004; Kaemmerer et al., 2007).
The aims of this chapter are to monitor whether pDHA is able to alter the 
structure and function of lysosomes in a way that reduces their capacity to 
degrade phagocytosed material, and to monitor changes in cellular fluorescence 
and accumulation of undegraded material.
7.2 Experimental design 
7.2.7 Cell viability after feeding with POS +/- pDHA
Initial observations after long-term feeding of cells with pDHA included changes 
in the colour of the culture m edium - becoming rather more pink than normal 
(usually correlated with cell death -  personal observation), particularly at the 
highest pDHA concentrations and longest time points. Additionally, it took 
longer to collect equivalent cell numbers by flow cytometry, implying lower cell 
concentrations and therefore initial cell numbers. Therefore, MTT assays were 
carried out after pDHA/POS feeding to monitor this problem.
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Phototoxicity of internalized pDHA to ARPE-19 cells after long-term feeding 
was also investigated. After feeding as described above, cells were washed then 
put in fresh medium for 24 hours to allow for internalization of any attached 
photoreceptors and/or liposomes prior to light exposure.
7.2.2 Lysosomal integrity after feeding with POS +/- pDHA
Acridine orange is a hydrophobic molecule with green fluorescence at low 
concentrations at neutral pH, e.g. in the cytoplasm (Brunk et al., 1995; Ollinger 
and Brunk, 1995). Its hydrophobicity allows it to transfer across cell and 
organelle membranes. At acidic pH, acridine orange becomes protonated and can 
no longer cross membranes. Instead, it aggregates, allowing accumulation against 
the concentration gradient in acidic compartments of the cell e.g. lysosomes, 
resulting in red fluorescence (de Duve et a l , 1974; Ollinger and Brunk, 1995). 
This allows clear fluorescent labelling o f lysosomes, with simultaneous 
excitation of the red and green emitting forms possible by illumination with blue 
light (488 nm) during either fluorescence microscopy or flow cytometry. On 
exposure to bright blue light, acridine orange acts as a photosensitizer and is able 
to damage lysosomal membranes, thus resulting in a loss of the pH gradient, de­
protonation of the acridine orange and a loss of red fluorescence, and increased 
cytoplasmic green fluorescence (Brunk et al., 1997). Therefore it is important to 
image the cells as quickly as possible and maintain cells in darkness after 
loading.
Acridine orange may also label RNA (red), however this requires higher 
concentrations than those used in these experiments (5 pg.ml'1), so is unlikely to 
have any effect on monitoring o f lysosomal labelling (Antunes et al., 2001).
Acridine orange labelling was monitored using two methods: fluorescence 
microscopy and flow cytometry. Microscopy allowed an overall check that 
acridine orange labelling was consistent with lysosomal labelling i.e. visible as 
granular red fluorescence, rather than for example, cytoplasmic red fluorescence 
which could possibly occur if cytoplasmic pH were to be drastically alter by 
bursting lysosomes. This technique has severe limitations, however, as imaging
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is relatively slow, and due to issues with phototoxicity of acridine orange itself, it 
is absolutely essential that all samples are treated identically. Therefore, after 
initial observations by fluorescence microscopy, flow cytometry was used for 
rapid analysis of large numbers of cells.
7.2.3 Intracellular deposit formation after feeding with POS +/- 
pDHA
Two methods were used to monitor formation of intracellular deposits in ARPE-
19 cells fed with POS and/or pDHA. Initially, flow cytometry was used as a 
rapid way to monitor changes in fluorescence. However, to correlate these 
findings with levels of lipofuscin-like granule formation, it was necessary to 
carry out imaging of the cells using TEM. This provides high resolution imaging 
of individual cells, and allows clear identification of electron-dense granules.
7.3 Results
7.3.1 MTT assay after feeding with POS/pDHA
7.3.1.1 Effects of long-term feeding on cell viability
When cells were fed with POS +/- pDHA for up to 3 weeks, mitochondrial 
activity showed significant differences between feeding treatments (two-way 
ANOVA P < 0.001; Figure 7.1). For cells fed for two weeks, Tukey’s post-tests 
showed a significant 20% increase in activity after feeding with POS + 10 pM 
pDHA (P < 0.001) and a significant 14% decrease after feeding with POS +
20 pM pDHA (P = 0.001), compared with control. There was no significant 
overall difference between the two time points investigated (2-way ANOVA P = 
0.314), however after 3 weeks o f feeding, supplemented cells varied to a greater 
extent from the control cells, with all showing a significant difference, with 
increases to 115%, 121% and 128% for POS + 0, 5, and lOpM pDHA 
respectively, and a decrease to 62% for POS + 20 pM (P = 0.004 for all 
comparisons with cells fed POS only, and P < 0.001 for all cells fed POS + 
pDHA).
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Figure 7.1 MTT assay carried out after feeding cells for 2 or 3 weeks with POS 
+/- pDHA at the indicated concentrations. All treatments were normalized to 
control cells at the same time point. Bars = SEM; n = 3-6.
7.3.1.2 Phototoxicity of pDHA afte r long-term  feeding
In separate experiments, cells were fed with POS and/or 20 pM pDHA in 
liposomes for 2 weeks, then washed and left for 24 hours to allow internalization 
o f any bound POS/liposomes. Cells were then exposed to light (15 mW.cm'2) or 
maintained in the dark for one hour, and the MTT assay was carried out 24 hours 
later (Figure 7.2). Two-way ANOVA showed no significant difference between 
light and dark treated cells (P  = 0.674). However, the different feeding 
conditions did significantly alter mitochondrial activity between groups (P <  
0.001). In dark conditions, pDHA alone caused a significant decrease compared 
with POS + pDHA (P  = 0.01), and in light conditions, pDHA alone caused a 
significant reduction in mitochondrial activity, to 83%, compared with all other 
treatments (P = 0.023 vs. control, P = 0.002 vs. POS, P < 0.001 vs. POS + 
pDHA).
i 1 2 weeks
i i 3 weeks
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Figure 7.2 MTT assay carried out after 2 weeks o f  feeding cells with POS and/or 
pDHA, followed by 1 hour light exposure (15 mW.cm2), then 24 hours post­
incubation in fresh medium. All treatments were normalized to the dark control 
Bars = SEM; n=3.
7.3.2 Lysosomal integrity
7.3.2.1 Fluorescence microscopy of acridine orange labelled cells
Cells labelled with acridine orange showed granular red fluorescence indicative 
of lysosomal uptake o f this fluorophore (Figure 7.3). The images indicate that 
intact lysosomes were present after all treatments, and that there was rather 
variable staining, even in different cells within the same treatment. As detached 
cells were used and they were rather dispersed on the slides, no further analysis 
of these images was carried out. Instead, flow cytometry was used to allow more 
rapid collection of fluorescence data of far greater numbers of cells with reduced 
risk of acridine orange induced phototoxicity.
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dark light
Figure 7.3 Cells labelled with acridine orange after 2 weeks o f feeding as 
indicated, then either dark-maintained or exposed to light (15 mW.cm'2) for 1 
hour prior to labelling. Blue = Hoechst labelling o f nuclei; green = cytoplasmic 
acridine orange; red = lysosomal acridine orange. Bar = 50 juM.
73.2.2 Flow cytometry of acridine orange labelled cells
Flow cytometry was used to monitor levels of red and green fluorescence (FL3 
and FL1 respectively) in cells labelled with acridine orange. Results show 
partitioning o f “events” (assumed to be individual cells) into 3 regions with 
different ratios o f red to green fluorescence, as marked on scatter plots in Figure
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7.4 (dark-maintained cells) and Figure 7.5 (light-exposed cells). Numbers of cells 
in each of these regions were counted. Mean values are compared in Figure 7.6.
The majority of cells fell into region 2 (between 73 and 94%, depending on prior 
treatment). This region includes cells with the greatest levels of red and green 
fluorescence of all the regions. Region 3, which has similar green fluorescence to 
region 2 but reduced red fluorescence, contained the majority of the remainder of 
cells (between 4 and 21%). Finally, region 4, the region with lowest red and 
green fluorescence, contained very few cells (between 0.3 and 3.9%). For regions 
2 and 3, data failed tests for normality and equal variances, so the non-parametric 
Kruskal-Wallis ANOVA on ranks was carried out instead of parametric tests. 
This test showed no significant difference in cell counts between different 
feeding treatments in either of these regions (region 2: P = 0.099; region 3: P = 
0.100). Two-way ANOVA (parametric) for cell counts in region 4 showed 
significant variation between treatments (P < 0.001) but no effect of light vs. 
dark (P = 0.342). Tukey’s post-tests indicated a significant increase in cells 
counted after feeding with 20 pM pDHA compared with all other treatment 
groups, from an average of -0.5%  to -3.9%  (P < 0.001 for all paired 
comparisons), but no significant differences between other treatments.
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Figure 7.4 Representative flow  cytometry scatter plots from a single experiment 
for cells fed  fo r  2 weeks with POS and/or pDHA, then maintained in the dark for  
1 hour and labelled with acridine orange. Region 1 (Rl) on the upper FSC/SSC 
plot was used to gate "events” fo r  counts and other plots. The lower FL1/FL3 
plots show gated events (i.e. those within R l only), and are labelled for regions 
2, 3 and 4 (R2, R3 and R4), which were used for further analysis and cell 
counting. FL1 = green fluorescence emission; FL3 = red fluorescence emission 
(arbitrary units).
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Figure 7.5 Representative flow  cytometry scatter plots from a single experiment 
for cells fed  fo r  2 weeks with POS and/or pDHA, then exposed to light 
(15 mW.cm'2) fo r  1 hour and labelled with acridine orange. Region 1 (Rl) on the 
FSC/SSC plot was used to gate “events ” fo r  counts and other plots. The lower 
FL1/FL3 plots show gated, and are labelled for regions 2, 3 and 4 (R2, R3 and 
R4), which were used fo r  further analysis and cell counting. FL1 = green 
fluorescence emission; FL3 = red fluorescence emission (arbitrary units).
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Figure 7.6 Counts o f  “events ” within each region as marked on the FL1 vs. FL3 
plots. Graphs correspond to counts within (A) region 2; (B) region 3; (C) region 
4. Bars = SEM; n = 3.
To further elucidate the differences between cells in the different regions of the 
fluorescence scatter plot described above, Figure 7.7 shows FSC/SSC plots to 
monitor cell size (forward scatter, FSC) and granularity (side scatter, SSC) of the 
cells in each region. All plots in Figure 7.7 were gated to include only those cells
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in region 1 (from the FSC/SSC plot, to remove the majority of non-cellular 
debris). These were then further gated to show only data points for cells within 
each region. The plots show that cells from regions 2 and 3 are distributed evenly 
throughout the total population o f cells, whereas cells from region 4 showed 
lower forward and side scatter, indicated smaller size and reduced granularity.
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Figure 7.7 Flow cytometry FSC/SSC plots o f  cells from each o f  the regions 
established in fluorescence scatter plots above. (A) Scatter plot o f  all cells which 
were used fo r  further analysis and counting, (B) cells contained within region 1 
(in FSC/SSC plot) and region 2 (from fluorescence plots); (C) cells from region 1 
and region 3; (D) cells from  region 1 and region 4.
7.3.3 Lysosom al enzyme activity
Cell lysates were initially exposed to pDHA in the presence of intense light 
(48 mW .cm'2) for 1 hour, but it was found that in controls (i.e. no pDHA), 
phosphatase activity was reduced by -40%  and glucosaminidase by -45%
1 5 0
7. Effects ofpDHA on RPE degradative functions
(Figure 7.8) compared with dark-maintained. Within each treatment — i.e. light or 
dark — there was no further significant effect of pDHA on activity of either 
enzyme compared with control.
120 -i
£  1004 
I  s o :
CO
|  60 <
40 -©
>5 20  -
0.0 0.5 1.0 1.5 2.0
B
■>
o
CO
©
E>»
N
C©
120 -i 
100 
80 
60
40 +  
20 
0
0.0
[pDHA] mM
—i— 
1.0
dark
light
dark
light
2.00.5  1.5
[pDHA] mM
Figure 7.8 Assays o f  enzyme activity in cell lysates, after 1 hour exposure to 
48 mW.cm'2 light, normalized to activity in the dark control (A) Phosphatase 
activity; (B) glucosaminidase activity. Bars = SEM; n = 3.
To overcome the large reduction in enzyme activity observed in light-treated cell 
lysates compared with dark-maintained, the light intensity was reduced for 
subsequent experiments and lysates were exposed for a longer period of time: 
2.8 mW.cm'2 for 24 hours. In these experiments, there was no significant
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difference between dark and light controls (Figure 7.9). Phosphatase activity in 
cell lysates was not significantly affected by DHA compared with controls 
(ANOVA P = 0.680), but there was a difference in light treated vs. dark 
maintained (ANOVA P  < 0.001) in the presence of pDHA -  at 1 mM pDHA, 
activity decreased significantly from 121% (dark) to 69% (light; P = 0.002) and 
on exposure to 2 mM pDHA, from 117% to 59% (P = 0.001). There was no 
significant difference in phosphatase activity of pure acid phosphatase enzyme in 
light vs. dark (P = 0.248) or due to the presence of pDHA (P = 0.086). 
Glucosaminidase activity of cell lysates was not affected by light vs. dark (P = 
0.994), however pDHA did significantly affect activity (P = 0.017), with 2 mM 
causing a significant increase in activity in dark conditions, from 100% in control 
to 205% in the presence of 2 mM pDHA (P = 0.024).
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Figure 7.9 Assays o f  enzyme activity after exposure to pDHA with 2.8 mW.cm2 
light, or dark, fo r  24 hours, normalized to activity in the dark control (A) 
Phosphatase activity in cell lysates; (B) phosphatase activity o f  pure acid 
phosphatase; (C) glucosaminidase activity in cell lysates. Bars = SEM; n = 3-4.
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7.3.4 Intracellular deposit formation
7.3.4.1 Monitoring changes in fluorescence by flow cytometry
Feeding cells with POS with or without pDHA liposomes caused significant 
variation in cellular fluorescence at all of the time points investigated i.e. 1, 2, 3 
and 4 weeks (P < 0.001 for all; Figures 7.10 and 7.11). In all cases, feeding cells 
with POS significantly increased fluorescence in comparison with control 
approximately 6-fold (P-values are shown in Appendix 4), with no further 
increase caused by addition o f 5 pM pDHA to the liposomes. At 1, 2 and 3 
weeks however, a further significant increase in fluorescence -  approximately 
10-fold (compared with control) after 1 and 2 weeks, and 18-fold after 3 weeks 
of feeding -  was observed after addition of 20 pM pDHA to the POS. This 
concentration could not be used for the 4 week feeding trial as it resulted in cell 
detachment, indicating cell death. Instead, 10 pM pDHA was used at this time 
point only, but this resulted in no significant increase in fluorescence above that 
observed after feeding POS alone. Feeding cells with 20 pM pDHA alone (no 
POS) for 2 weeks resulted in a significant ~5-fold increase in fluorescence 
compared with control (P = 0.033), but this fluorescence still remained 
significantly lower (approximately 50%) than POS + 20 pM pDHA (P = 0.007). 
Feeding cells for 4 weeks with either 5 or 10 pM pDHA (without POS) resulted 
in no significant change in fluorescence emission compared with control cells (P 
= 0.928 and 0.102 respectively).
It should also be noted that the peak width (indicating variation within the 
samples) varied with treatment. Of note, the cells fed POS, POS + 5 pM pDHA 
or POS + 10 pM pDHA showed a broader peak than control cells. In contrast, 
those fed POS + 20 pM pDHA, or pDHA alone (all concentrations) showed a 
narrower peak, similar to the control cells.
Further comparisons were also carried out between the different time points after 
feeding cells with control medium, POS, POS + 5 pM pDHA and POS + 20 pM 
pDHA (see Figure 7.12) for 1 to 4 weeks. Two-way ANOVA confirmed 
significant effects of both duration of feeding and the actual treatments cells were
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exposed to (P  <  0.001 for both). Feeding for 4 weeks did not give any significant 
change in fluorescence compared with the other time points, however there was 
variation between 1 week and 2 weeks (P = 0.004) and 1 week and 3 weeks of 
feeding (P  <  0.001). The main difference between all of these time points 
compared with 4 weeks, is that they included cells which were fed with POS + 
20 pM pDHA, which the 4 week time point did not. Overall, all treatments 
differed significantly from each other (all P < 0.001) except for POS vs. POS + 
5 pM pDHA which showed no significant difference (P  = 0.861), correlating 
with the findings at each individual time point described above.
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Figure 7.10 Representative flow cytometry data from individual wells in a single 
experiment showing histograms fo r  green fluorescence emission in cells fed  with 
POS and/or pDHA, for between 1 and 4 weeks. A total o f 10,000 cells was 
counted for each condition and time point. FL-1H indicates green fluorescence 
intensity (arbitrary units).
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Figure 7.12 Changes in fluorescence after feeding cells with POS +/- pDHA, for  
between 1 and 4 weeks. Bars = SEM; n = 3-4.
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7.3.4.2 Monitoring of granule formation using TEM
TEM images of cells fed for two or four weeks with medium alone (control), 
bovine POS or POS + pDHA liposomes (20 pM pDHA for two weeks, and 
10 pM for 4 weeks, corresponding to the highest concentrations used in flow 
cytometry fluorescence measurements), are shown in Figure 7.13. Graphs in 
Figure 7.14 show the average number o f granules counted per ARPE-19 cell 
cross-section. Counts were divided into two types of granules: “granular” -  
possibly early stage phagolysosomes -  and “homogeneous” -  lipofuscin-like 
granules. Although the number o f granules per cell appears to double in control 
cells after 4 weeks of feeding compared with 2 weeks, this difference was not 
significant. There were, however, overall differences in total granules, 
homogeneous granules and granular granules over all treatments (one-way 
ANOVA P-values: <0.001, <0.001 and 0.034 respectively). Post-tests revealed 
significant increase in total and homogeneous granule numbers in cells fed for 2 
weeks with POS + DHA compared with control (total granules increased from 20 
to 35 granules; P  = 0.001; homogeneous increased from 2.2 to 11.5, P  = 0.01). A 
significant increase in homogeneous granules was also observed after 4 weeks of 
feeding with POS + DHA compared with control (increased from 2.7 to 12.5, P = 
0.006). No further statistically significant changes were observed.
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Figure 7.13 TEM images o f  cells fe d  with POS +/- pDHA liposomes for (A) 2 
weeks or (B) 4 weeks. Green arrows = examples o f  “granular ” granules; red 
arrows = “homogeneous ” granules; scale bars = 2 pm.
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Figure 7.14 Average number o f  granular and homogeneous granules counted 
per cell after feeding cells with POS +/- pDHA liposomes for 2 or 4 weeks. Bars 
represent the mean o f  counts from  10 different cells. Bars = SEM for each 
granule type.
1A Discussion
The aim of this chapter was to determine the effects of pDHA on functionality of 
lysosomes, and their ability to fully degrade phagocytosed material.
MTT assays indicated that cell viability is reduced slightly in some situations of 
cells fed 20 pM pDHA. This suggests that caution should be taken in interpreting 
results with these concentrations, as it is possible that cells may have died and 
detached, thus potentially leading to underestimation of the observed effects if 
these cells are the “most” loaded with pDHA/POS. The MTT results justify the 
use of lower concentrations for the 4-week feeding programme, to reduce the risk 
of even further cell death.
Acridine orange labelled cells separated into three regions on fluorescence scatter 
plots obtained using flow cytometry (Figures 7.4 and 7.5). It is likely that these 
three regions correspond to 3 distinct populations of cells. Region 2 (with 
maximal green and red fluorescence compared with the other regions) should
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correspond to cells that have readily taken up acridine orange, and had acridine 
orange accumulate in lysosomes and due to having the highest red fluorescence, 
indicates this group has the highest number of lysosomes, or rather, the greater 
total volume of intact lysosomes. Clearly, and in agreement with the fluorescent 
microscope images, the majority o f cells in all feeding regimens contain 
functional, intact, lysosomes. Region 3, with equal green fluorescence to region 2 
but lower red fluorescence, corresponds to cells with reduced lysosomal acridine 
orange -  suggesting loss of lysosomal integrity or reduction in lysosomal volume 
compared with cells in region 2. Finally, region 4 corresponds to cells containing 
less acridine orange, in both cytoplasmic and lysosomal compartments. This 
suggests both reduced lysosomal volume, possibly due to membrane disruption, 
and also reduction in cytoplasmic volume, otherwise equivalent green 
fluorescence to that observed in regions 2 and 3 would be expected. This 
correlates with the reduced cell volume shown in Figure 7.7, and indicates these 
cells could be undergoing apoptotic cell shrinkage.
As only very small changes in acridine orange fluorescence were detected, 
another approach to these experiments would be to induce changes in green 
fluorescence, to take advantage of increased sensitivity of detection of this 
wavelength by the flow cytometer, to detect smaller changes. In the current 
protocol, because cells are loaded with acridine orange after any potential 
lysosomal damage has occurred, all cells should contain the same cytoplasmic 
concentration as it is taken up (and released) passively. Cells with intact 
lysosomes would contain more aggregated acridine orange, but this would not 
affect cytoplasmic levels if  cells are imaged or analysed by flow cytometry 
quickly, with minimal light exposure. As an alternative, cells could be prepared 
as for the current protocol and loaded with acridine orange, then if all cells were 
to be exposed to intense light, all those with intact lysosomes would undergo 
photosensitized loss of lysosomal membrane integrity due to the acridine orange 
(Brunk et a l , 1997), resulting in release of aggregated acridine orange, and an 
increase in cytoplasmic (green) fluorescence. Thus, those cells which had 
previously had greater numbers of intact lysosomes would now show greater 
green fluorescence compared with those that had fewer intact lysosomes. 
Obviously this would require strict control of light exposure between
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experiments, and prompt measurement of samples by flow cytometry after 
exposure to prevent leakage o f non-aggregated acridine orange from the cells.
As one of the important functions o f RPE cells is to phagocytose and digest spent 
POS, loss of lysosomal function would limit this process and this could result in 
build-up of material in RPE. Considering the nature of the phagocytosed 
material, this is likely to lead to build-up of phototoxic material, which could 
lead to production of reactive oxygen species, thus resulting in damage to various 
cellular components. Additionally, it is widely thought that lysosomal rupture 
can result in cell death via the apoptotic pathway, and that this may occur in 
response to oxidative stress. This process is thought to involve lysosomal iron, 
and to result in release o f lytic enzymes such as cathepsin D, normally involved 
in degradation of phagocytosed material, which can act upon other targets in the 
cytoplasm, such as mitochondria or pro-caspase enzymes. This can result in 
activation of the apoptotic pathway, or necrosis at higher levels of insult (Brunk 
et a l , 1995; Brunk et al., 1997; Antunes et a l ,  2001).
Light exposure of cells fed with either lipofuscin or in vitro peroxidized POS has 
previously been shown to cause loss of lysosomal integrity, measured using 
acridine orange (Wihlmark et a l ,  1997; Davies et a l, 2001). Considering the 
presence of pDHA in lipofuscin granules and peroxidized POS, and the ability of 
lysosomal leakage to cause cell death as described above, these previous results 
suggest that this pathway could play a role in pDHA-induced RPE cell death. 
Although the findings here show limited lysosomal disruption, further study is 
essential to confirm this. There are indications of differences in lysosomal 
integrity between dark and light treated cells but due to the limited data, no 
significant differences can be confirmed.
Phosphatase and glucosaminidase activities of RPE cell extracts were shown here 
to be significantly altered in the presence of pDHA. Light caused a significant 
reduction in phosphatase activity in the presence of pDHA, in agreement with 
published data showing that lipofuscin causes a reduction in lysosomal enzyme 
activity (Wassell et a l ,  1999; Shamsi and Boulton, 2001). In contrast, 
glucosaminidase activity was increased in the presence of pDHA, with no effect
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of light. In this thesis, only two types of enzymatic activity were investigated -  
phosphatase and glucosaminidase. Obviously there is a great deal of scope for 
expanding these experiments to include other enzymes -  in particular cathepsin 
D, a major proteolytic enzyme which has been shown to play an important role in 
degradation of phagocytosed POS (Rakoczy et al., 1997).
Feeding cells with pDHA was shown to cause an increase in cellular 
fluorescence and presence of intracellular lipofuscin-like granules. Increases in 
cellular fluorescence do not necessarily indicate accumulation of undegraded 
material, as it is possible for lipids from liposomes to incorporate directly into the 
cell membrane, rather than entering the cells via phagocytosis. It is therefore 
essential to complement fluorescence data with TEM images. Results for feeding 
for 2 weeks correlate strongly -  with POS increasing both fluorescence and 
granule numbers, and addition of 20 pM pDHA causing a further increase in 
both. At 4 weeks, the higher 20 pM pDHA concentration could not be used, so 
direct comparisons between the two time points are not possible. However, 
fluorescence and TEM data do correlate at the longer time point, showing an 
increase in fluorescence and granule formation in the presence of POS, but no 
further increase caused by the addition of 10 pM pDHA. These observations 
could be explained by the findings, described above, that pDHA was able to alter 
lysosomal integrity and enzyme function. It should also be considered that lipid 
peroxidation may result in an increase in rates of phagocytosis (Finnemann and 
Silverstein, 2001; Sun et al., 2006), thereby potentially overwhelming 
degradative capacity o f the cell, and potentially also leading to an increase in 
undegraded material.
In summary, this chapter has shown that pDHA is able to alter the degradative 
capacity of RPE cells, by causing changes in lysosomal enzyme activity and loss 
of lysosomal integrity. These changes could cause RPE cell dysfunction directly 
-  by inducing apoptosis after lysosomal leakage -  or indirectly by causing 
accumulation of phototoxic material within cells.
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8. Discussion and conclusions
8.1 General discussion
The overall aim of this thesis was to determine whether pDHA is (photo-)toxic to 
RPE cells, and thus, through this or other pathways, it may play a role in the 
pathogenesis of AMD. Results shown here have demonstrated that pDHA is highly 
toxic to RPE cells in vitro, and can lead to lysosomal dysfunction and formation of 
fluorescent and undegraded material within RPE cells. The physiological relevance of 
these in vitro findings is discussed below.
The in vitro peroxidation of DHA occurred readily by autoxidation. The rate of 
peroxidation was greater when lipids were prepared as liposomes compared with a dry 
film. Thus, the hydration state appears to play an important role in peroxidation. POS 
disc membranes where DHA would be found in the retina are surrounded by aqueous 
cytoplasm, thus making the peroxidation o f DHA in the form of liposomes more 
physiologically relevant than DHA peroxidized as a lipid film.
Other sources of pDHA within the retina, such as lipofuscin and lipid deposits in 
Bruch’s membrane, are in fact lipophilic granules that only have contact with water at 
their surface. Thus, DHA within these deposits would have limited access to water. 
The rate of peroxidation could therefore be different to membrane lipids, and would 
be more similar to that o f the lipid film studied. However, the starting concentrations 
of pDHA within these granules are likely to be higher than in POS, as unperoxidized 
DHA would be recycled to POS rather than accumulating in lipofuscin etc. Also, the 
known ability of DHA peroxides to induce photosensitized production of reactive 
oxygen species, as shown in this thesis, and the exclusion of water-soluble 
antioxidants, would further enhance the process of autoxidation in these deposits.
The easily peroxidizable nature o f DHA combined with continual light exposure and 
the presence of photosensitizers in POS (e.g. ATR and A2E (Pawlak et al., 2003)) 
suggest that levels of pDHA would increase with age of photoreceptor discs, with the 
oldest and most peroxidized discs/lipids found at the distal end of POS. This is 
consistent with findings that lipid peroxidation may provide signals for increased 
phagocytosis (Finnemann and Silverstein, 2001; Sun et a l , 2006), and thus the theory 
that phagocytosis is a necessary process, acting as a surrogate antioxidant -  by
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physically removing peroxidized POS tips (Winkler, 2008). Findings in this thesis 
confirm the need to remove or detoxify these peroxidized lipids, as extracellular 
pDHA is clearly able to directly induce (photo-)toxicity in RPE cells. The protective 
effects of antioxidants are important here, as these could firstly prevent or reduce the 
peroxidation of pDHA, and may also subsequently reduce toxicity, as occurred in 
experiments carried out in this thesis.
The presence of pDHA in extracellular Bruch’s membrane deposits in vivo provides 
another pathway o f direct cytotoxicity o f extracellular pDHA. The action of 
antioxidants within these granules could be limited, as their lipophilic interior would 
prevent penetration of water-soluble antioxidants. As discussed in Chapters 1 and 5, a 
combination of antioxidants is often required to provide protection from oxidative 
stress (Bohm et al., 1998; AREDS Research Group, 2001; Wrona et a l , 2003; 
Moeller et a l , 2006) -  with lipophilic antioxidants potentially providing initial 
deactivation of lipid radicals or other species, and resultant antioxidant radicals in turn 
being mopped up by water soluble antioxidants which may then be removed via the 
circulation. In these lipophilic deposits it is therefore possible for semioxidized 
antioxidants to accumulate and act in a pro-oxidant manner, as described in Chapter 5. 
Water soluble antioxidants could, however, act on any reactive oxygen species 
released from the granules, either into the extracellular space or into nearby cells, 
where greater levels of enzymatic antioxidants would also be present compared with 
outside the cell (Halliwell and Gutteridge, 2007c).
Reductions in the levels of diet-derived antioxidants occur with age, possibly due to 
decreased ingestion and/or absorption (Newsome et a l , 1994). This could explain the 
increased levels in both lipid peroxidation products and other downstream products 
such as lipofuscin and Bruch’s membrane deposits. Reduced antioxidant activity 
could lead to increased severity o f lipid peroxidation, and lack of detoxification of 
reactive oxygen species produced by the various sources of pDHA, thus exacerbating 
not only the direct effects of pDHA, but also the pathway of formation of lipofuscin 
and sub-RPE deposits, resulting in an ever worsening cycle of peroxidation and 
subsequent damage.
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Experimental findings of the protective effects of PE have proven to be interesting. 
PE showed protection against pDHA-induced toxicity in cell experiments, yet showed 
no decrease in yields o f superoxide or singlet oxygen production by pDHA. The 
presence of PE did, however, decrease the lifetime of singlet oxygen, suggesting a 
quenching role. As the expected lifetime o f singlet oxygen is considerably shorter in 
lipid-only environments and in membranes compared with benzene, this further 
reduction by PE could have implications for the ability of singlet oxygen produced by 
pDHA to interact with other molecules, thus potentially affecting its toxicity.
Toxicity of pDHA was observed not only upon light exposure, but also to a lesser 
extent in dark conditions. As singlet oxygen is caused by photo-activation of pDHA, 
toxicity in the dark suggests that other mechanisms must also be involved. Production 
of superoxide apparently does not contribute significantly, as PE is able to protect 
cells and maintain viability at control levels, whereas it had no effects on superoxide 
production by pDHA liposomes. In vivo, it is possible that RPE cells could be 
protected from pDHA-induced superoxide production by extracellular SOD -  the 
main, and possibly only, extracellular antioxidant enzyme (Halliwell and Gutteridge, 
2007c). It is unlikely this enzyme would play a role in vitro, however, as pDHA 
exposures were short (1 hour) and medium was changed immediately before the 
exposure. Therefore, as discussed in Chapters 5 and 6, the role of PE in protecting 
cells may be via the ability o f PE to form adducts with lipid peroxides, particularly 
lipid aldehydes. The change in absorption spectrum of pDHA + POPE compared with 
pDHA + POPC does suggest the formation of such adducts. However, further 
biochemical studies would need to be carried out to confirm this.
Although not studied here, the formation o f PE-pDHA adducts could also have 
implications on lysosomal function. Lysosomal enzyme function was altered by 
pDHA in this study, but the exact mechanisms were not investigated. As it is known 
that lipid peroxidation products can interact with proteins, including enzymes such as 
lysosomal degradative enzymes, it could be speculated that increased levels of PE 
could inhibit this effect, and possibly preserve lysosomal enzyme activity.
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Although superoxide does not appear to have a major impact on extracellular pDHA 
toxicity, it could play a role in the ability of pDHA to disrupt lysosomal function. 
pDHA which is internalized in the process of POS phagocytosis could produce 
superoxide, as demonstrated in Chapter 6. Because of the low pH in lysosomes, it is 
likely that superoxide would become protonated to form the considerably more 
reactive hydroperoxyl radical (HO2 ’). This radical, along with singlet oxygen, could 
react with unsaturated lipids of the lysosomal membrane to cause lysosomal rupture. 
HO2* can also travel through the membrane more easily than superoxide, potentially 
leading to more widespread damage (Halliwell and Gutteridge, 2007a). Both 
lysosomal rupture, and release of HO2* without rupture, could lead to cell dysfunction.
Lipofuscin has previously been shown to be phototoxic to RPE cells (Wassell et al., 
1999; Davies et al., 2001) and to photosensitize the production of superoxide and 
singlet oxygen (Boulton et al., 1993; Rozanowska et al., 1995; Rozanowska et al.,
1998). Additionally, lipofuscin can photo-induce lipid peroxidation (Wassell et al.,
1999). However, the actual identity o f the photosensitizing agent(s) within lipofuscin 
is not yet known. pDHA has been shown in this work to be capable of all of these 
actions -  production of singlet oxygen and superoxide have been demonstrated here 
(Chapter 6), and both of these could contribute to lipid peroxidation. Additionally, 
pDHA shows stronger absorption at shorter visible wavelengths, consistent with the 
wavelength dependence of lipofuscin actions (Rozanowska et al., 1995; Rozanowska 
et al., 1998). Thus, due to the known presence of pDHA in lipofuscin granules (Gu et 
al., 2003a; Ng et al., 2008), it may be postulated that pDHA is in fact responsible for 
the phototoxicity of lipofuscin. In addition to direct toxicity, pDHA may play a role in 
photo-activation of A2E. It has been suggested that this component of lipofuscin can 
not act solely as the main contributor of lipofuscin phototoxicity, but may require 
transfer of energy from a blue-absorbing chromophores (Haralampus-Grynaviski et 
al., 2003). Again, it could be proposed that pDHA could carry out this function, thus 
playing a second role in inducing toxicity of lipofuscin.
The effects of pDHA on cultured cells were studied extensively in this project. A 
summary is shown in Figure 8.1, extrapolated to the context of the intact retina to 
demonstrate the potential implications of the in vitro findings in this thesis on the RPE 
and photoreceptors in vivo. This extrapolation is based on the known presence of
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pDHA in POS, lipofuscin in RPE cells, and in Bruch’s membrane deposits (Crabb et 
al., 2002; Gu et al., 2003a; Ng et al., 2008), and the known photosensitizing abilities 
of lipofuscin (Boulton et al., 1993; Rozanowska et al., 1995; Rozanowska et al., 
1998).
This figure shows: (A) increased peroxidation of DHA in aged discs of the POS, 
resulting in extracellular phototoxic insult to RPE cells. (B) Phagocytosis of distal 
POS tips (B) leads to further peroxidation of DHA in phagolysosomes and 
photosensitized production o f reactive oxygen species, leading to direct effects on 
lysosomal enzyme activity, loss of lysosomal integrity, and increased accumulation of 
lipofuscin. (C) The presence o f pDHA in lipofuscin, drusen and Bruch’s membrane 
deposits leads to intra- and extracellular phototoxic insults on RPE cells. (D) Overall, 
the combined effects o f pDHA result in RPE dysfunction, with subsequent POS 
dysfunction and impairment o f the visual transduction cascade. Contributing factors to 
these effects are the presence of high levels of light and oxygen. Antioxidants are 
expected to be able to play a protective role against pDHA toxic insult.
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Figure 8.1 Summary o f  the findings o f  this thesis, extrapolated to the context o f the 
intact retina. (A)DHA peroxidation and phototoxicity in POS; (B) DHA peroxidation 
and phototoxicity in phagolysosomes; (C) DHA as a photosensitizing constituent o f  
lipofuscin, drusen and Bruch's membrane deposits; (D) final outcome o f RPE 
dysfunction as a result o f  the multiple sources and pathways ofpDHA toxicity.
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8.2 Conclusions
• pDHA readily peroxidizes in vitro, resulting in formation of products which are 
able to absorb light at visible wavelengths
• Exposure of ARPE-19 cells to pDHA induces reduction in mitochondrial activity 
and subsequent cell death via the apoptosis pathway
• Light exposure aggravates pDHA-induced toxicity
• Phosphatidylethanolamine, glutathione, N-acetylcysteine, and a-tocopherol are all 
able to protect cells, at least partially, from pDHA-induced cytotoxicity
• pDHA photosensitizes the production of singlet oxygen and superoxide. Yields of 
these reactive oxygen species are not, however, reduced by PE
• pDHA is able to reduce the functionality of lysosomal degradation pathways in 
RPE cells, specifically by altering lysosomal enzyme activity and causing loss of 
lysosomal integrity
• Long-term feeding of cells with POS + pDHA results in an increase of cellular 
fluorescence and accumulation o f undegraded material
Overall, this thesis provides evidence that extracellular pDHA can be directly 
phototoxic to cells, resulting in apoptotic cell death. This finding is highly significant 
considering the levels of DHA in close proximity to the RPE, and regular exposure of 
the retina to light. Additionally, pDHA may be internalized in conjunction with POS 
phagocytosis, and result in dysfunction of lysosomal degradation pathways, leading to 
accumulation of undegraded fluorescent -  potentially phototoxic -  material.
Overall, pDHA clearly has the ability to cause RPE cell dysfunction. In vivo, this 
could result in a loss of the support role normally provided by the RPE for 
photoreceptors, potentially resulting in dysfunction or death of these cells too, and 
eventual disruption to the visual pathway. The similarities between the observed 
effects of pDHA and published work on lipofuscin suggest that pDHA plays a 
prominent role in age-related changes in the retina, and the pathogenesis of AMD.
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8.3 Future work
Precise identification of the products formed during DHA peroxidation could lead to 
identification of a marker of oxidative damage in the retina. This could potentially be 
detected in vivo using non-invasive Raman or fluorescence techniques, and could 
provide a target for future therapeutic intervention. It would be of interest to identify 
products which separate into the polar and non-polar phases during lipid extraction, 
and to investigate the phototoxicity o f the lipids in these two phases separately.
As discussed in Chapters 1 and 5, lipid aldehydes have previously been shown to 
interact with proteins. Samples could be extracted from long-term feeding 
experiments and analysed for formation o f such adducts, to further understand the 
mechanisms by which pDHA affects POS degradation.
Many components o f Chapter 7 warrant further investigation. Longer feeding 
durations could make results more relevant to in vivo accumulation of undegraded 
material. Further studies of acridine orange labelling and lysosomal integrity could be 
carried out, including investigating whether light exposure of fed cells can lead to 
delayed apoptosis, possibly as a result o f lysosomal rupture. Many other lysosomal 
enzymes, particularly cathepsin D, could be investigated for inhibition by pDHA.
The use of freshly isolated primary RPE cells is important to show the relevance of 
the findings in ARPE-19 cells, and also to investigate whether cells of different ages 
have adapted to a certain extent to greater levels of oxidative stress due to the 
presence of pDHA/lipofuscin etc.
Broader experiments could also be carried out using animal models -  mimicking the 
experiments of subretinal linoleic acid injection (Tamai et al., 2002), but using 
pDHA, to investigate whether the wider context of the retina alters the effect of 
pDHA observed in vitro. Alternatively, formation of pDHA in retinas subjected to 
oxidative stress in vivo could be monitored. Using an intact animal would also allow 
investigations of broader responses to pDHA such as that of the immune system, and 
also whether pDHA deposits could play a role in inducing neovascularization.
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Appendix 1 -  Statistical results for Chapter 4
All P-values marked with grey are considered to be “not significant” (i.e. > 0.05).
R ose bengal concentration
Post-incubation 0.05|jM 0.1|jM 0.2|jM 0.5|jM 1 |jM
Oh. dk 0.9352 0.808 0.8095 0.7186 0.8895
Oh, It 0.054 0.0234 0.0037 0.0025 0.0002
1h. It 0.1077 0.0562 0.0037 0.0009 0.0004
2h, It 0.3086 0.0118 0.0043 0.0002 0.0007
4h, It 0.0214 0.0001 0.0002 <0.0001 <0.0001
24h, It 0.2948 0.3532 0.0199 0.0133 0.0126
Table A l.l P-values fo r  one-sample t-tests to compare mitochondrial activity results 
o f treated cells with control 100% value (corresponding to data in Figure 4.5A).
9mW.cm'2 Ohs P  = 0.001
DHA It pDHAdk pDHA It
DHA dk 0.581 0.017 0.001
DHA It 0.178 0.011
pDHAdk 0.224
9mW.cm'2 24hs P < 0.001
DHA It pDHAdk pDHA It
DHA dk 0.706 <0.001 <0.001
DHA It <0.001 <0.001
pDHAdk 0.264
15mW.cm‘2 Ohs P  <0.001
DHA It pDHAdk pDHA It
DHA dk 0.707 0.002 <0.001
DHA It 0.008 0.001
pDHAdk 0.683
15mW.cm‘2 24hs P < 0.001
DHA It pDHAdk pDHA It
DHA dk 0.360 0.002 0.001
DHA It 0.015 0.006
pDHAdk 0.996
Table A1.2 P-values fo r  one-way ANOVA (indicated above each table) and Tukey’s 
post-tests to compare the effects o f  2 mM  (p)DHA on mitochondrial activity at either 9 
or 15 mW.cm2 light (corresponding to data in Figure 4.7). dk = dark; It = light.
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Ohs 24 hs
9mW.cm"2 dk 0.0404 0.6488
9mW .cm '2 It 0.0007 0.0176
15mW .cm'2 dk 0.0348 0.1802
15mW .crrf2 It 0.0355 0.1369
Table A l .3 P-values fo r  one-sample t-tests to compare mitochondrial activity o f  cells 
treated with 2 mM DHA (unperoxidized; either 9 or 15 mW.cm2 light intensity) with 
control 100% value (corresponding to data in Figure 4.7). dk = dark; It = light.
9 mW .cm'2 P < 0.001
Ohs It 24 hs dk 24 hs It
Ohs dk 0.592 <0.001 <0.001
Ohs It 0.01 <0.001
24 hs dk 0.323
15 mW.crrf2 P < 0.001
Ohs It 24 hs dk 24 hs It
Ohs dk 0.723 <0.001 <0.001
Ohs It <0.001 <0.001
24 hs dk 0.950
Table A  1.4 P-values fo r  one-way A N  OVA and Tukey’s post-tests to compare the 
effects o f 2 mM pDHA on mitochondrial activity when MTT assay was carried out at 
Ohs vs. 24 hspost-exposure, at either 9 or 15 mW.cm 2 light (corresponding to data in 
Figure 4.7). dk = dark; It = light.
9 mW.cm 2, 
dark
9 mW.crrr2, 
light
15 mW.cnr2, 
dark
15 mW.cm-2, 
light
EC50 1.36 1.06 0.94 0.26
SE 0.44 0.10 0.15 0.05
df 35 31 17 24
Table A1.5 Non-linear regression parameters obtained from sigmoidal curve-fit o f  
MTT assay data fo r  cells exposed to pDHA and assay carried out 24 hours after 
exposure (corresponding to data in Figure 4.8). SE = standard error; df=  degrees o f  
freedom. These values were used to calculate the student t ratio and P-value.
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Equation A l.l  Equation used to calculated the t-ratio, subsequently used to calculate 
the P-value using the student t-test distribution, using Microsoft Excel, fo r  
comparison o f  EC50 values (corresponding to data in Figure 4.8).
0.5 mM 1 mM 2 mM
0 mM >0.05 <0.001 <0.05
0.5 mM <0.05 >0.05
1 mM >0.05
Table A1.6 P-values fo r  one-way Tukey’s post-tests (following one-way AN OVA, P = 
0.0004) to compare the effects o f  pDHA on nuclear condensation (corresponding to 
data in Figure 4.12A).
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Appendix 2 -  Statistical results for Chapter 5
All P-values marked with grey are considered to be “not significant” (i.e. > 0.05).
T reatm ent ANOVA P -v alu e
Zeaxanthin, light <0.0001
Zeaxanthin, dark <0.0001
a-Tocopherol, light 0.0002
a-Tocopherol, dark 0.0003
Table A2.1 One-way AN  OVA P-values to compare mitochondrial activity in light or 
dark maintained cells with pDHA, supplemented with either zeaxanthin or a- 
tocopherol (corresponding to data in Figure 5.2A (zeaxanthin) and 5.2B (a- 
tocopherol)).
LIGHT pDHA pDHA+ZX1 pDHA+ZX2 pDHA+ZX4
Control <0.001 <0.001 <0.001 <0.001
pDHA >0.05 >0.05 <0.05
pDHA+ZX1 >0.05 >0.05
pDHA+ZX2 >0.05
DARK pDHA pDHA+ZX1 pDHA+ZX2 pDHA+ZX4
Control <0.01 <0.001 <0.001 <0.001
pDHA >0.05 >0.05 <0.05
pDHA+ZX1 >0.05 >0.05
PDHA+ZX2 >0.05
LIGHT pDHA pDHA+AT10 pDHA+AT20 pDHA+AT40
Control <0.001 <0.05 >0.05 >0.05
pDHA >0.05 <0.01 <0.001
pDHA+AT10 >0.05 <0.05
pDHA+AT20 >0.05
DARK pDHA pDHA+AT10 pDHA+AT20 pDHA+AT 40
Control <0.001 <0.05 >0.05 >0.05
pDHA >0.05 <0.01 <0.01
pDHA+AT10 >0.05 >0.05
pDHA+AT20 >0.05
Table A2.2 P-values fo r  Tukey-Kramer post-tests, corresponding to one-way AN OVA 
tests in Table A2.1, to compare mitochondrial activity in light or dark maintained 
cells exposed to pDHA, supplemented with either zeaxanthin or a-tocopherol 
(corresponding to data in Figure 5.2A (zeaxanthin) and 5.2B (a-tocopherol)). ZX = 
zeaxanthin; A T  = a-tocopherol; numbers indicate antioxidant concentration (juM).
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Table A2.3 P-values for Tukey-Kramer post-tests, 
(one-way ANOVA P-value <0.0001) to compare 
mitochondrial activity in light or dark maintained 
cells exposed to pDHA, supplemented with 
zeaxanthin and/or a-tocopherol (corresponding to 
data in Figure 5.3. ZX = zeaxanthin; AT  = a- 
tocopherol; numbers indicate antioxidant 
concentration (pM); dk = dark-maintained (all 
others are light-exposed).
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POPC dk POPE dk control It POPC It POPE It
control dk <0.001 >0.05 >0.05 <0.001 >0.05
POPC dk <0.01 <0.001 <0.01 >0.05
POPE dk >0.05 <0.001 >0.05
control It <0.001 >0.05
POPC It <0.001
Table A2.3 P-values fo r  one-way Tukey Kramer post-tests (following one-way 
ANOVA, P < 0.0001) to compare the effects o f  pDHA + POPE or pDHA + POPC (as 
indicated) on mitochondrial activity (corresponding to data in Figure 5.5). dk = dark; 
It = light; POPC = cells exposed to pDHA + POPC liposomes; POPE = cells 
exposed to pDHA + POPE liposomes.
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Table A2.4 P-values for Tukey-Kramer post-tests, (one­
way ANOVA P-value <0.0001) to compare mitochondrial 
activity in light or dark maintained cells exposed to 
pDHA, supplemented with GST, GSH and/or NAC 
(corresponding to data in Figure 5.6). ZX  = zeaxanthin; 
A T  = a-tocopherol; numbers indicate antioxidant 
concentration (pM); dk = dark-maintained (all others are 
light-exposed).
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Appendix 3 -  Statistical results for Chapter 6
All P-values marked with grey are considered to be “not significant” (i.e. > 0.05).
liposomes: k A .
pDHA + POPC 0.614 0.198
pDHA+ POPE 0.543 0.004
Table A3.1 P-values fo r  one-way ANOVA to investigate differences in A«, and k 
values for pDHA + POPC and pDHA  + POPE groups (corresponding to Figure 6.9).
pDHA, light vs: P -v a lu e
pDHA + catalase, light >0.05
pDHA, dark <0.01
Table A3.2 P-values fo r  one-way ANOVA Dunnett’s post-test to investigate 
difference in Ax values between pDHA + POPE samples (corresponding to Figure 
6.9B).
pDHA, light vs: P -v alu e
pDHA + cata lase, light >0.05
pDHA + SOD, light <0.01
pDHA, dark <0.01
no pDHA, light <0.01
Table A3.3 P-values fo r  one-way ANOVA Dunnett’s post-test (comparison with 
control i.e. pDHA, light) to investigate differences in reduced cytochrome C levels at t 
= 60 minutes within pDHA + POPC group (corresponding to Figure 6.10). Initial 
ANOVA value: P < 0.0001.
pDHA, light vs: P -v a lu e
pDHA + cata lase, light >0.05
pDHA+ SOD, light <0.01
pDHA, dark <0.01
no pDHA, light <0.01
Table A3.4 P-values fo r  one-way ANOVA Dunnett’s post-test to investigate 
differences in reduced cytochrome C levels at t = 60 minutes within pDHA + POPE 
group (corresponding to Figure 6.10). Initial ANOVA value: P < 0.0001.
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Appendix 4 — Statistical results for Chapter 7
All P-values marked with grey are considered to be “not significant” (i.e. > 0.05).
2 WEEKS POS POS + 5 pM pDHA POS + 10 pM pDHA POS +20 pM pDHA
Cont 0 .145 0 .3 6 6 <0.001 0.001
POS 1 0.002 <0.001
POS + 5 mM pDHA 0.006 <0.001
POS + 10 pM pDHA <0.001
3 WEEKS POS POS + 5 pM pDHA POS + 10 pM pDHA POS +20 pM pDHA
Cont 0.004 <0.001 <0.001 <0.001
POS 0.439 0.008 <0.001
POS + 5 pM pDHA 0.303 <0.001
POS + 10 pM pDHA <0.001
Table A4.1 P-values fo r  two-way ANOVA to investigate the effects on mitochondrial
activity o f  feeding cells with POS +/- pDHA for 2 or 3 weeks (corresponding to 
Figure 7.1). Initial ANOVA P-values were: P = 0.314 for comparison o f  2 weeks vs. 3 
weeks, and P < 0.001 fo r  comparison o f  the feeding treatments.
DARK PO S PO S + pDHA pDHA
control 0.974 0.178 0.453
POS 0.339 0.253
POS + pDHA 0.01
LIGHT PO S PO S + pDHA pDHA
control 0.567 0.105 0.023
POS 0.667 0.002
POS + pDHA <0.001
Table A4.2 P-values fo r  two-way ANOVA to investigate the effects on mitochondrial 
activity o f  feeding cells with POS +/- pDHA fo r  2 weeks, followed by exposure to light 
or maintenance in the dark (corresponding to Figure 7.2). Initial ANOVA P-values 
were: P = 0.674 fo r  comparison o f  light vs. dark, and P < 0.001 for comparison o f  
the feeding treatments.
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POS POS + 10 pM pDHA POS + 20 pMpDHA 10 pM pDHA 20 pM pDHA
control 0.964 0.981 1.000 0.977 <0.001
POS 1.000 0.993 1.000 <0.001
POS + 10 pMpDHA 0.997 1.000 <0.001
POS +20pMpDHA 0.997 <0.001
10 pM pDHA <0.001
Table A4.3 P-values fo r  two-way ANOVA to investigate the effects on cell numbers in 
region 4 o f  FL1/FL3 scatter plots o f  feeding cells with POS +/- pDHA for 2 weeks, 
followed by exposure to light or maintenance in the dark and loading with acridine 
orange (corresponding to Figure 7.6C). Initial ANOVA P-values were: P = 0.674 for  
comparison o f  light vs. dark, and P < 0.001 fo r  comparison o f  the feeding treatments.
Phosphatase Glucosaminidase
Dark 0.148 0.706
Light 0.825 0.955
Table A4.4 P-values fo r  one-way ANOVA to investigate effects o f  pDHA on enzyme 
activities in cell lysates (corresponding to Figure 7.8)
c o m  p a r i s o n p h o s p h a t a s e
( l y s a t e )
p h o s p h a t a s e
( e n z y m e )
g l u c o s a m i n i d a s e
l ig h t  v s .  d a r k < 0 .0 0 1 0.248 0.994
c o n c e n t r a t i o n 0.680 0.086 0 . 0 1 7
B [ p D H A ] l ig h t  v s  d a r k
0  m M 0.552
1 m M 0 . 0 0 2
2  m M 0 .0 0 1
C c o m p a r i s o n d a r k  g r o u p l ig h t  g r o u p
~
0  v s .  1 m M 0.113 0.570
0  v s .  2  m M 0 . 0 2 4 0.270
1 v s .  2  m M
.
0.756 0.831
Table A4.5 (A) P-values fo r  two-way ANOVA to investigate effects o f  pDHA 
concentration and light vs. dark on enzyme activities in cell lysates or pure acid 
phosphatase enzyme (corresponding to Figure 7.9). Tukey’s post-tests were 
subsequently carried out only fo r  data sets with significant ANOVA P-values (i.e. P < 
0.05); (B) P-values fo r  Tukey’s post-tests fo r  phosphatase activity in cell lysates, 
comparing effects o f  light vs. dark at each pDHA concentration; (C) P-values for  
Tukey’s post-tests fo r  glucosaminidase activity in cell lysates, comparing effects o f  
different pDHA concentrations in both light and dark experiments.
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1 WEEK POS POS + 5 pM pDHA POS +20 pM pDHA
control <0.001 <0.001 <0.001
POS 0 .7 0 5 <0.001
POS +5 pM pDHA <0.001
2 WEEKS POS POS + 5 pM pDHA POS +20 pM pDHA 20 pM pDHA
control 0.045 0.005 <0.001 0.033
POS 0 .7 8 6 0.002 0 .9 9 4
POS +5 pM pDHA 0.013 0 .9 6 5
POS +20 pM pDHA 0.007
3 WEEKS POS POS + 5 pM pDHA POS +20 pM pDHA
control 0.042 0.017 <0.001
POS 0 .911 <0.001
POS +5 pM pDHA <0.001
4 WEEKS POS POS + 5 pM pDHA POS + 10 pM pDHA 5 pM pDHA 10 pM pDHA
control 0.001 0.002 0.003 0 .928 0 .1 0 2
POS 0 .9 9 6 0 .9 7 0 0.004 0.111
POS +5pM pDHA 1 .000 0.009 0 .2 3 0
POS + 10 pM pDHA 0.014 0 .3 4 0
5 pM pDHA 0 .4 0 3
Table A4.6 P-values fo r  one-way ANOVA Tukey's post-test, fo r  comparing effects o f
feeding cells with POS +/- pDHA on cellular fluorescence intensity, at 4 different 
durations o f  feeding (corresponding to Figure 7.11). Initial ANOVA P-values were < 
0.001 for all.
A
B
Table A4.7 P-values fo r  post-tests following two-way ANOVA to investigate the 
effects o f  duration o f  feeding and different feeding regimes on cellular fluorescence 
(corresponding to Figure 7.12. Initial ANOVA P-values were < 0.001 fo r  both o f  
these effects.
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2 weeks 3 w eeks 4 weeks
1 week 0.004 <0.001 0.170
2 weeks 0.309 0.708
3 weeks 0.074
POS POS + 5 pM pDHA POS + 20 pM pDHA
control <0.001 <0.001 <0.001
POS 0.861 <0.001
POS + 5 pM pDHA <0.001
Appendix 4
TOTAL COUNT 2wks POS 2wks POS+DHA 4wks control 4wks POS 4wks POS+DHA
2wks control 0 .3 9 3 0.001 0.541 0.002 0 .1 9 4
2wks POS 0 2 0 1 1 .000 0 .2 5 9 0 .9 9 8
2wks POS+DHA 0 .1 2 3 1 .000 0 .4 0 3
4wks control 0 .1 6 4 0 .9 8 6
4wks POS 0 .4 8 6
HOMOGENEOUS 2wks POS 2wks POS+DHA 4wks control 4wks POS 4wks POS+DHA
2wks control 0 .7 4 0 0.010 1 .000 0.042 0.003
2wks POS 0 .2 6 4 0 .8 4 2 0 .5 7 3 0 .1 2 5
2wks POS+DHA 0.017 0 .9 9 4 0 .9 9 9
4wks control 0 .068 0.006
4wks POS 0 .9 4 0
GRANULAR 2wks POS 2wks POS+DHA 4wks control 4wks POS 4wks POS+DHA
2wks control 0 .7 4 8 0 .0 7 9 0 .5 6 0 0 .062 0 .9 9 0
2wks POS 0 .7 2 7 1 .000 0 .662 0 .9 7 3
2wks POS+DHA 0 .8 8 0 1.000 0 .2 7 3
4wks control 0 .8 3 3 0 .8 9 4
4wks POS 0 .2 2 5
Table A4.8 Tukey’s post-test P-values fo r  comparison o f  total, homogeneous and 
granular granule numbers in cells fe d  fo r  either 2 weeks or 4 weeks with either 
control medium, POS, or POS + pDHA, corresponding to data shown in Figure 7.14. 
Initial one-way ANOVA P-values fo r  the groups were: < 0.001 (for both total 
granules and homogeneous granules) and 0.034 fo r  granular granules. Grey- 
coloured cells indicate non-significant P-values (i.e. P > 0.05).
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Appendix 5 -  Conference presentations of this work
L. Bakker, M. Boulton, M. Rozanowska: Phototoxicity o f  peroxidized 
docosahexaenoic acid in retinal pigment epithelial cells. 1st Meeting of the 
International Society for Ocular Cell Biology (ISOCB), September 2006, Cambridge, 
UK (poster).
L. Bakker, A. Pawlak, B. Rozanowski, M. Boulton, M. Rozanowska: Phototoxicity o f  
peroxidized docosahexaenoate. Society for Free Radical Biology and Medicine 13th 
Annual Meeting, November 2006, Denver, USA, (poster).
L. Bakker, M.E. Boulton, M. Rozanowska: Mechanisms o f  phototoxicity o f  
peroxidized docosahexaenoate and protection by antioxidants. Society for Free 
Radical Biology and Medicine 14th Annual Meeting, November 2007, Washington 
DC, USA, (poster).
M. Rozanowska, L. Bakker, M.E. Boulton, A. Pawlak, B. Rozanowski: Protective 
effects o f  phosphatidylethanolamine (PE) against (photo)toxicity to the retinal 
pigment epithelium (RPE) o f  peroxidized docosahexaenoate (DHE). 2nd Meeting of 
the International Society for Ocular Cell Biology (ISOCB), September 2008, San 
Diego, USA.
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